
<html lang="en"     class="pb-page"  data-request-id="fb36c59c-7d49-4833-a2ff-f010957f695b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-12;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm5001908;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1" /></meta><meta name="dc.Creator" content="Xue Zhi  Zhao" /></meta><meta name="dc.Creator" content="Steven J.  Smith" /></meta><meta name="dc.Creator" content="Mathieu  Métifiot" /></meta><meta name="dc.Creator" content="Christophe  Marchand" /></meta><meta name="dc.Creator" content="Paul L.  Boyer" /></meta><meta name="dc.Creator" content="Yves  Pommier" /></meta><meta name="dc.Creator" content="Stephen H.  Hughes" /></meta><meta name="dc.Creator" content="Terrence R.  Burke, Jr." /></meta><meta name="dc.Description" content="There are currently three HIV-1 integrase (IN) strand transfer inhibitors (INSTIs) approved by the FDA for the treatment of AIDS. However, the emergence of drug-resistant mutants emphasizes the nee..." /></meta><meta name="Description" content="There are currently three HIV-1 integrase (IN) strand transfer inhibitors (INSTIs) approved by the FDA for the treatment of AIDS. However, the emergence of drug-resistant mutants emphasizes the nee..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 16, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5001908" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5001908" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5001908" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5001908" /></link>
        
    
    

<title>4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5001908" /></meta><meta property="og:title" content="4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0009.jpeg" /></meta><meta property="og:description" content="There are currently three HIV-1 integrase (IN) strand transfer inhibitors (INSTIs) approved by the FDA for the treatment of AIDS. However, the emergence of drug-resistant mutants emphasizes the need to develop additional agents that have improved efficacies against the existent resistant mutants. As reported herein, we modified our recently disclosed 1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides IN inhibitors to develop compounds that have improved efficacies against recombinant IN in biochemical assays. These new compounds show single-digit nanomolar antiviral potencies against HIV vectors that carry wild-type (WT) IN in a single round replication assay and have improved potency against vectors harboring the major forms of drug resistant IN mutants. These compounds also have low toxicity for cultured cells, which in several cases, results in selectivity indices (CC50/EC50) of greater than 10000. The compounds have the potential, with additional structural modifications, to yield clinical agents that are effective against the known strains of resistant viruses." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5001908"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5001908">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5001908&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5001908&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5001908&amp;href=/doi/10.1021/jm5001908" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5190-5202</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500140c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500221p" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm501059k"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xue+Zhi++Zhao">Xue Zhi Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+J.++Smith">Steven J. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mathieu++M%C3%A9tifiot">Mathieu Métifiot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Marchand">Christophe Marchand</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+L.++Boyer">Paul L. Boyer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yves++Pommier">Yves Pommier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+H.++Hughes">Stephen H. Hughes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terrence+R.++Burke%2C++Jr.">Terrence R. Burke, Jr.</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Chemical Biology Laboratory, and <sup>‡</sup>HIV Drug Resistance Program, Center for Cancer Research, NCI at Frederick, National Institutes of Health, Building 376, Boyles Street, P.O. Box B, Frederick, Maryland 21702, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Laboratory of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 301-846-5906. Fax: 301-846-6033. E-mail: <a href="/cdn-cgi/l/email-protection#771502051c120312371f121b1e0f59191e1f59101801"><span class="__cf_email__" data-cfemail="bfddcacdd4dacbdaffd7dad3d6c791d1d6d791d8d0c9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5001908&amp;href=/doi/10.1021%2Fjm5001908" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5190–5202</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 5, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 February 2014</li><li><span class="item_label"><b>Published</b> online</span>16 June 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 June 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5001908" title="DOI URL">https://doi.org/10.1021/jm5001908</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5001908"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1619</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5001908" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xue&quot;,&quot;last_name&quot;:&quot;Zhi Zhao&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;J. Smith&quot;},{&quot;first_name&quot;:&quot;Mathieu&quot;,&quot;last_name&quot;:&quot;Métifiot&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Marchand&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;L. Boyer&quot;},{&quot;first_name&quot;:&quot;Yves&quot;,&quot;last_name&quot;:&quot;Pommier&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;H. Hughes&quot;},{&quot;first_name&quot;:&quot;Terrence&quot;,&quot;last_name&quot;:&quot;R. Burke&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;5190-5202&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5001908&quot;},&quot;abstract&quot;:&quot;There are currently three HIV-1 integrase (IN) strand transfer inhibitors (INSTIs) approved by the FDA for the treatment of AIDS. However, the emergence of drug-resistant mutants emphasizes the need to develop additional agents that have improved efficacies against the existent resistant mutants. As reported herein, we modified our recently disclosed 1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides IN inhibitors to develop compounds that have improved efficacies against recombinant IN in biochemical assays. These new compounds show single-digit nanomolar antiviral potencies against HIV vectors that carry wild-type (WT) IN in a single round replication assay and have improved potency against vectors harboring the major forms of drug resistant IN mutants. These compounds also have low toxicity for cultured cells, which in several cases, results in selectivity indices (CC50/EC50) of greater than 10000. The compounds have the potential, with additional structural modifications, to yield clinical agent&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5001908&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001908" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5001908&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001908" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5001908&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001908" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5001908&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001908&amp;href=/doi/10.1021/jm5001908" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5001908" /></input><a href="/doi/pdf/10.1021/jm5001908" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5001908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5001908%26sid%3Dliteratum%253Aachs%26pmid%3D24901667%26genre%3Darticle%26aulast%3DZhao%26date%3D2014%26atitle%3D4-Amino-1-hydroxy-2-oxo-1%252C8-naphthyridine-Containing%2BCompounds%2BHaving%2BHigh%2BPotency%2Bagainst%2BRaltegravir-Resistant%2BIntegrase%2BMutants%2Bof%2BHIV-1%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D12%26spage%3D5190%26epage%3D5202%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291074" title="Purification">Purification</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jmcmar.2014.57.issue-12/production/jmcmar.2014.57.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001908&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">There are currently three HIV-1 integrase (IN) strand transfer inhibitors (INSTIs) approved by the FDA for the treatment of AIDS. However, the emergence of drug-resistant mutants emphasizes the need to develop additional agents that have improved efficacies against the existent resistant mutants. As reported herein, we modified our recently disclosed 1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides IN inhibitors to develop compounds that have improved efficacies against recombinant IN in biochemical assays. These new compounds show single-digit nanomolar antiviral potencies against HIV vectors that carry wild-type (WT) IN in a single round replication assay and have improved potency against vectors harboring the major forms of drug resistant IN mutants. These compounds also have low toxicity for cultured cells, which in several cases, results in selectivity indices (CC<sub>50</sub>/EC<sub>50</sub>) of greater than 10000. The compounds have the potential, with additional structural modifications, to yield clinical agents that are effective against the known strains of resistant viruses.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Acquired immunodeficiency syndrome (AIDS) is an infectious disease caused by the human immunodeficiency virus (HIV). Reverse transcriptase (RT), protease (PR), and integrase (IN) are the three viral enzymes that are required for viral replication and all three have been targeted by anti-AIDS therapeutics. IN catalyzes the insertion of viral DNA into the host genome in two sequential steps, termed “3′-processing” (3′-P) and “strand transfer” (ST). The 3′-P reaction cleaves two nucleotides from the 3′ end of the viral DNA, exposing a deoxycytosine residue that is used in a nucleophilic attack on the host DNA in the ST reaction. Both of these reactions involve two Mg<sup>2+</sup> ions held in place by three acidic residues Asp64, Asp116, and Glu152 that collectively constitute the “DDE” motif.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> IN inhibitors are the most recently developed class of anti-AIDS drugs. Merck’s raltegravir (RAL, <b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) (October 2007)<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and Gilead’s elvitegravir (EVG) (August 2012)<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> were the first two IN inhibitors to be approved by the FDA. The approved IN inhibitors selectively block the ST step, and members of this class of drugs are called “IN strand transfer inhibitors” (INSTIs) because of their ability to preferentially block the enzyme’s ST reaction relative to the 3′-P reaction.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> All of the known INSTIs share important structural features, which include a coplanar arrangement of three heteroatoms that chelate the two catalytic Mg<sup>2+</sup> ions, and a halobenzyl ring that binds to the penultimate base (a deoxycytidine) adjacent to the deoxyadenosine that lies at the 3′ end of the viral DNA after the 3′-P reaction. Binding of INSTIs blocks the ST reaction by displacing the viral 3′-terminal deoxyadenosine from the catalytic Mg<sup>2+</sup> ions. Treatment with <b>1</b> and EVG selects for resistant forms of HIV, and there is considerable cross-resistance to these two drugs. GlaxoSmithKline’s dolutegravir (DTG, <b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>)<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> is a recently FDA-approved second-generation INSTI (August 2013), which shows improved efficacies against RAL and EVG-resistant strains of HIV.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> However, <b>2</b> also selects for resistant strains of HIV.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This emphasizes the need to develop agents that can overcome resistant strains of IN, including the emerging strains resistant to <b>2</b>. We recently reported that 1-hydroxy-1,8-naphthyridin-2<i>H</i>-one-3-carboxamides, which include both 4-unsubstituted and 4-hydroxyl-containing analogues (<b>3</b> and <b>4</b>, respectively, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), potently inhibit wild-type (WT) IN in biochemical assays and show good antiviral efficacies in single-round infection assays of HIV-1 infectivity (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Importantly, members of this series retain good antiviral potency against a set of mutants resistant to <b>1</b> in these latter assays. Here we describe structural variation at the 4-position of compound <b>3</b>, which yielded agents of type <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) that enhance their efficacy against additional mutant forms of IN that are resistant to <b>1</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of HIV-1 integrase inhibitors described in the text. Mg<sup>2+</sup>-chelating heteroatoms are shown in red, with the 4-position of the 1-hydroxy-1,8-naphthyridin-2(1<i>H</i>)-one ring being indicated in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001908&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Inhibitor Design</h3><div class="NLM_p">IN is a member of the polynucleotidyl transferase class of enzymes that share similar catalytic mechanisms.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> There is also a large body of data that describes the known INSTIs, their efficacy against WT and drug-resistant forms of HIV, and their interactions with prototype foamy virus (PFV) IN. Accordingly, the structures of previously described inhibitors can be used to aid the design of new anti-IN compounds. This is exemplified by the development of <b>1</b> by Merck, which can be traced to dihydroxypyrimidine carboxamide inhibitors of the hepatitis C virus NS5b RNA polymerase (RNAP).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Inhibitors of HIV-1 ribonuclease H (RNase H) have been reported, which, like INSTIs, inhibit their target enzyme by chelating two Mg<sup>2+</sup> ions in the enzyme active site. In RNase H, the Mg<sup>2+</sup> ions are held in place by a “DEDD motif” (D443, E478, D498, and D549).<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> Compounds that inhibit both IN and RNase H have been reported.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> By analogy to the RNAP example, the known RNase H inhibitors might provide insights that can be used to design improved INSTI inhibitors. Accordingly, the design of our bicyclic 1-hydroxy-1,8-naphthyridin-2<i>H</i>-one INSTIs (<b>3</b> and <b>4</b>)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> was guided by the report that compounds such as the biaryl-containing <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), which have submicromolar inhibitory potency against RNase H (IC<sub>50</sub> = 0.64 μM), also have low micromolar inhibitory potency against HIV-1 IN (ST IC<sub>50</sub> = 2.4 μM).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In the case of <b>6</b>, the reported EC<sub>50</sub> value (half-maximal concentration providing protection against viral-induced cell death) in a HIV-1 HXB2 single-cycle viral replication assay in HeLa P4-2 cells was 34 μM.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HIV-1 ribonuclease H (RNase H) inhibitors <b>6</b> and integrase inhibitor <b>5a</b> with the core metal-chelating 1-hydroxy-1,8-naphthyridin-2(1<i>H</i>)-one system shown in red and the key 4-amino group indicated in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001908&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Metal chelation by the 1-hydroxy-1,8-naphthyridin-2<i>H</i>-one nucleus, which is common to <b>3</b>, <b>4</b>, and <b>6</b>, can theoretically be achieved via the heteroatom triad formed by the <i>N</i>-hydroxyl group, the 2-oxo group, and the 8-naphthyridine nitrogen. However, an important component of <b>3</b> and <b>4</b>, not found in <b>6</b>, is a halobenzyl group, which is known to be important for binding to IN by interacting with the penultimate deoxycytosine in the 3′-end of enzyme-bound viral DNA.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In the case of <b>3</b> and <b>4</b>, this binding function is served by a 2′,4′-difluorobenzyl carboxamide group, which is appended at the 3-position of the bicyclic nucleus. Previous work has shown that the nature and pattern of halogen phenyl substitution can significantly affect the potency of INSTIs.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In developing <b>3</b> and <b>4</b>, we found that a 2′,4′-difluorobenzyl moiety, which is present in <b>2</b>, was superior to the other halobenzyl rings we tested.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> An important feature of <b>3</b> and <b>4</b> is that the carbonyl oxygen of the 2′,4′-difluorobenzyl amide group may not be an obligatory component of the metal-chelating triad. As a consequence, there may be greater flexibility in this region of the molecule than is found with inhibitors, such as <b>1</b>, where the halobenzyl amide carbonyl participates in Mg<sup>2+</sup> chelation. This flexibility is reminiscent of what is seen with <b>2</b>, where the flexibility of the haloamide component is thought to contribute to the ability of <b>2</b> to maintain efficacy against certain forms of IN that are resistant to <b>1</b>.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a></div><div class="NLM_p last">In our current work, we further modified the 1-hydroxy-1,8-naphthyridin-2<i>H</i>-one nucleus by incorporating new functionalities at the 4-position. In undertaking these efforts, we noted that for RNase H inhibitors such as <b>6</b>, an extended aryl functionality increased their inhibitory potency.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Therefore, we began by preparing inhibitor <b>5a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In contrast to <b>6</b>, where the aryl functionality is attached through a methylene unit, for reasons of synthetic simplicity, we employed a 4-amine group in <b>5a</b>. Subsequently, we prepared a series of analogues (<b>5a</b>–<b>5v</b>) using an iterative process of design, synthesis, biological evaluation, and redesign.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis</h3><div class="NLM_p">Amidation of methyl ester <b>7</b> (obtained in three steps from commercially available methyl 2-fluoronicotinate)<a onclick="showRef(event, 'ref9 ref21'); return false;" href="javascript:void(0);" class="ref ref9 ref21">(9, 21)</a> using 2,4-difluorobenzylamine gave the known amide <b>8</b> in 70% yield (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref9 ref21'); return false;" href="javascript:void(0);" class="ref ref9 ref21">(9, 21)</a> Subsequent reaction with toluenesulfonyl chloride produced the tosylated analogue <b>9</b> (93% yield), which was treated with a variety of amines to provide <b>10a</b>–<b>10v</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). A subset of these amines (<b>10a</b>–<b>10u</b>) was converted to final products (<b>5a</b>–<b>5u</b>) by hydrogenolysis of the <i>N</i>-benzyloxy group (H<sub>2</sub>/10% Pd·C). In the case of final product <b>5p</b>, acetylation of intermediate <b>10o</b> to yield <b>10p</b> was done prior to debenzylation. For final product <b>5v</b>, treatment of intermediate <b>10v</b> with TFA yielded the free amine <b>11</b> prior to debenzylation (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-Amino-<i>N</i>-(2,4-difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides <b>5a</b>–<b>5v</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001908&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2,4-diFBnNH<sub>2</sub>; (ii) TsCl, TEA, MeCN; (iii) R<sup>1</sup>R<sup>2</sup>NH or R<sup>1</sup>R<sup>2</sup>NH-HCl, DIEA, DMF; (iv) Ac<sub>2</sub>O, TEA, DCM; (v) TFA, DCM; (vi) H<sub>2</sub>, 10% Pd·C, MeOH.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Biological Evaluation</h3><div class="NLM_p">Compounds were evaluated in biochemical assays using radiolabeled oligonucleotides to measure their inhibitory potential in the 3′-P and ST reactions.<a onclick="showRef(event, 'ref9 ref22'); return false;" href="javascript:void(0);" class="ref ref9 ref22">(9, 22)</a> The initial series of compounds was designed to examine the role of aromatic functionality at the 4-position. The IN ST inhibitory potency of <b>5a</b> (IC<sub>50</sub> = 0.34 ± 0.08 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was approximately 10-fold better than the value previously reported for <b>6</b>, which contains a similar 1,4-phenyl group.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The conformationally constrained biphenyl amine analogue <b>5b</b> was slightly less potent than <b>5a</b>. In contrast, introducing a 4′-nitrile or a 4′-amino group onto <b>5a</b> (giving <b>5c</b> and <b>5d</b>, respectively) slightly increased the potency of the compound in the ST reaction relative to <b>5a</b>. Importantly, shortening the 4-substituent by removal of one phenyl ring gave an approximate 19-fold enhancement in potency relative to <b>5a</b> (<b>5e</b>, ST IC<sub>50</sub> = 0.018 ± 0.006 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Potencies of Carboxamides <b>5a</b>–<b>5e</b> Obtained Using an in Vitro IN Assay<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0006.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0007.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Assays were performed using a gel-based protocol with Mg<sup>2+</sup> cofactor as describe in ref <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">22</a>.</p></div></div><div></div></div><div class="NLM_p">Antiviral potencies were evaluated in a cell-based assay using lentiviral vectors carrying WT IN as well as mutant forms of IN that are resistant to <b>1</b>, Y143R, N155H, and the double mutant, G140S/Q148H.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> In these assays, amine <b>5a</b> was approximately two orders-of-magnitude more potent against the WT enzyme (EC<sub>50</sub> = 372 ± 63 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) than what has been reported for <b>6</b> (32 μM).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> All members of the series (<b>5a</b>–<b>5e</b>) showed nanomolar ST inhibitory potencies against WT enzyme, with <b>5d</b> and <b>5e</b> being significantly more potent (EC<sub>50</sub> = 6.3 ± 2.4 and 14 ± 1.9 nM, respectively) than other members of the series (EC<sub>50</sub> values >100 nM). Because all compounds showed no cytotoxicity up to 250 μM), selectivity indices (SI = CC<sub>50</sub>/EC<sub>50</sub>) were from at least 500 to greater than approximately 40000 (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Of particular note, while compound <b>5e</b> was only slightly less potent against the WT vector than what has been reported for <b>1</b> (EC<sub>50</sub> = 4 ± 2 nM), it was significantly less susceptible to loss of efficacy against the mutants: Y143R (2-fold loss versus a reported 54-fold loss for <b>1</b>), N155H (8-fold loss versus a reported 39-fold loss for <b>1</b>), and G140S/Q148H (32-fold versus a reported 425-fold loss for <b>1</b>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The large loss of potency incurred by <b>1</b> against the Y143R mutant derives from a loss of π–π stacking of the inhibitor with the Y143 phenyl ring. The ability of compounds in the current series to retain good efficacy against the Y143R mutant indicates that they do not have a similar interaction as <b>1</b> with the aryl ring of Y143.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiviral Potencies of Carboxamides <b>5a</b>–<b>5e</b> in Cells Infected with HIV-1 Constructs Containing WT or Mutant IN</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="×" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="×">EC<sub>50</sub> (FC, IN mutants<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a>)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">CC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub> (nM, WT)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="×">Y143R</th><th class="colsep0 rowsep0" align="center">N155H</th><th class="colsep0 rowsep0" align="center">G140S/Q148H</th><th class="colsep0 rowsep0" align="center" char=".">SI<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="char" char=".">>250</td><td class="colsep0 rowsep0" align="char" char="±">372 ± 63</td><td class="colsep0 rowsep0" align="char" char="×">1× </td><td class="colsep0 rowsep0" align="center">N/A<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">N/A<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">>672</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="char" char=".">>250</td><td class="colsep0 rowsep0" align="char" char="±">171 ± 57</td><td class="colsep0 rowsep0" align="char" char="×">3× </td><td class="colsep0 rowsep0" align="center">N/A<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">N/A<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">>1462</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="char" char=".">>250</td><td class="colsep0 rowsep0" align="char" char="±">123 ± 21</td><td class="colsep0 rowsep0" align="char" char="×">3× </td><td class="colsep0 rowsep0" align="center">N/A<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">N/A<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">>2033</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="char" char=".">>250</td><td class="colsep0 rowsep0" align="char" char="±">6.3 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="×">16× </td><td class="colsep0 rowsep0" align="center">67× </td><td class="colsep0 rowsep0" align="center">N/A<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">>39683</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="char" char=".">>250</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="×">2× </td><td class="colsep0 rowsep0" align="center">8× </td><td class="colsep0 rowsep0" align="center">32× </td><td class="colsep0 rowsep0" align="char" char=".">>17857</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Cytotoxic concentration resulting in 50% reduction in the level of ATP in human osteosarcoma (HOS) cells.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Values obtained from cells infected with lentiviral vector harboring WT IN.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Cells were infected with viral constructs carrying IN mutations and indicated values correspond to the fold-change (FC) in EC<sub>50</sub> relative to WT.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Selectivity index calculated as the ratio of CC<sub>50</sub> to EC<sub>50</sub>.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Not available.</p></div></div></div><div class="NLM_p">We prepared an additional series of analogues (<b>5f</b>–<b>5v</b>) in which several alkylamines were introduced at the 4-position (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In biochemical assays in vitro, most of these analogues exhibited low nanomolar inhibitory potencies in the ST reaction. However, compounds <b>5i</b> and <b>5k</b>, which contained cycloheptyl and <i>n</i>-butylphenyl substituents, respectively, had ST IC<sub>50</sub> values of 0.46 ± 0.18 and 0.28 ± 0.11 μM, respectively, which were markedly elevated relative to other members of the series. A third member of the series, having an (<i>S</i>)-ethyl <i>N</i>-prolinate group, was also significantly less potent [(<i>S</i>)-<b>5u</b>, ST IC<sub>50</sub> = 0.31 ± 0.04 μM] (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Potencies of Carboxamides <b>5f</b>–<b>5v</b> Obtained Using an in Vitro IN Assay<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0008.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="±">3′-processing</th><th class="colsep0 rowsep0" align="center" char="±">strand transfer</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="center">–CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">3.7 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">0.027 ± 0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="center">–CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">–CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">21 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">0.087 ± 0.012</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" colspan="2" align="center">–morpholino</td><td class="colsep0 rowsep0" align="char" char="±">77 ± 12</td><td class="colsep0 rowsep0" align="char" char="±">0.079 ± 0.013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="center">–cycloheptyl</td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="±">0.46 ± 0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5j</b></td><td class="colsep0 rowsep0" align="center">–CH<sub>2</sub>CH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">8.0 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">0.050 ± 0.012</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="center">–CH<sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">12 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">0.28 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5l</b></td><td class="colsep0 rowsep0" align="center">–CH<sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">8.2 ± 1.6</td><td class="colsep0 rowsep0" align="char" char="±">0.024 ± 0.009</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5m</b></td><td class="colsep0 rowsep0" align="center">–CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.016 ± 0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5n</b></td><td class="colsep0 rowsep0" align="center">–CH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">4.5 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.039 ± 0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5o</b></td><td class="colsep0 rowsep0" align="center">–CH<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">0.55 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">0.010 ± 0.009</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5p</b></td><td class="colsep0 rowsep0" align="center">–CH<sub>2</sub>CH<sub>2</sub>OAc</td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">0.027 ± 0.006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5q</b></td><td class="colsep0 rowsep0" align="center">–CH<sub>2</sub>CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">0.71 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">0.021 ± 0.011</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>5r</b></td><td class="colsep0 rowsep0" align="center">–NHCH(CH<sub>3</sub>)CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">0.017 ± 0.011</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>5r</b></td><td class="colsep0 rowsep0" align="center">–NHCH(CH<sub>3</sub>)CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">5.8 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">0.027 ± 0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>5s</b></td><td class="colsep0 rowsep0" align="center">–NHCH(Ph)CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">16.7 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">0.010 ± 0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>5s</b></td><td class="colsep0 rowsep0" align="center">–NHCH(Ph)CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">13.5 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">0.0082 ± 0.0015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>5t</b></td><td class="colsep0 rowsep0" align="center">–NHCH(CH<sub>2</sub>OH)CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">5.8 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">0.0084 ± 0.0032</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>5t</b></td><td class="colsep0 rowsep0" align="center">–NHCH(CH<sub>2</sub>OH)CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">4.4 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">0.013 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>5u</b></td><td class="colsep0 rowsep0" align="center">–Pro-OEt</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">86 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">0.31 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5v</b></td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="center">–H</td><td class="colsep0 rowsep0" align="char" char="±">2.5 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">0.019 ± 0.002</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Assays were performed using a gel-based protocol with Mg<sup>2+</sup> cofactor as describe in refs <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a> and <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">22</a>.</p></div></div></div><div class="NLM_p">Antiviral potencies were determined for <b>5f</b>–<b>5v</b> in cells infected with viral vectors harboring WT and mutant forms of IN (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Most compounds of the series displayed EC<sub>50</sub> values in the low nanomolar range against the WT vector, with a majority of the compounds showing single-digit nanomolar potencies. These compounds also showed low cytotoxicity, which resulted in good SI values, with several compounds showing SI > 10000. Noteworthy exceptions were compounds <b>5g</b>, <b>5h</b>, and (<i>S</i>)-<b>5u</b>, which not only had significantly reduced antiviral potencies (EC<sub>50</sub> values of 268 ± 8, 1200 ± 260, and 590 ± 72 nM, respectively) but also showed greater cytotoxicity (CC<sub>50</sub> values of 13 ± 1.8, 8.4 ± 3.2, and 18 ± 7 μM, respectively) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). These latter compounds are the only members of the series having tertiary amines at the 4-position. As such, these analogues would not be able to form internal hydrogen bonds between their 4-amino groups and the 3-carboxamide carbonyl oxygen. In spite of their poor antiviral efficacies, the in vitro ST IC<sub>50</sub> values for <b>5g</b> and <b>5h</b> (87 and 79 nM, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) were only modestly elevated relative to most other members of the series (typically 30 nM or lower). In some cases, the in vitro IC<sub>50</sub> values for <b>5g</b> and <b>5h</b> were better than compounds such as <b>5i</b> and <b>5k</b> (460 and 280 nM, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), which paradoxically exhibited good EC<sub>50</sub> values against the WT vector (12 ± 3 and 50 ± 13 nM, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). These data could indicate that being able to form an intramolecular hydrogen bond between the 4-amino group and the 3-carboxamide carbonyl oxygen has a more important role for the activity of the compounds in an antiviral assay done in cultured cells than in the biochemical assay done in vitro.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Antiviral Potencies of Carboxamides <b>5f</b>–<b>5v</b> in Cells Infected with HIV-1 Constructs Containing WT or Mutant IN</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="rowsep1 colsep0" colspan="3" align="center">EC<sub>50</sub> (nM, IN mutants<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a>)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">CC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub> (nM, WT)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Y143R</th><th class="colsep0 rowsep0" align="center">N155H</th><th class="colsep0 rowsep0" align="center">G140S/Q148H</th><th class="colsep0 rowsep0" align="center" char=".">SI<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 0.6</td><td class="colsep0 rowsep0" align="left">6.1 ± 2.5 (2×)</td><td class="colsep0 rowsep0" align="left">18 ± 5.2 (6×)</td><td class="colsep0 rowsep0" align="left">87 ± 11 (28×)</td><td class="colsep0 rowsep0" align="char" char=".">>80645</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="center">13 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">268 ± 8</td><td class="colsep0 rowsep0" align="left">273 ± 52 (1×)</td><td class="colsep0 rowsep0" align="left">2300 ± 700 (9×)</td><td class="colsep0 rowsep0" align="left">6800 ± 400 (25×)</td><td class="colsep0 rowsep0" align="char" char=".">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" align="center">8.4 ± 3.2</td><td class="colsep0 rowsep0" align="char" char="±">1200 ± 260</td><td class="colsep0 rowsep0" align="left">1800 ± 870 (1.5×)</td><td class="colsep0 rowsep0" align="left">3730 ± 920 (3×)</td><td class="colsep0 rowsep0" align="left">6920 ± 2000 (6×)</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="center">68 ± 8.7</td><td class="colsep0 rowsep0" align="char" char="±">12 ± 3</td><td class="colsep0 rowsep0" align="left">6.6 ± 1.7 (0.55×)</td><td class="colsep0 rowsep0" align="left">14 ± 4 (1×)</td><td class="colsep0 rowsep0" align="left">35 ± 12 (3×)</td><td class="colsep0 rowsep0" align="char" char=".">5667</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5j</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 8</td><td class="colsep0 rowsep0" align="left">18 ± 2.6 (1×)</td><td class="colsep0 rowsep0" align="left">79 ± 5.2 (6×)</td><td class="colsep0 rowsep0" align="left">119 ± 3.4 (9×)</td><td class="colsep0 rowsep0" align="char" char=".">>17857</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="center">102 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">50 ± 13</td><td class="colsep0 rowsep0" align="left">40 ± 15 (0.80×)</td><td class="colsep0 rowsep0" align="left">116 ± 22 (2×)</td><td class="colsep0 rowsep0" align="left">243 ± 39 (5×)</td><td class="colsep0 rowsep0" align="char" char=".">2040</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5l</b></td><td class="colsep0 rowsep0" align="center">94 ± 24</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 1.4</td><td class="colsep0 rowsep0" align="left">8.8 ± 2.7 (1×)</td><td class="colsep0 rowsep0" align="left">12 ± 4.5 (2×)</td><td class="colsep0 rowsep0" align="left">71 ± 0.14 (10×)</td><td class="colsep0 rowsep0" align="char" char=".">12703</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5m</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">7.2 ± 3.0</td><td class="colsep0 rowsep0" align="left">7.4 ± 0.5 (1×)</td><td class="colsep0 rowsep0" align="left">44 ± 6.7 (6×)</td><td class="colsep0 rowsep0" align="left">154 ± 16 (21×)</td><td class="colsep0 rowsep0" align="char" char=".">>34722</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5n</b></td><td class="colsep0 rowsep0" align="center">9.6 ± 3.7</td><td class="colsep0 rowsep0" align="char" char="±">35 ± 11</td><td class="colsep0 rowsep0" align="left">57 ± 13 (2×)</td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">277</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5o</b></td><td class="colsep0 rowsep0" align="center">24 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">5.2 ± 0.6</td><td class="colsep0 rowsep0" align="left">4.6 ± 1.8 (0.88×)</td><td class="colsep0 rowsep0" align="left">25 ± 4 (5×)</td><td class="colsep0 rowsep0" align="left">43 ± 15 (8×)</td><td class="colsep0 rowsep0" align="char" char=".">4615</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5p</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">4.5 ± 1.5</td><td class="colsep0 rowsep0" align="left">4.8 ± 2.9 (1×)</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.3 (0.69×)</td><td class="colsep0 rowsep0" align="left">35 ± 14 (8×)</td><td class="colsep0 rowsep0" align="char" char=".">>55556</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5q</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 1.2</td><td class="colsep0 rowsep0" align="left">4.6 ± 2.2 (1×)</td><td class="colsep0 rowsep0" align="left">19 ± 7 (5×)</td><td class="colsep0 rowsep0" align="left">36 ± 16 (9×)</td><td class="colsep0 rowsep0" align="char" char=".">>65789</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>5r</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">4.2 ± 1.6</td><td class="colsep0 rowsep0" align="left">4.8 ± 1.4 (1×)</td><td class="colsep0 rowsep0" align="left">15.3 ± 3.3 (4×)</td><td class="colsep0 rowsep0" align="left">141 ± 20 (33×)</td><td class="colsep0 rowsep0" align="char" char=".">>59 524</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>5r</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">11.3 ± 4.7</td><td class="colsep0 rowsep0" align="left">8.1 ± 1.7 (0.7×)</td><td class="colsep0 rowsep0" align="left">27 ± 9.9 (2×)</td><td class="colsep0 rowsep0" align="left">89 ± 26 (8×)</td><td class="colsep0 rowsep0" align="char" char=".">>22 124</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>5s</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">9 ± 2.4</td><td class="colsep0 rowsep0" align="left">8.5 ± 1.9 (0.9×)</td><td class="colsep0 rowsep0" align="left">17.6 ± 6.4 (2×)</td><td class="colsep0 rowsep0" align="left">55.6 ± 6.2 (6×)</td><td class="colsep0 rowsep0" align="char" char=".">>27 778</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>5s</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 3.3</td><td class="colsep0 rowsep0" align="left">8.2 ± 1.8 (1 × )</td><td class="colsep0 rowsep0" align="left">22 ± 4 (3 × )</td><td class="colsep0 rowsep0" align="left">48 ± 12 (6 × )</td><td class="colsep0 rowsep0" align="char" char=".">>33 784</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>5t</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">9.7 ± 3</td><td class="colsep0 rowsep0" align="left">11 ± 4 (1 × )</td><td class="colsep0 rowsep0" align="left">29 ± 8 (3 × )</td><td class="colsep0 rowsep0" align="left">122 ± 33 (13 × )</td><td class="colsep0 rowsep0" align="char" char=".">>25 773</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>5t</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">14.2 ± 3.7</td><td class="colsep0 rowsep0" align="left">10.2 ± 1.4 (0.7 × )</td><td class="colsep0 rowsep0" align="left">71 ± 5 (5 × )</td><td class="colsep0 rowsep0" align="left">284 ± 120 (20 × )</td><td class="colsep0 rowsep0" align="char" char=".">>17 606</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>5u</b></td><td class="colsep0 rowsep0" align="center">18 ± 7</td><td class="colsep0 rowsep0" align="char" char="±">590 ± 72</td><td class="colsep0 rowsep0" align="left">1660 ± 920 (3 × )</td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5v</b></td><td class="colsep0 rowsep0" align="center">>250</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.7</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.6 (2 × )</td><td class="colsep0 rowsep0" align="left">5.3 ± 2.3 (5 × )</td><td class="colsep0 rowsep0" align="left">35 ± 9 (32 × )</td><td class="colsep0 rowsep0" align="char" char=".">>227 273</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Cytotoxic concentration resulting in 50% reduction in the level of ATP in human osteosarcoma (HOS) cells.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Values obtained from cells infected with lentiviral vector carrying WT IN.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Cells were infected with viral constructs carrying IN mutations and indicated values correspond to the fold-change (FC) in EC<sub>50</sub> relative to WT.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Selectivity index (SI) calculated as the ratio of CC<sub>50</sub> to EC<sub>50</sub>.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Not available.</p></div></div></div><div class="NLM_p">The main objective of the current study was to derive minimally cytotoxic inhibitors having good antiviral potency against cells infected with WT virus, which also retained their efficacy against viruses harboring mutant forms of IN that are resistant to <b>1</b>. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, relative to their potencies against WT, almost all members of the current series maintained complete or nearly complete efficacy against virus having the Y143R mutant. In addition, most members of the series showed good retention of efficacy against virus having the N155H and G140S/Q148H mutants (with a few exceptions, 10-fold or less loss of potency) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Members of the series also commonly exhibited high SI values, in the range of four orders-of-magnitude.</div><div class="NLM_p">On the basis of these data, we examined selected members of the series (<b>5o</b>–<b>5q</b> and <b>5v</b>) against a more extensive panel of INSTI-resistant mutants that included R263 K and G118R mutants, which have recently been identified through in vitro selection studies with second-generation INSTIs.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> For reference, we also included <b>1</b> and <b>2</b> as well as the parent 1-hydroxy-1,8-naphthyridin-2<i>H</i>-ones (<b>3</b> and <b>4</b>), which formed the starting points for the current series. Although <b>1</b> is potent against viral vectors that carry WT IN (EC<sub>50</sub> = 4 ± 2 nM), it shows extensive loss of antiviral efficacy against the mutants, Y143R (EC<sub>50</sub> = 162 ± 16 nM; 41-fold loss), N155H (EC<sub>50</sub> = 154 ± 33 nM; 38-fold loss), and G140S/Q148H (EC<sub>50</sub> = 1900 ± 300 nM; 475-fold loss). Compound <b>1</b> is more tolerant of the G118R mutant (EC<sub>50</sub> = 36 ± 5 nM; 9-fold loss) and even less affected by the R263 K mutant (EC<sub>50</sub> = 9 ± 4 nM; 2-fold loss) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In contrast, the recently FDA-approved second-generation inhibitor <b>2</b>, while showing similar potency to <b>1</b> against WT vector (EC<sub>50</sub> = 1.6 ± 0.9 nM), exhibits a significantly smaller loss of potency against vectors having the mutants Y143R (EC<sub>50</sub> = 4.3 ± 1.2 nM; 3-fold loss), N155H (EC<sub>50</sub> = 3.6 ± 1.3 nM; 2-fold loss), and G140S/Q148H (EC<sub>50</sub> = 5.8 ± 0.5 nM; 4-fold loss) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). However, as expected, <b>2</b> shows some loss of potency against virus having the R263 K (EC<sub>50</sub> = 11 ± 3 nM; 7-fold loss) and G118R (EC<sub>50</sub> = 13 ± 5 nM; 8-fold loss) mutants.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Antiviral Potencies of <b>5o</b>–<b>5q</b> and <b>5v</b> Compared with <b>1</b>, <b>2</b>, and Previously Reported Carboxamides <b>3</b> and <b>4</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> in Cells Infected with HIV-1 Constructs Containing WT or Mutant IN</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="rowsep1 colsep0" colspan="5" align="center">EC<sub>50</sub> [nM/(FC), IN mutants<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>]</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub> (nM, WT)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Y143R</th><th class="colsep0 rowsep0" align="center">N155H</th><th class="colsep0 rowsep0" align="center">R263 K</th><th class="colsep0 rowsep0" align="center">G118R</th><th class="colsep0 rowsep0" align="center">G140S/Q148H</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">4 ± 2</td><td class="colsep0 rowsep0" align="left">162 ± 16 (41×)</td><td class="colsep0 rowsep0" align="left">154 ± 33 (38×)</td><td class="colsep0 rowsep0" align="left">9 ± 4 (2×)</td><td class="colsep0 rowsep0" align="left">36 ± 5 (9×)</td><td class="colsep0 rowsep0" align="left">1900 ± 300 (475×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.9</td><td class="colsep0 rowsep0" align="left">4.3 ± 1.2 (3×)</td><td class="colsep0 rowsep0" align="left">3.6 ± 1.3 (2×)</td><td class="colsep0 rowsep0" align="left">11 ± 3 (7×)</td><td class="colsep0 rowsep0" align="left">13 ± 5 (8×)</td><td class="colsep0 rowsep0" align="left">5.8 ± 0.5 (4×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">5.1 ± 1.9</td><td class="colsep0 rowsep0" align="left">4.9 ± 0.8 (1×)</td><td class="colsep0 rowsep0" align="left">134 ± 23 (26×)</td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">438 ± 121 (86×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="±">6.2 ± 2.9</td><td class="colsep0 rowsep0" align="left">11 ± 2 (2×)</td><td class="colsep0 rowsep0" align="left">31 ± 8 (5×)</td><td class="colsep0 rowsep0" align="left">36 ± 8 (6×)</td><td class="colsep0 rowsep0" align="left">107 ± 8 (17×)</td><td class="colsep0 rowsep0" align="left">308 ± 125 (50×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5o</b></td><td class="colsep0 rowsep0" align="char" char="±">5.2 ± 0.6</td><td class="colsep0 rowsep0" align="left">4.6 ± 1.8 (0.88×)</td><td class="colsep0 rowsep0" align="left">25 ± 4 (5×)</td><td class="colsep0 rowsep0" align="left">26 (5×)</td><td class="colsep0 rowsep0" align="left">27 ± 1 (5×)</td><td class="colsep0 rowsep0" align="left">43 ± 15 (8×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5p</b></td><td class="colsep0 rowsep0" align="char" char="±">4.5 ± 1.5</td><td class="colsep0 rowsep0" align="left">4.8 ± 2.9 (1×)</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.3 (0.69×)</td><td class="colsep0 rowsep0" align="left">16 ± 5 (4×)</td><td class="colsep0 rowsep0" align="left">44 ± 11 (10×)</td><td class="colsep0 rowsep0" align="left">35 ± 14 (8×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5q</b></td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 1.2</td><td class="colsep0 rowsep0" align="left">4.6 ± 2.2 (1×)</td><td class="colsep0 rowsep0" align="left">19 ± 7 (5×)</td><td class="colsep0 rowsep0" align="left">26 ± 8 (7×)</td><td class="colsep0 rowsep0" align="left">41 ± 18 (11×)</td><td class="colsep0 rowsep0" align="left">36 ± 16 (9×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5v</b></td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.66</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.6 (2×)</td><td class="colsep0 rowsep0" align="left">5.3 ± 2.3 (5×)</td><td class="colsep0 rowsep0" align="left">6.4 ± 2.3 (6×)</td><td class="colsep0 rowsep0" align="left">16 ± 5 (15×)</td><td class="colsep0 rowsep0" align="left">35 ± 9 (32×)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Values obtained from cells infected with lentiviral vector harboring WT IN.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Cells were infected with viral constructs carrying IN mutations and indicated values correspond to the fold-change (FC) in EC<sub>50</sub> relative to WT.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Not available.</p></div></div></div><div class="NLM_p">Among the current series, the antiviral potencies of <b>5o</b>–<b>5q</b> are approximately equivalent to <b>1</b> against WT enzyme, with <b>5v</b> being slightly more potent (equivalent to <b>2</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Compounds <b>5p</b>, <b>5q</b>, and <b>5v</b> also show fold-loss of potencies that are approximately equivalent to <b>2</b> against the panel of mutants, with the exception of <b>5v</b>, which shows greater fold-loss of potency against the mutant G140S/Q138H (32-fold). However, because <b>5v</b> has greater potency against the WT virus than either <b>5p</b> or <b>5q</b>, the effective antiviral potencies against virus having the G140S/Q138H mutant are approximately equal for the three compounds (EC<sub>50</sub> = 35 nM). A summary analysis of Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> shows that <b>5p</b> exhibits a profile against the panel of mutants that is similar to <b>2</b>. Because of its slightly better potency against WT IN, compound <b>5v</b> exhibits the best overall performance among the new inhibitors, with both absolute potencies and fold-loss of potencies against the various mutant vectors that are similar to <b>2</b>. The sole exception is the G140S/Q148H mutant, where <b>5v</b> suffers an approximate 7-fold loss of potency relative to <b>2</b>. Importantly, <b>5v</b> shows from 5- to 10-fold enhanced performance across the entire panel relative to the starting compound <b>4</b>. The standard assays are performed in the presence of 5% fetal bovine serum (FBS). To examine the potential effects of serum protein binding on their antiviral potencies, compounds <b>5p</b>, <b>5q</b>, and <b>5v</b> were evaluated against the WT vector in the presence of increasing amounts FBS (5%, 10%, and 15%). These experiments showed that the antiviral potencies of the compounds were essentially unchanged relative to values shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, which were obtained in the presence of 5% fetal bovine serum protein (data not shown).</div><div class="NLM_p">The title compounds were originally designed to chelate the two Mg<sup>2+</sup> ions at the IN active site. However, HIV-1 reverse transcriptase (RT) also contains two active sites, the polymerase active site and the RNase H active site, each of which has two bound Mg<sup>2+</sup> ions. To examine whether representative compounds of the series could also bind Mg<sup>2+</sup> ions at one or both of the active sites in RT, we tested <b>5p</b>, <b>5q</b>, and <b>5v</b>, to see whether they inhibited either the RNase H or the polymerase activity of RT. Nevirapine, a well-known nonnucleoside reverse transcriptase inhibitor (NNRTI), was included as a positive control in the polymerase inhibition assays. The polymerase inhibition assays show that all three compounds are able to inhibit the DNA-dependent DNA polymerase activity of HIV-1 RT (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). However, the data also show that the compounds differ in their potency. All of the compounds are less potent than nevirapine in the polymerase assay, Compound <b>5v</b> the most potent, followed by <b>5p</b>, then <b>5q</b>. It is not clear at this point whether the compounds are binding the Mg<sup>2+</sup> ions at the polymerase active site or binding within the NNRTI-binding pocket near the polymerase active site, similar to nevirapine. It is also possible that they may be binding at some other site in HIV-1 RT.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Polymerase and RNase H inhibition assays (A): The effects of <b>5p</b>, <b>5q</b>, and <b>5v</b> on the DNA-dependent DNA polymerase activity of RT are shown. Reactions were performed with WT RT in the presence of various concentrations of compounds (0, 0.02, 0.1, 0.5, 1, or 10 μM). Samples were precipitated with EtOH and then fractionated on a 15% polyacrylamide sequencing gel. After electrophoresis, the gel was exposed to X-ray film. RNase H inhibition assay (B,C,D): The effects of <b>5p</b>, <b>5q</b>, and <b>5v</b> on the RNase H activity of RT are shown. The reactions were incubated for the amount of time indicated (1, 5, 10, and 15 min) in the presence of the indicated concentration of the individual compounds (0, 0.1, 0.5, 1, and 10 μM). The size of intact RNA (full length) is 60 NT, as shown in the “No-RT” lane. The RNA fragments derived from the −17 and −8 families of cleavages are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001908&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The compounds were also tested for their ability to inhibit the RNase H activity of RT. When RT binds an RNA–DNA template/primer (T/P), the 3′ end of the DNA primer is preferentially located at the polymerase active site; the RNase H active site contacts the RNA template approximately 17 to 18 nucleotides (NT) from the polymerase active site.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The initial RNase H cleavage occurs approximately 17 NT from the polymerase active site. These cleavages have been designated as the −17 family of cleavages. The RT then alters its interactions with the T/P, so that RNase H can make additional secondary cleavages approximately 8 NT from the 3′ end of the primer (−8 cleavages). The full length RNA is 60 NT in length. We found that <b>5p</b>, <b>5q</b>, and <b>5v</b> varied in their abilities to inhibit RNase H activity (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B–D). However, the ranking of the potencies of the compounds in the RNase H assay is different from the polymerase assay (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A), which suggests that the compounds are interacting with the RT in different places in the two assays. The data show that <b>5q</b> is the most potent inhibitor of RNase H (it was the least potent compound in the polymerase assay). Compound <b>5q</b> did not completely block RNase H activity, even at the highest concentration; a large amount of full length RNA was present in the reaction that contained <b>5q</b> at the 10 μM concentration. It is also apparent that more of the product of the −17 cleavages remained after 10 and 15 min as compared to the “no compound” controls. This results from partial blocking the −8 cleavages. Similar results were obtained with <b>5v</b>, while <b>5p</b> had very little effect on RNase H activity. At the highest concentration, there were subtle effects on the −8 cleavages, but the compound is obviously less potent, in the RNase H assay, than the other two. It is quite difficult to use the results of the in vitro assays to estimate IC<sub>50</sub> values. In the polymerase assay, it is clear that all of the compounds are less potent than nevirapine. We did not have a potent RNase H inhibitor that would allow us to make a similar comparison in the RNase H inhibitor assay. Although it is clear that the current compounds are primarily IN inhibitors, because these compounds can inhibit both the RNase H and polymerase activity of HIV-1 RT, they could serve as the starting point for the synthesis of additional compounds that would be specifically designed to inhibit these alternate targets. In that regard, because there are no potent RNase H inhibitors, and because many of the known RNase H inhibitors are relatively toxic, using these compounds as leads to develop new RNase H inhibitors is a potentially attractive option.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Our current study examines the effects of introducing an amine functionality at the 4-position of our previously reported 1-hydroxy-1,8-naphthyridin-2<i>H</i>-ones (<b>3</b> and <b>4</b>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The focus of the work was to enhance antiviral potency, with particular emphasis on retaining efficacy against viruses harboring mutant forms of IN that have been shown to be resistant to the first-generation INSTI, <b>1</b>. For reference we employed <b>2</b>, which is a recently FDA-approved second-generation INSTI with improved performance against the known resistant mutants. Most members of the series of new inhibitors (<b>5</b>) show single-digit nanomolar antiviral potency against WT enzyme, with SI values greater than 10000. As a whole, the family of new inhibitors exhibited a smaller fold-change than <b>1</b> in antiviral assays that employed IN mutants Y143R, N155H, and the double mutant G140S/Q148H. Among the new inhibitors, compound <b>5p</b> showed a profile against the panel of mutants that was comparable to <b>2</b>, with <b>5v</b> exhibiting the best overall absolute performance among the new inhibitors, approximately 5- to 10-fold enhancement relative to the starting compound <b>4</b>. Although <b>2</b> is more effective than first-generation INSTIs in its ability to retain efficacy against resistant forms of IN, it has been shown that <b>2</b> can select for resistant forms of the enzyme. Therefore, there is a continuing need for the development of new agents as potential alternatives to the currently approved panel of three FDA-approved INSTIs. The structural class of agents presented herein may represent an attractive platform for developing such next-generation INSTIs.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Synthetic</h3><div class="NLM_p last"><sup>1</sup>H and <sup>13</sup>C NMR data were obtained on a Varian 400 MHz spectrometer or a Varian 500 MHz spectrometer and are reported in ppm relative to TMS and referenced to the solvent in which the spectra were collected. Solvent was removed by rotary evaporation under reduced pressure, and anhydrous solvents were obtained commercially and used without further drying. Purification by silica gel chromatography was performed using CombiFlash R<sub>f</sub> 200i with EtOAc–hexanes solvent systems. Preparative high pressure liquid chromatography (HPLC) was conducted using a Waters Prep LC4000 system having photodiode array detection and Phenomenex C<sub>18</sub> columns (catalogue no. 00G-4436-P0-AX, 250 mm × 21.2 mm 10 μm particle size, 110 Å pore) at a flow rate of 10 mL/min. Binary solvent systems consisting of A = 0.1% aqueous TFA and B = 0.1% TFA in acetonitrile were employed with gradients as indicated. Products were obtained as amorphous solids following lyophilization. Electrospray ionization–mass spectra (ESI-MS) were acquired with an Agilent LC/MSD system equipped with a multimode ion source. Purities of samples subjected to biological testing were assessed using this system and shown to be ≥95%. High-resolution mass spectra (HRMS) were acquired by LC/MS-ESI using an LTQ-Orbitrap-XL at 30K resolution.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Procedure A</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Preparation of 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10a</b>–<b>10v</b>)</h4><div class="NLM_p last">A solution of <i>p</i>-methylbenzenesulfonate (<b>9</b>) (1.0 mmol), <i>N</i>-ethyl-<i>N</i>-isopropylpropan-2-amine (10 mmol) and amines R<sup>1</sup>R<sup>2</sup>NH or R<sup>1</sup>R<sup>2</sup>NH·HCl (5.0 mmol) in DMF (2.0 mL) was heated to 50 °C (1 h). The crude mixture was purified by CombiFlash silica gel chromatography (hexanes and ethyl acetate) to provide amides (<b>10a</b>–<b>10v</b>).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure B</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Preparation of <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides (<b>5a</b>–<b>5v</b>)</h4><div class="NLM_p last">Amides (<b>10a</b>–<b>10u</b> or <b>11</b>; 0.2 mmol) were dissolved in MeOH (15 mL) and EtOAc (5 mL) and the solution degassed and stirred at room temperature under H<sub>2</sub> over Pd·C (10%, 0.2 mmol) (1 h). The mixture was filtered and the filtrate was concentrated, and the resulting residue was purified by HPLC to provide amides (<b>5a</b>–<b>5v</b>).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-4-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>8</b>)</h4><div class="NLM_p last">A solution of methyl 1-(benzyloxy)-4-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate (<b>7</b>)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (1.0 g, 3.17 mmol) and (2,4-difluorophenyl)methanamine (2.0 mL, 15.86 mmol) in DMF (3.0 mL) was subjected to microwave irradiation with stirring (140 °C; 2 h). The resulting product mixture was purified by CombiFlash silica gel chromatography to provide <b>8</b> as a white solid (964 mg, 70% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.35 (t, <i>J</i> = 5.5 Hz, 1H), 8.80 (dd, <i>J</i> = 4.7, 1.8 Hz, 1H), 8.49 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.67 (dd, <i>J</i> = 7.6, 1.8 Hz, 2H), 7.42–7.36 (m, 4H), 7.31 (dd, <i>J</i> = 7.9, 4.7 Hz, 1H), 6.89–6.82 (m, 2H), 5.28 (s, 2H), 4.66 (d, <i>J</i> = 6.0 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 438.1 (MH<sup>+</sup>).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl 4-Methylbenzenesulfonate (<b>9</b>)</h4><div class="NLM_p last">To a suspension of <b>8</b> (967 mg, 2.21 mmol) in CH<sub>3</sub>CN (10 mL) and CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) were added <i>N</i>-ethyl-<i>N</i>-isobutyl-2-methylpropan-1-amine (2.81 mL, 13.27 mmol) and 4-methylbenzene-1-sulfonyl chloride (1.27 g, 6.63 mmol), and the mixture was stirred at room temperature (overnight). The resulting mixture was purified by CombiFlash silica gel chromatography using solid loading to provide <b>9</b> as a colorless oil (1.21 g, 93% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.76 (dd, <i>J</i> = 4.7, 1.7 Hz, 1H), 8.28 (t, <i>J</i> = 5.8 Hz, 1H), 8.23 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 7.90–7.88 (m, 2H), 7.66–7.64 (m, 2H), 7.47–7.45 (m, 1H), 7.40–7.35 (m, 5H), 7.9–7.26 (m, 1H), 6.86–6.78 (m, 2H), 5.30 (s, 2H), 4.50 (d, <i>J</i> = 5.9 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 592.1 (MH<sup>+</sup>).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4-([1,1′-Biphenyl]-4-ylamino)-1-(benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10a</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with [1,1′-biphenyl]-4-amine as outlined in general procedure A, provided <b>10a</b> as a colorless oil in 97% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 13.23 (s, 1H), 10.86 (t, <i>J</i> = 5.5 Hz, 1H), 8.62 (dd, <i>J</i> = 4.5, 1.5 Hz, 1H), 7.91 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.71–7.69 (m, 2H), 7.58–7.34 (m, 7H), 7.28–7.23 (m, 5H), 7.09 (d, <i>J</i> = 8.5 Hz, 2H), 6.88 (dd, <i>J</i> = 8.3, 4.5 Hz, 1H), 6.84 (d, <i>J</i> = 8.8 Hz, 1H), 5.32 (s, 2H), 4.65 (d, <i>J</i> = 5.8 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 589.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 4-((9<i>H</i>-Fluoren-2-yl)amino)-1-(benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10b</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with 9<i>H</i>-fluoren-2-amine as outlined in general procedure A, provided <b>10b</b> as a colorless oil in 99% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 13.31 (s, 1H), 10.87 (t, <i>J</i> = 5.7 Hz, 1H), 8.59 (ddd, <i>J</i> = 4.6, 1.7, 0.7 Hz, 1H), 7.85 (ddd, <i>J</i> = 8.3, 1.6, 0.7 Hz, 1H), 7.76–7.15 (m, 8H), 7.05 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 6.88–6.84 (m, 3H), 6.83–6.78 (m, 2H), 6.72–6.66 (m, 2H), 5.33 (s, 2H), 4.65 (d, <i>J</i> = 5.8 Hz, 2H), 3.84 (s, 2H). ESI-MS <i>m</i>/<i>z</i>: 601.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-(Benzyloxy)-4-((4′-cyano-[1,1′-biphenyl]-4-yl)amino)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10c</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with 4′-amino-[1,1′-biphenyl]-4-carbonitrile as outlined in general procedure A provided <b>10c</b> as a yellow solid in 98% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 13.21 (s, 1H), 10.84 (t, <i>J</i> = 5.7 Hz, 1H), 8.66 (dd, <i>J</i> = 4.5, 1.6 Hz, 1H), 7.91 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 7.74–7.60 (m, 4H), 7.55–7.53 (m, 2H), 7.44–7.38 (m, 4H), 7.13 (d, <i>J</i> = 8.5 Hz, 2H), 6.94 (dd, <i>J</i> = 8.3, 4.6 Hz, 1H), 6.88–6.80 (m, 2H), 6.78–6.75 (m, 2H), 5.33 (s, 2H), 4.65 (d, <i>J</i> = 5.8 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 614.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 4-((4′-Amino-[1,1′-biphenyl]-4-yl)amino)-1-(benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10d</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with benzidine as outlined in general procedure A, provided <b>10d</b> as a colorless oil in 97% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 13.20 (s, 1H), 10.83 (t, <i>J</i> = 5.8 Hz, 1H), 8.66–8.50 (m, 1H), 7.88 (dd, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.69–7.67 (m, 2H), 7.44 (d, <i>J</i> = 8.4 Hz, 2H), 7.39–7.34 (m, 3H), 7.32–7.287 (m, 4H), 7.02 (d, <i>J</i> = 8.6 Hz, 2H), 6.86–6.80 (m, 2H), 6.72–6.67 (m, 2H), 5.29 (s, 2H), 4.62 (d, <i>J</i> = 5.8 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 604.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-4-(phenylamino)-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10e</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with aniline as outlined in general procedure A, provided <b>10e</b> as a yellow solid in 65% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 13.19 (s, 1H), 10.85 (t, <i>J</i> = 5.7 Hz, 1H), 8.61 (dd, <i>J</i> = 4.5, 1.7 Hz, 1H), 7.81 (dd, <i>J</i> = 8.3, 1.6 Hz, 1H), 7.69 (dd, <i>J</i> = 7.8, 1.6 Hz, 2H), 7.43–7.36 (m, 4H), 7.31 (dd, <i>J</i> = 10.7, 4.9 Hz, 2H), 7.18 (t, <i>J</i> = 7.4 Hz, 1H), 7.06–7.041 (m, 2H), 6.87–6.79 (m, 3H), 5.32 (s, 2H), 4.64 (d, <i>J</i> = 5.8 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 513.1 (MH<sup>+</sup>).</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-4-(methylamino)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10f</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with methanamine (2.0 M in THF) as outlined in general procedure A, provided <b>10f</b> as a white solid in 72% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.09 (d, <i>J</i> = 4.9 Hz, 1H), 10.83 (t, <i>J</i> = 5.6 Hz, 1H), 8.70 (dd, <i>J</i> = 4.6, 1.5 Hz, 1H), 8.47 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.69 (dd, <i>J</i> = 7.7, 1.6 Hz, 2H), 7.41–7.35 (m, 4H), 7.20–7.17 (m, 1H), 6.86–6.78 (m, 2H), 5.26 (s, 2H), 4.61 (d, <i>J</i> = 5.8 Hz, 2H), 3.41 (d, <i>J</i> = 5.6 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 451.1 (MH<sup>+</sup>).</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-4-(dimethylamino)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10g</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with dimethylamine hydrochloride as outlined in general procedure A, provided <b>10g</b> as a white solid in 91% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.61 (dd, <i>J</i> = 4.6, 1.7 Hz, 1H), 8.20 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 8.05 (t, <i>J</i> = 5.9 Hz, 1H), 7.67 (dd, <i>J</i> = 7.5, 1.8 Hz, 2H), 7.55 (dd, <i>J</i> = 15.1, 8.5 Hz, 1H), 7.41–7.36 (m, 3H), 7.19 (dd, <i>J</i> = 8.1, 4.6 Hz, 1H), 6.88–6.78 (m, 2H), 5.22 (s, 2H), 4.66 (d, <i>J</i> = 6.0 Hz, 2H), 2.95 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 465.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-4-morpholino-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10h</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with morpholine as outlined in general procedure A, provided <b>10h</b> as a colorless oil in 99% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.48 (dd, <i>J</i> = 4.6, 1.6 Hz, 1H), 8.07–8.03 (m, 2H), 7.68–7.60 (m, 3H), 7.39 (dd, <i>J</i> = 4.2, 2.2 Hz, 3H), 7.13 (dd, <i>J</i> = 8.0, 4.6 Hz, 1H), 6.89–6.80 (m, 2H), 5.08 (s, 2H), 4.64 (d, <i>J</i> = 5.9 Hz, 2H), 3.61–3.59 (m, 4H), 3.05–3.03 (m, 4H). ESI-MS <i>m</i>/<i>z</i>: 507.1 (MH<sup>+</sup>).</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-(Benzyloxy)-4-(cycloheptylamino)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10i</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with cycloheptanamine as outlined in general procedure A, provided <b>10i</b> as a colorless oil in 96% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.77 (d, <i>J</i> = 9.1 Hz, 1H), 10.77 (t, <i>J</i> = 5.7 Hz, 1H), 8.69 (dd, <i>J</i> = 4.6, 1.6 Hz, 1H), 8.24 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.68 (dd, <i>J</i> = 7.8, 1.6 Hz, 2H), 7.41–7.34 (m, 4H), 7.19 (dd, <i>J</i> = 8.2, 4.5 Hz, 1H), 6.86–6.78 (m, 2H), 5.26 (s, 2H), 4.63 (d, <i>J</i> = 5.7 Hz, 2H), 4.01 (dq, <i>J</i> = 13.2, 4.4 Hz, 1H), 2.13–2.05 (m, 2H), 1.82–1.74 (m, 4H), 1.62–1.60 (m, 4H), 1.52–1.42 (m, 2H). ESI-MS <i>m</i>/<i>z</i>: 533.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-4-(phenethylamino)-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10j</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with 2-phenylethanamine as outlined in general procedure A, provided <b>10j</b> as a colorless oil in 78% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.06 (t, <i>J</i> = 4.7 Hz, 1H), 10.77 (t, <i>J</i> = 5.7 Hz, 1H), 8.67–8.66 (m, 1H), 8.30 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.69–7.66 (m, 2H), 7.38–7.36 (m, 4H), 7.29–7.21 (m, 6H), 7.12 (dd, <i>J</i> = 8.2, 4.5 Hz, 1H), 6.88–6.79 (m, 2H), 5.24 (s, 2H), 4.63 (d, <i>J</i> = 5.8 Hz, 2H), 3.96–3.91 (m, 2H), 3.08–3.05 (m, 2H). ESI-MS <i>m</i>/<i>z</i>: 541.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-4-((4-phenylbutyl)amino)-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10k</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with 4-phenylbutan-1-amine as outlined in general procedure A, provided <b>10k</b> as a colorless oil in 93% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.99 (t, <i>J</i> = 4.6 Hz, 1H), 10.79 (t, <i>J</i> = 5.7 Hz, 1H), 8.68–8.66 (m, 1H), 8.31 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.68 (dd, <i>J</i> = 7.5, 1.5 Hz, 2H), 7.39–7.33 (m, 3H), 7.26 (dd, <i>J</i> = 10.9, 3.9 Hz, 3H), 7.18–7.12 (m, 4H), 6.83–6.78 (m, 2H), 5.24 (s, 2H), 4.62 (d, <i>J</i> = 5.7 Hz, 2H), 3.68 (q, <i>J</i> = 6.3 Hz, 2H), 2.65 (t, <i>J</i> = 7.0 Hz, 2H), 1.81 (qd, <i>J</i> = 6.9, 3.5 Hz, 4H). ESI-MS <i>m</i>/<i>z</i>: 569.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-4-(pentylamino)-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10l</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with pentan-1-amine as outlined in general procedure A, provided <b>10l</b> as a colorless oil in 95% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.99 (t, <i>J</i> = 4.6 Hz, 1H), 10.79 (t, <i>J</i> = 5.7 Hz, 1H), 8.68 (dd, <i>J</i> = 4.5, 1.2 Hz, 1H), 8.39 (dd, <i>J</i> = 8.2, 1.4 Hz, 1H), 7.68 (dd, <i>J</i> = 7.5, 1.5 Hz, 2H), 7.42–7.35 (m, 4H), 7.17 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 6.86–6.78 (m, 2H), 5.25 (s, 2H), 4.63 (d, <i>J</i> = 5.7 Hz, 2H), 3.70 (td, <i>J</i> = 7.0, 5.1 Hz, 2H), 1.83–1.75 (m, 2H), 1.53–1.26 (m, 4H), 0.92 (t, <i>J</i> = 6.9 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 507.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-4-(isopropylamino)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10m</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with propan-2-amine as outlined in general procedure A, provided <b>10m</b> as a colorless oil in 73% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.66 (d, <i>J</i> = 8.9 Hz, 1H), 10.78 (t, <i>J</i> = 5.6 Hz, 1H), 8.71–8.67 (m, 1H), 8.28 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.69–7.67 (m, 2H), 7.40–7.34 (m, 4H), 7.19–7.16 (m, 1H), 6.86–6.78 (m, 2H), 5.26 (s, 2H), 4.63 (d, <i>J</i> = 5.7 Hz, 2H), 4.24–4.17 (m, 1H), 1.40 (d, <i>J</i> = 6.3 Hz, 6H). ESI-MS <i>m</i>/<i>z</i>: 479.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>tert</i>-Butyl (2-((1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)ethyl)carbamate (<b>10n</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with <i>tert</i>-butyl (2-aminoethyl)carbamate as outlined in general procedure A, provided <b>10n</b> as a white solid in 37% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.74 (s, 1H), 10.75 (t, <i>J</i> = 5.5 Hz, 1H), 8.69–8.56 (m, 1H), 8.34 (d, <i>J</i> = 7.9 Hz, 1H), 7.64 (dd, <i>J</i> = 7.4, 1.6 Hz, 2H), 7.36–7.31 (m, 4H), 7.17–7.13 (m, 1H), 6.82–6.74 (m, 2H), 5.20 (s, 2H), 5.09 (d, <i>J</i> = 18.3 Hz, 1H), 4.57 (d, <i>J</i> = 5.7 Hz, 2H), 3.77 (dd, <i>J</i> = 10.8, 5.4 Hz, 2H), 3.39 (dd, <i>J</i> = 11.4, 5.5 Hz, 2H), 1.36 (s, 9H). ESI-MS <i>m</i>/<i>z</i>: 580.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-4-((2-hydroxyethyl)amino)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10o</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with 2-aminoethanol as outlined in general procedure A, provided <b>10o</b> as a white solid in 71% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.74 (t, <i>J</i> = 4.8 Hz, 1H), 10.80 (t, <i>J</i> = 5.7 Hz, 1H), 8.69–8.68 (m, 1H), 8.41 (dd, <i>J</i> = 8.2, 1.0 Hz, 1H), 7.68 (dd, <i>J</i> = 7.3, 1.5 Hz, 2H), 7.41–7.35 (m, 4H), 7.19–7.15 (m, 1H), 6.86–6.78 (m, 2H), 5.24 (s, 2H), 4.61 (d, <i>J</i> = 5.7 Hz, 2H), 3.90–3.80 (m, 2H), 3.82 (dd, <i>J</i> = 10.0, 5.1 Hz, 2H), 2.88 (bs, 1H). ESI-MS <i>m</i>/<i>z</i>: 481.1 (MH<sup>+</sup>).</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-((1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)ethyl Acetate (<b>10p</b>)</h4><div class="NLM_p last">To a solution of <b>10o</b> (46 mg, 0.10 mmol) in CH<sub>2</sub>CL<sub>2</sub> (3 mL) was added triethylamine (32 μL, 0.23 mmol) and acetic anhydride (11 μL, 0.12 mmol) and the solution was stirred at room temperature (1.5 h). Purification by CombiFlash silica gel chromatography provided <b>10p</b> as a white solid (26 mg, 52% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.93 (t, <i>J</i> = 5.2 Hz, 1H), 10.70 (t, <i>J</i> = 5.7 Hz, 1H), 8.67 (dd, <i>J</i> = 4.6, 1.6 Hz, 1H), 8.29 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.64 (dt, <i>J</i> = 4.1, 2.2 Hz, 2H), 7.37–7.29 (m, 4H), 7.16 (dd, <i>J</i> = 8.2, 4.5 Hz, 1H), 6.83–6.75 (m, 2H), 5.22 (s, 2H), 4.58 (d, <i>J</i> = 5.8 Hz, 2H), 4.29 (t, <i>J</i> = 5.6 Hz, 2H), 3.89 (q, <i>J</i> = 5.5 Hz, 2H), 2.05 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 523.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Methyl (1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)glycinate (<b>10q</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with methyl 2-aminoacetate hydrochloride as outlined in general procedure A, provided <b>10q</b> as a white solid in 95% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.27 (t, <i>J</i> = 5.5 Hz, 1H), 10.70 (t, <i>J</i> = 5.6 Hz, 1H), 8.71 (dd, <i>J</i> = 4.6, 1.6 Hz, 1H), 8.22 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.67 (dd, <i>J</i> = 7.8, 1.7 Hz, 2H), 7.44–7.35 (m, 4H), 7.20 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 6.87–6.78 (m, 2H), 5.26 (s, 2H), 4.66 (d, <i>J</i> = 5.7 Hz, 2H), 4.44 (d, <i>J</i> = 5.6 Hz, 2H), 3.81 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 509.1 (MH<sup>+</sup>).</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Methyl (1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)-<span class="smallcaps smallerCapital">l</span>-alaninate [(<i>S</i>)-<b>10r</b>]</h4><div class="NLM_p last">Treatment of <b>9</b> with methyl (<i>S</i>)-2-aminopropanoate hydrochloride as outlined in general procedure A, provided (<i>S</i>)-<b>10r</b> as a white solid in 93% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.85 (d, <i>J</i> = 8.8 Hz, 1H), 10.67 (t, <i>J</i> = 5.6 Hz, 1H), 8.67–8.66 (m, 1H), 8.15 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.63 (dd, <i>J</i> = 7.4, 1.6 Hz, 2H), 7.37–7.31 (m, 4H), 7.17–7.14 (m, 1H), 6.83–6.75 (m, 2H), 5.23 (s, 2H), 4.64–4.58 (m, 1H), 4.61 (d, <i>J</i> = 6.3 Hz, 2H), 3.70 (s, 3H), 1.61 (d, <i>J</i> = 6.9 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 523.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl (1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)-<span class="smallcaps smallerCapital">d</span>-alaninate [(<i>R</i>)-<b>10r</b>]</h4><div class="NLM_p last">Treatment of <b>9</b> with methyl (<i>R</i>)-2-zminopropanoate hydrochloride as outlined in general procedure A, provided (<i>R</i>)-<b>10r</b> as a white solid in 95% yield. <sup>1</sup>H NMR (400 MHz, cdcl<sub>3</sub>) δ 11.85 (d, <i>J</i> = 8.8 Hz, 1H), 10.67 (t, <i>J</i> = 5.6 Hz, 1H), 8.67–8.66 (m, 1H), 8.15 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.63 (dd, <i>J</i> = 7.4, 1.6 Hz, 2H), 7.37–7.317 (m, 4H), 7.17–7.14 (m, 1H), 6.83–6.75 (m, 2H), 5.23 (s, 2H), 4.64–4.58 (m, 1H), 4.61 (d, <i>J</i> = 6.3 Hz, 3H), 3.70 (s, 3H), 1.61 (d, <i>J</i> = 6.9 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 523.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl (<i>S</i>)-2-((1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)-2-phenylacetate [(<i>S</i>)-<b>10s</b>]</h4><div class="NLM_p last">Treatment of <b>9</b> with methyl (<i>S</i>)-2-amino-2-phenylacetate hydrochloride as outlined in general procedure A, provided (<i>S</i>)-<b>10s</b> as a white solid in 91% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.76 (d, <i>J</i> = 8.3 Hz, 1H), 10.65 (t, <i>J</i> = 5.7 Hz, 1H), 8.61 (dd, <i>J</i> = 4.6, 1.6 Hz, 1H), 8.01 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.62 (dd, <i>J</i> = 7.6, 1.8 Hz, 2H), 7.51 (dd, <i>J</i> = 7.9, 1.2 Hz, 2H), 7.39–7.31 (m, 7H), 7.01 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 6.83–6.75 (m, 2H), 5.53 (d, <i>J</i> = 8.3 Hz, 1H), 5.20 (s, 2H), 4.67 (qd, <i>J</i> = 15.3, 5.8 Hz, 2H), 3.69 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 585.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Methyl (<i>R</i>)-2-((1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)-2-phenylacetate [(<i>R</i>)-<b>10s</b>]</h4><div class="NLM_p last">Treatment of <b>9</b> with methyl (<i>R</i>)-2-amino-2-phenylacetate hydrochloride as outlined in general procedure A, provided (<i>R</i>)-<b>10s</b> as a white solid in 91% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.76 (d, <i>J</i> = 8.3 Hz, 1H), 10.64 (t, <i>J</i> = 5.6 Hz, 1H), 8.62–8.60 (m, 1H), 8.02–7.96 (m, 2H), 7.61 (dd, <i>J</i> = 7.3, 1.8 Hz, 2H), 7.50 (d, <i>J</i> = 7.4 Hz, 2H), 7.43–7.24 (m, 7H), 7.01 (dd, <i>J</i> = 8.2, 4.5 Hz, 1H), 6.83–6.75 (m, 2H), 5.53 (d, <i>J</i> = 8.3 Hz, 1H), 5.20 (s, 2H), 4.66 (qd, <i>J</i> = 15.3, 5.7 Hz, 2H), 3.68 (s, 3H), 3.65 (d, <i>J</i> = 0.8 Hz, 4H). ESI-MS <i>m</i>/<i>z</i>: 585.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Methyl (<i>S</i>)-2-((1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)-3-hydroxypropanoate [(<i>S</i>)-<b>10t</b>]</h4><div class="NLM_p last">Treatment of <b>9</b> with methyl (<i>S</i>)-2-amino-3-hydroxypropanoate hydrochloride as outlined in general procedure A, provided (<i>S</i>)-<b>10ts</b> as a white solid in 83% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.21 (d, <i>J</i> = 9.7 Hz, 1H), 10.66 (t, <i>J</i> = 5.6 Hz, 1H), 8.67 (dd, <i>J</i> = 4.5, 1.6 Hz, 1H), 8.30 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.63 (dd, <i>J</i> = 7.6, 1.8 Hz, 2H), 7.36–7.31 (m, 4H), 7.17 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 6.83–6.75 (m, 2H), 5.22 (s, 2H), 4.60–4.57 (m, 3H), 3.99 (t, <i>J</i> = 4.8 Hz, 2H), 3.75 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 539.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Methyl (<i>R</i>)-2-((1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)-3-hydroxypropanoate [(<i>R</i>)-<b>10t</b>]</h4><div class="NLM_p last">Treatment of <b>9</b> with methyl (<i>R</i>)-2-amino-3-hydroxypropanoate hydrochloride as outlined in general procedure A, provided (<i>R</i>)-<b>10t</b> as a white solid in 97% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.19 (d, <i>J</i> = 9.4 Hz, 1H), 10.67 (s, 1H), 8.68 (d, <i>J</i> = 4.2 Hz, 1H), 8.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.63 (d, <i>J</i> = 6.0 Hz, 2H), 7.35–7.32 (m, 4H), 7.17 (dd, <i>J</i> = 8.1, 4.5 Hz, 1H), 6.82–6.76 (m, 2H), 5.22 (s, 2H), 4.60–4.58 (m, 3H), 3.99 (t, <i>J</i> = 5.4 Hz, 2H), 3.75 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 539.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Ethyl (1-(Benzyloxy)-3-((2,4-difluorobenzyl)carbamoyl)-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)-<i>L</i>-prolinate (<b>10u</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with ethyl (<i>S</i>)-pyrrolidine-2-carboxylate hydrochloride as outlined in general procedure A, provided <b>10u</b> as a white solid in 73% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.64 (dd, <i>J</i> = 4.6, 1.5 Hz, 1H), 8.34 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 8.16 (t, <i>J</i> = 5.8 Hz, 1H), 7.66 (dd, <i>J</i> = 7.5, 1.6 Hz, 2H), 7.49 (dd, <i>J</i> = 15.0, 8.5 Hz, 1H), 7.37–7.32 (m, 3H), 7.23–7.19 (m, 1H), 6.86–6.75 (m, 2H), 5.24 (q, <i>J</i> = 8.7 Hz, 2H), 4.62 (d, <i>J</i> = 3.4 Hz, 2H), 4.37 (dd, <i>J</i> = 8.5, 3.8 Hz, 1H), 4.01–3.94 (m, 2H), 3.76–3.73 (m, 1H), 3.50–3.45 (m, 1H), 2.40–2.34 (m, 1H), 2.02–1.98 (m, 3H), 1.07 (t, <i>J</i> = 7.1 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 563.2 (MH<sup>+</sup>).</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(Benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-4-((2,4-dimethoxybenzyl)amino)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>10v</b>)</h4><div class="NLM_p last">Treatment of <b>9</b> with (2,4-dimethoxyphenyl)methanamine as outlined in general procedure A, provided <b>10u</b> as a colorless oil in 89% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.00 (t, <i>J</i> = 6.0 Hz, 1H), 10.76 (t, <i>J</i> = 5.7 Hz, 1H), 8.65 (dd, <i>J</i> = 4.6, 1.5 Hz, 1H), 8.28 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.70–7.68 (m, 2H), 7.40–7.33 (m, 4H), 7.26–7.24 (m, 1H), 7.08 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 6.84–6.76 (m, 2H), 6.47–6.45 (m, 2H), 5.26 (s, 2H), 4.73 (d, <i>J</i> = 6.1 Hz, 2H), 4.59 (d, <i>J</i> = 5.7 Hz, 2H), 3.79 (s, 3H), 3.76 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 587.2 (MH<sup>+</sup>), 609.2 (MNa<sup>+</sup>).</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-Amino-1-(benzyloxy)-<i>N</i>-(2,4-difluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>11</b>)</h4><div class="NLM_p last">To a solution of <b>10v</b> (93 mg, 0.16 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) was added TFA (1.0 mL), and the mixture was stirred at room temperature (5 min) then concentrated by rotary evaporation under reduced pressure. Purification of the resulting residue by CombiFlash silica gel chromatography provided <b>11</b> as a white solid (69 mg, 100% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.62 (t, <i>J</i> = 5.7 Hz, 1H), 8.75 (dd, <i>J</i> = 4.6, 1.6 Hz, 1H), 8.04 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 7.67 (dd, <i>J</i> = 7.7, 1.7 Hz, 2H), 7.38–7.35 (m, 4H), 7.24 (dd, <i>J</i> = 8.1, 4.6 Hz, 1H), 6.87–6.78 (m, 2H), 5.26 (s, 2H), 4.63 (d, <i>J</i> = 5.8 Hz, 2H). ESI-MS: <i>m</i>/<i>z</i> 437.1 (M+H<sup>+</sup>).</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-([1,1′-Biphenyl]-4-ylamino)-<i>N</i>-(2,4-difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5a</b>)</h4><div class="NLM_p last">Treatment of <b>10a</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 50% B to 90% B over 30 min; retention time = 22.8 min) provided <b>5a</b> as a white powder in 70% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.31 (s, 1H), 10.60 (t, <i>J</i> = 5.8 Hz, 1H), 8.61 (dd, <i>J</i> = 4.5, 1.7 Hz, 1H), 7.86 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 7.61–7.55 (m, 4H), 7.44–7.36 (m, 3H), 7.27 (t, <i>J</i> = 7.3 Hz, 1H), 7.20–7.15 (m, 1H), 7.13 (d, <i>J</i> = 8.5 Hz, 2H), 7.07 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 7.02–6.97 (m, 1H), 4.46 (d, <i>J</i> = 5.7 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 499.1 (MH<sup>+</sup>). HRMS calcd C<sub>28</sub>H<sub>21</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [MH<sup>+</sup>], 499.1576; found, 499.1583.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4-((9<i>H</i>-Fluoren-2-yl)amino)-<i>N</i>-(2,4-difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5b</b>)</h4><div class="NLM_p last">Treatment of <b>10b</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 60% B to 80% B over 30 min; retention time = 21.3 min) provided <b>5b</b> as a white powder in 65% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.54 (s, 1H), 10.68 (t, <i>J</i> = 5.7 Hz, 1H), 8.59 (dd, <i>J</i> = 4.5, 1.6 Hz, 1H), 7.82 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.79 (d, <i>J</i> = 7.5 Hz, 1H), 7.76 (d, <i>J</i> = 8.1 Hz, 1H), 7.49 (d, <i>J</i> = 7.5 Hz, 1H), 7.41 (dd, <i>J</i> = 15.3, 8.7 Hz, 1H), 7.31–7.29 (m, 2H), 7.24–7.20 (m, 1H), 7.20–7.17 (m, 1H), 7.07 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.02–6.97 (m, 2H), 4.47 (d, <i>J</i> = 5.8 Hz, 2H), 3.79 (s, 2H). ESI-MS <i>m</i>/<i>z</i>: 511.1 (MH<sup>+</sup>). HRMS calcd C<sub>29</sub>H<sub>21</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [MH<sup>+</sup>], 511.1576; found, 511.1582.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-((4′-Cyano-[1,1′-biphenyl]-4-yl)amino)-<i>N</i>-(2,4-difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5c</b>)</h4><div class="NLM_p last">Treatment of <b>10c</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 30% B to 80% B over 30 min; retention time = 22.3 min) provided <b>5c</b> as a white powder in 39% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.13 (s, 1H), 10.53 (t, <i>J</i> = 6.2 Hz, 1H), 8.64 (d, <i>J</i> = 4.4 Hz, 1H), 7.88 (d, <i>J</i> = 8.2 Hz, 1H), 7.83 (bs, 4H), 7.67 (d, <i>J</i> = 8.4 Hz, 2H), 7.43 (dd, <i>J</i> = 15.6, 8.3 Hz, 1H), 7.21–7.16 (m, 3H), 7.11 (dd, <i>J</i> = 9.0, 3.8 Hz, 1H), 7.00 (t, <i>J</i> = 8.9 Hz, 1H), 4.46 (d, <i>J</i> = 6.1 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 524.1 (MH<sup>+</sup>). HRMS calcd C<sub>29</sub>H<sub>20</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub> [MH<sup>+</sup>], 524.1529; found, 524.1521.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-((4′-Amino-[1,1′-biphenyl]-4-yl)amino)-<i>N</i>-(2,4-difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5d</b>)</h4><div class="NLM_p last">Treatment of <b>10d</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 30% B to 70% B over 30 min; retention time = 15.6 min) provided <b>5d</b> as a white powder in 51% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.42 (s, 1H), 10.89 (bs, 1H), 10.67 (t, <i>J</i> = 5.8 Hz, 1H), 8.62 (dd, <i>J</i> = 4.5, 1.6 Hz, 1H), 7.85 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.47 (t, <i>J</i> = 7.9 Hz, 2H), 7.43–7.40 (m, 3H), 7.23–7.18 (m, 1H), 7.09 (d, <i>J</i> = 8.6 Hz, 2H), 7.02–7.00 (m, 2H), 6.76 (d, <i>J</i> = 8.4 Hz, 2H), 4.48 (d, <i>J</i> = 5.9 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 514.1 (MH<sup>+</sup>). HRMS calcd C<sub>28</sub>H<sub>22</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub> [MH<sup>+</sup>], 514.1685; found, 514.1690.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-2-oxo-4-(phenylamino)-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5e</b>)</h4><div class="NLM_p last">Treatment of <b>10e</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 40% B to 90% B over 30 min; retention time = 20.2 min) provided <b>5e</b> as a white powder in 86% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.39 (s, 1H), 10.86 (s, 1H), 10.65 (t, <i>J</i> = 5.7 Hz, 1H), 8.61 (dd, <i>J</i> = 4.5, 1.6 Hz, 1H), 7.75 (dd, <i>J</i> = 8.2, 1.7 Hz, 1H), 7.42 (dd, <i>J</i> = 15.4, 8.7 Hz, 1H), 7.27 (t, <i>J</i> = 7.8 Hz, 2H), 7.22–7.17 (m, 1H), 7.13–7.00 (m, 5H), 4.47 (d, <i>J</i> = 5.8 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 423.1 (MH<sup>+</sup>). HRMS calcd C<sub>22</sub>H<sub>17</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [MH<sup>+</sup>], 423.1263; found, 423.1269.</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-4-(methylamino)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5f</b>)</h4><div class="NLM_p last">Treatment of <b>10f</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 20% B to 50% B over 30 min; retention time = 26.4 min) provided <b>5f</b> as a white powder in 63% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.19 (bs, 1H), 10.08 (bs, 1H), 8.59 (d, <i>J</i> = 3.8 Hz, 1H), 8.55 (d, <i>J</i> = 8.1 Hz, 1H), 7.48 (dd, <i>J</i> = 15.4, 8.5 Hz, 1H), 7.22 (dd, <i>J</i> = 8.0, 4.5 Hz, 1H), 7.18–7.13 (m, 1H), 7.00 (dd, <i>J</i> = 9.7, 7.6 Hz, 1H), 4.42 (d, <i>J</i> = 5.6 Hz, 2H), 3.12 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 361.1 (MH<sup>+</sup>). HRMS calcd C<sub>17</sub>H<sub>15</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [MH<sup>+</sup>], 361.1107; found, 361.1105.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(2,4-Difluorobenzyl)-4-(dimethylamino)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5g</b>)</h4><div class="NLM_p last">Treatment of <b>10g</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 20% B to 45% B over 30 min; retention time = 21.6 min) provided <b>5g</b> as a yellow solid in 89% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (t, <i>J</i> = 5.9 Hz, 1H), 8.57 (dd, <i>J</i> = 4.5, 1.5 Hz, 1H), 8.19 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.70 (dd, <i>J</i> = 15.5, 8.7 Hz, 1H), 7.25 (dd, <i>J</i> = 8.0, 4.6 Hz, 1H), 7.18–7.13 (m, 1H), 7.02 (td, <i>J</i> = 8.5, 2.6 Hz, 1H), 4.38 (d, <i>J</i> = 5.8 Hz, 2H), 2.76 (s, 6H). ESI-MS <i>m</i>/<i>z</i>: 375.1 (MH<sup>+</sup>). HRMS calcd C<sub>18</sub>H<sub>17</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [MH<sup>+</sup>], 375.1263; found, 375.1260.</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-4-morpholino-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5h</b>)</h4><div class="NLM_p last">Treatment of <b>10h</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 20% B to 45% B over 30 min; retention time = 20.5 min) provided <b>5h</b> as a yellow solid in 82% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.91 (t, <i>J</i> = 5.8 Hz, 1H), 8.62–8.61 (m, 1H), 8.23 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.70 (dd, <i>J</i> = 15.4, 8.7 Hz, 1H), 7.30 (dd, <i>J</i> = 8.0, 4.6 Hz, 1H), 7.21–7.16 (m, 1H), 7.05 (td, <i>J</i> = 8.5, 2.2 Hz, 1H), 4.41 (d, <i>J</i> = 5.8 Hz, 2H), 3.67–3.65 (m, 4H), 2.98–2.96 (m, 4H). ESI-MS <i>m</i>/<i>z</i>: 417.1 (MH<sup>+</sup>). HRMS calcd C<sub>20</sub>H<sub>19</sub>F<sub>2</sub>N<sub>4</sub>O<sub>4</sub> [MH<sup>+</sup>], 417.1369; found, 417.1364.</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-(Cycloheptylamino)-<i>N</i>-(2,4-difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5i</b>)</h4><div class="NLM_p last">Treatment of <b>10i</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 40% B to 80% B over 30 min; retention time = 25.8 min) provided <b>5i</b> as a yellow solid in 87% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.68 (bs, 1H), 10.45 (t, <i>J</i> = 5.7 Hz, 1H), 8.62 (dd, <i>J</i> = 4.5, 1.5 Hz, 1H), 8.35 (dd, <i>J</i> = 8.3, 1.5 Hz, 1H), 7.45–7.39 (m, 1H), 7.26 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 7.17 (ddd, <i>J</i> = 10.5, 9.4, 2.6 Hz, 1H), 7.03–6.98 (m, 1H), 4.44 (d, <i>J</i> = 5.7 Hz, 2H), 4.02 (bs, 1H), 1.93–1.88 (m, 2H), 1.58–1.50 (m, 4H), 1.47–1.45 (m, 4H), 1.31–1.38 (s, 2H). ESI-MS <i>m</i>/<i>z</i>: 443.1 (MH<sup>+</sup>). HRMS calcd C<sub>23</sub>H<sub>25</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [MH<sup>+</sup>], 443.1889; found, 443.1897.</div></div><div id="sec4_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-2-oxo-4-(phenethylamino)-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5j</b>)</h4><div class="NLM_p last">Treatment of <b>10j</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 40% B to 80% B over 30 min; retention time = 22.0 min) provided <b>5j</b> as a yellow solid in 93% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.80 (bs, 1H), 10.36 (t, <i>J</i> = 5.8 Hz, 1H), 8.59 (dd, <i>J</i> = 4.5, 1.5 Hz, 1H), 8.48 (dd, <i>J</i> = 8.3, 1.6 Hz, 1H), 7.42 (dd, <i>J</i> = 15.3, 8.6 Hz, 1H), 7.22–7.18 (m, 6H), 7.18–7.14 (m, 1H), 7.03–6.98 (m, 1H), 4.43 (d, <i>J</i> = 5.8 Hz, 2H), 3.82–3.78 (m, 2H), 2.87 (t, <i>J</i> = 7.3 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 451.1 (MH<sup>+</sup>). HRMS calcd C<sub>24</sub>H<sub>21</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [MH<sup>+</sup>], 451.1576; found, 451.1584.</div></div><div id="sec4_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-2-oxo-4-((4-phenylbutyl)amino)-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5k</b>)</h4><div class="NLM_p last">Treatment of <b>10k</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 40% B to 80% B over 30 min; retention time = 26.7 min) provided <b>5k</b> as a yellow solid in 78% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.96 (bs, 1H), 10.48 (t, <i>J</i> = 5.5 Hz, 1H), 8.62 (dd, <i>J</i> = 4.6, 1.5 Hz, 1H), 8.51 (dd, <i>J</i> = 8.3, 1.6 Hz, 1H), 7.42 (dd, <i>J</i> = 15.4, 8.7 Hz, 1H), 7.25–7.16 (m, 4H), 7.12–7.07 (m, 3H), 7.07 (d, <i>J</i> = 7.0 Hz, 1H), 7.01–6.97 (m, 1H), 4.46 (d, <i>J</i> = 5.7 Hz, 2H), 3.61 (bs, 2H), 2.54 (t, <i>J</i> = 6.9 Hz, 2H), 1.61–1.60 (m, 4H). ESI-MS <i>m</i>/<i>z</i>: 479.2 (MH<sup>+</sup>). HRMS calcd C<sub>26</sub>H<sub>25</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [MH<sup>+</sup>], 479.1889; found, 479.1894.</div></div><div id="sec4_3_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-2-oxo-4-(pentylamino)-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5l</b>)</h4><div class="NLM_p last">Treatment of <b>10l</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 40% B to 80% B over 30 min; retention time = 23.7 min) provided <b>5l</b> as a yellow solid in 72% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.95 (bs, 1H), 10.47 (t, <i>J</i> = 5.7 Hz, 1H), 8.63 (dd, <i>J</i> = 4.5, 1.5 Hz, 1H), 8.54 (dd, <i>J</i> = 8.3, 1.5 Hz, 1H), 7.46–7.40 (m, 1H), 7.24 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 7.19 (ddd, <i>J</i> = 10.5, 9.4, 2.6 Hz, 1H), 7.04–6.99 (m, 1H), 4.46 (d, <i>J</i> = 5.8 Hz, 2H), 3.60–3.57 (m, 2H), 1.57 (dd, <i>J</i> = 14.0, 7.0 Hz, 2H), 1.29–1.21 (m, 4H), 0.81 (t, <i>J</i> = 7.1 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 417.1 (MH<sup>+</sup>). HRMS calcd C<sub>17</sub>H<sub>13</sub>F<sub>2</sub>N<sub>2</sub>O<sub>4</sub> [MH<sup>+</sup>], 417.1733; found, 417.1734.</div></div><div id="sec4_3_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-4-(isopropylamino)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5m</b>)</h4><div class="NLM_p last">Treatment of <b>10m</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 40% B to 80% B over 30 min; retention time = 17.0 min) provided <b>5m</b> as a white solid in 80% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.47 (bs, 1H), 10.42 (t, <i>J</i> = 5.9 Hz, 1H), 8.64 (dd, <i>J</i> = 4.5, 1.6 Hz, 1H), 8.41 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.44 (dd, <i>J</i> = 15.4, 8.6 Hz, 1H), 7.27 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 7.22–7.17 (m, 1H), 7.02 (td, <i>J</i> = 8.6, 2.6 Hz, 1H), 4.46 (d, <i>J</i> = 5.8 Hz, 2H), 4.17–4.09 (m, 1H), 1.20 (s, 3H), 1.18 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 389.1 (MH<sup>+</sup>). HRMS calcd C<sub>19</sub>H<sub>19</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [MH<sup>+</sup>], 389.1420; found, 389.1422.</div></div><div id="sec4_3_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-((2-Aminoethyl)amino)-<i>N</i>-(2,4-difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5n</b>)</h4><div class="NLM_p last">Treatment of <b>10n</b> as described under general procedure B and removal of <i>tert</i>-butyl protection [TFA–CH<sub>2</sub>Cl<sub>2</sub> (1:1, 2 mL), room temperature] followed by purification using preparative HPLC (linear gradient of 0% B to 40% B over 30 min; retention time = 25.9 min) provided <b>5n</b> as a white solid in 61% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.65 (s, 1H), 9.88 (t, <i>J</i> = 5.9 Hz, 1H), 9.09 (s, 1H), 8.69 (dd, <i>J</i> = 4.5, 1.3 Hz, 1H), 8.48 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.83 (bs, 2H), 7.65 (dd, <i>J</i> = 15.6, 8.8 Hz, 1H), 7.34 (dd, <i>J</i> = 8.1, 4.6 Hz, 1H), 7.27–7.21 (m, 1H), 7.08 (dd, <i>J</i> = 9.9, 7.3 Hz, 1H), 4.50 (d, <i>J</i> = 5.5 Hz, 2H), 3.68 (q, <i>J</i> = 5.9 Hz, 2H), 3.10 (bs, 2H). ESI-MS <i>m</i>/<i>z</i>: 390.1 (MH<sup>+</sup>). HRMS calcd C<sub>18</sub>H<sub>18</sub>F<sub>2</sub>N<sub>5</sub>O<sub>3</sub> [MH<sup>+</sup>], 390.1372; found, 390.1363.</div></div><div id="sec4_3_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-(2,4-Difluorobenzyl)-1-hydroxy-4-((2-hydroxyethyl)amino)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5o</b>)</h4><div class="NLM_p last">Treatment of <b>10o</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 20% B to 50% B over 30 min; retention time = 21.6 min) provided <b>5o</b> as a yellow solid in 70% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.13 (bs, 1H), 10.49 (t, <i>J</i> = 5.5 Hz, 1H), 8.62 (dd, <i>J</i> = 4.5, 1.5 Hz, 1H), 8.55 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.42 (dd, <i>J</i> = 15.3, 8.6 Hz, 1H), 7.23 (dd, <i>J</i> = 8.2, 4.5 Hz, 1H), 7.22–7.16 (m, 1H), 7.02 (dd, <i>J</i> = 9.3, 7.7 Hz, 1H), 4.46 (d, <i>J</i> = 5.6 Hz, 2H), 3.68–3.65 (m, 2H), 3.56 (t, <i>J</i> = 5.2 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 391.1 (MH<sup>+</sup>). HRMS calcd C<sub>18</sub>H<sub>17</sub>F<sub>2</sub>N<sub>4</sub>O<sub>4</sub> [MH<sup>+</sup>], 391.1212; found, 391.1215.</div></div><div id="sec4_3_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-((3-((2,4-Difluorobenzyl)carbamoyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)ethyl Acetate (<b>5p</b>)</h4><div class="NLM_p last">Treatment of <b>10p</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 30% B to 50% B over 30 min; retention time = 23.6 min) provided <b>5p</b> as a white powder in 79% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.55 (bs, 1H), 10.34 (t, <i>J</i> = 5.5 Hz, 1H), 8.69 (d, <i>J</i> = 4.5 Hz, 1H), 8.55 (d, <i>J</i> = 8.2 Hz, 1H), 7.52 (dd, <i>J</i> = 15.4, 8.6 Hz, 1H), 7.32 (dd, <i>J</i> = 8.1, 4.3 Hz, 1H), 7.27–7.22 (m, 1H), 7.07 (t, <i>J</i> = 7.4 Hz, 1H), 4.51 (d, <i>J</i> = 5.7 Hz, 2H), 4.19 (t, <i>J</i> = 5.1 Hz, 2H), 3.84 (d, <i>J</i> = 4.9 Hz, 2H), 2.00 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 433.1 (MH<sup>+</sup>). HRMS calcd C<sub>20</sub>H<sub>19</sub>F<sub>2</sub>N<sub>4</sub>O<sub>5</sub> [MH<sup>+</sup>], 433.1318; found, 433.1308.</div></div><div id="sec4_3_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Methyl 2-((3-((2,4-Difluorobenzyl)carbamoyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)acetate (<b>5q</b>)</h4><div class="NLM_p last">Treatment of <b>10q</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 20% B to 50% B over 30 min; retention time = 28.4 min) provided <b>5q</b> as a white solid in 44% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.43 (brs, 1H), 10.09 (t, <i>J</i> = 5.7 Hz, 1H), 8.62 (dd, <i>J</i> = 4.5, 1.3 Hz, 1H), 8.43 (dd, <i>J</i> = 8.2, 1.4 Hz, 1H), 7.50 (dd, <i>J</i> = 15.5, 8.7 Hz, 1H), 7.25 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 7.20–7.12 (m, 1H), 7.00 (td, <i>J</i> = 8.2, 2.4 Hz, 1H), 4.42 (s, 2H), 4.41 (s, 2H), 3.60 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 419.1 (MH<sup>+</sup>). HRMS calcd C<sub>19</sub>H<sub>17</sub>F<sub>2</sub>N<sub>4</sub>O<sub>5</sub> [MH<sup>+</sup>], 419.1162; found, 419.1163.</div></div><div id="sec4_3_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Methyl (<i>S</i>)-2-((3-((2,4-Difluorobenzyl)carbamoyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)propanoate [(<i>S</i>)-<b>5r</b>]</h4><div class="NLM_p last">Treatment of (<i>S</i>)-<b>10r</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 30% B to 50% B over 30 min; retention time = 26.4 min) provided (<i>S</i>)-<b>5r</b> as a white solid in 40% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.18 (t, <i>J</i> = 5.8 Hz, 1H), 10.02 (d, <i>J</i> = 8.4 Hz, 1H), 8.70 (dd, <i>J</i> = 4.5, 0.9 Hz, 1H), 8.46 (d, <i>J</i> = 8.2 Hz, 1H), 7.57 (dd, <i>J</i> = 15.4, 8.5 Hz, 1H), 7.34–7.31 (m, 1H), 7.23 (dd, <i>J</i> = 13.8, 6.1 Hz, 1H), 7.07 (td, <i>J</i> = 8.6, 2.7 Hz, 1H), 4.78–4.71 (m, 1H), 4.49 (qd, <i>J</i> = 15.5, 6.0 Hz, 2H), 3.61 (d, <i>J</i> = 0.5 Hz, 3H), 1.47 (d, <i>J</i> = 6.9 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 433.1 (MH<sup>+</sup>). HRMS calcd C<sub>20</sub>H<sub>19</sub>F<sub>2</sub>N<sub>4</sub>O<sub>5</sub> [MH<sup>+</sup>], 433.1318; found, 433.1305.</div></div><div id="sec4_3_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Methyl (<i>R</i>)-2-((3-((2,4-Difluorobenzyl)carbamoyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)propanoate [(<i>R</i>)-<b>5r</b>]</h4><div class="NLM_p last">Treatment of (<i>R</i>)-<b>10r</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 30% B to 50% B over 30 min; retention time = 26.4 min) provided (<i>R</i>)-<b>5r</b> as a white solid in 40% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.18 (t, <i>J</i> = 5.8 Hz, 1H), 10.02 (d, <i>J</i> = 9.6 Hz, 1H), 8.70 (dd, <i>J</i> = 4.6, 1.5 Hz, 1H), 8.46 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.57 (dd, <i>J</i> = 15.5, 8.8 Hz, 1H), 7.33 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 7.24 (ddd, <i>J</i> = 10.6, 9.4, 2.6 Hz, 1H), 7.10–7.05 (m, 1H), 4.74 (dq, <i>J</i> = 13.9, 6.9 Hz, 1H), 4.49 (qd, <i>J</i> = 15.2, 5.7 Hz, 2H), 3.61 (s, 3H), 1.47 (d, <i>J</i> = 6.9 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 433.1 (MH<sup>+</sup>). HRMS calcd C<sub>20</sub>H<sub>19</sub>F<sub>2</sub>N<sub>4</sub>O<sub>5</sub> [MH<sup>+</sup>], 433.1318; found, 433.1303.</div></div><div id="sec4_3_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Methyl (<i>S</i>)-2-((3-((2,4-Difluorobenzyl)carbamoyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)-2-phenylacetate [(<i>S</i>)-<b>5s</b>]</h4><div class="NLM_p last">Treatment of (<i>S</i>)-<b>10s</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 40% B to 70% B over 30 min; retention time = 22.6 min) provided (<i>S</i>)-<b>5r</b> as a white solid in 51% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.72 (d, <i>J</i> = 8.0 Hz, 1H), 10.57 (t, <i>J</i> = 5.9 Hz, 1H), 8.67 (dd, <i>J</i> = 4.5, 1.2 Hz, 1H), 8.46 (dd, <i>J</i> = 8.2, 1.4 Hz, 1H), 7.49 (dd, <i>J</i> = 15.4, 8.6 Hz, 1H), 7.37 (d, <i>J</i> = 4.2 Hz, 3H), 7.35–7.31 (m, 1H), 7.29–7.24 (m, 2H), 7.09 (dd, <i>J</i> = 9.8, 7.3 Hz, 1H), 6.01 (d, <i>J</i> = 8.1 Hz, 1H), 4.55 (d, <i>J</i> = 5.7 Hz, 2H), 3.61 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 495.1 (MH<sup>+</sup>). HRMS calcd C<sub>25</sub>H<sub>21</sub>F<sub>2</sub>N<sub>4</sub>O<sub>5</sub> [MH<sup>+</sup>], 495.1475; found, 495.1457.</div></div><div id="sec4_3_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Methyl (<i>R</i>)-2-((3-((2,4-Difluorobenzyl)carbamoyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)-2-phenylacetate [(<i>R</i>)-<b>5s</b>]</h4><div class="NLM_p last">Treatment of (<i>R</i>)-<b>10s</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 40% B to 60% B over 30 min; retention time = 26.3 min) provided (<i>R</i>)-<b>5s</b> as a white solid in 31% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.72 (d, <i>J</i> = 8.3 Hz, 1H), 10.57 (t, <i>J</i> = 5.4 Hz, 1H), 8.67 (d, <i>J</i> = 4.5 Hz, 1H), 8.46 (d, <i>J</i> = 8.2 Hz, 1H), 7.49 (dd, <i>J</i> = 15.2, 8.6 Hz, 1H), 7.37–7.36 (m, 2H), 7.33 (dd, <i>J</i> = 8.1, 4.1 Hz, 1H), 7.29–7.24 (m, 2H), 7.09 (dd, <i>J</i> = 9.8, 7.1 Hz, 1H), 6.01 (d, <i>J</i> = 8.1 Hz, 1H), 4.55 (d, <i>J</i> = 5.6 Hz, 2H), 3.61 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 495.1 (MH<sup>+</sup>). HRMS calcd C<sub>25</sub>H<sub>21</sub>F<sub>2</sub>N<sub>4</sub>O<sub>5</sub> [MH<sup>+</sup>], 495.1475; found, 495.1460.</div></div><div id="sec4_3_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Methyl (<i>S</i>)-2-((3-((2,4-Difluorobenzyl)carbamoyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)-3-hydroxypropanoate [(<i>S</i>)-<b>5t</b>]</h4><div class="NLM_p last">Treatment of (<i>S</i>)-<b>10t</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 30% B to 50% B over 30 min; retention time = 15.9 min) provided (<i>S</i>)-<b>5t</b> as a white solid in 44% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.72 (bs, 1H), 10.62 (bs, 1H), 10.37 (t, <i>J</i> = 5.9 Hz, 1H), 8.70 (dd, <i>J</i> = 4.5, 1.5 Hz, 1H), 8.38 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.52 (dd, <i>J</i> = 15.4, 8.7 Hz, 1H), 7.31 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 7.25 (ddd, <i>J</i> = 10.5, 9.4, 2.6 Hz, 1H), 7.10–7.06 (m, 1H), 4.77–4.72 (m, 1H), 4.51 (qd, <i>J</i> = 15.3, 5.6 Hz, 2H), 3.81 (qd, <i>J</i> = 11.1, 4.3 Hz, 2H), 3.63 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 449.1 (MH<sup>+</sup>). HRMS calcd C<sub>20</sub>H<sub>19</sub>F<sub>2</sub>N<sub>4</sub>O<sub>6</sub> [MH<sup>+</sup>], 449.1267; found, 449.1256.</div></div><div id="sec4_3_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Methyl (<i>R</i>)-2-((3-((2,4-Difluorobenzyl)carbamoyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)amino)-3-hydroxypropanoate [(<i>R</i>)-<b>5t</b>]</h4><div class="NLM_p last">Treatment of (<i>R</i>)-<b>10t</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 25% B to 50% B over 30 min; retention time = 20.5 min) provided (<i>R</i>)-<b>5t</b> as a white solid in 42% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.61 (d, <i>J</i> = 8.7 Hz, 1H), 10.37 (t, <i>J</i> = 5.6 Hz, 1H), 8.70 (dd, <i>J</i> = 4.5, 1.4 Hz, 1H), 8.38 (dd, <i>J</i> = 8.2, 1.4 Hz, 1H), 7.52 (dd, <i>J</i> = 15.6, 8.7 Hz, 1H), 7.32 (dd, <i>J</i> = 8.2, 4.6 Hz, 1H), 7.25 (ddd, <i>J</i> = 11.2, 10.6, 6.4 Hz, 1H), 7.07 (dd, <i>J</i> = 9.7, 7.3 Hz, 1H), 4.75 (dt, <i>J</i> = 8.8, 4.3 Hz, 1H), 4.51 (qd, <i>J</i> = 15.4, 5.8 Hz, 2H), 3.81 (qd, <i>J</i> = 11.0, 4.4 Hz, 2H), 3.63 (s, 3H). ESI-MS <i>m</i>/<i>z</i>: 449.1 (MH<sup>+</sup>). HRMS calcd C<sub>20</sub>H<sub>19</sub>F<sub>2</sub>N<sub>4</sub>O<sub>6</sub> [MH<sup>+</sup>], 449.1267; found, 449.1255.</div></div><div id="sec4_3_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Ethyl (<i>S</i>)-1-(3-((2,4-Difluorobenzyl)carbamoyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)pyrrolidine-2-carboxylate [(<i>S</i>)-<b>5u</b>]</h4><div class="NLM_p last">Treatment of (<i>S</i>)-<b>10u</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 40% B to 70% B over 30 min; retention time = 12.5 min) provided (<i>S</i>)-<b>5u</b> as a yellow solid in 48% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.91 (t, <i>J</i> = 5.9 Hz, 1H), 8.65 (dd, <i>J</i> = 4.6, 1.5 Hz, 1H), 8.39 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.73 (dd, <i>J</i> = 15.4, 8.7 Hz, 1H), 7.34 (dd, <i>J</i> = 8.0, 4.6 Hz, 1H), 7.26–7.20 (m, 1H), 7.09 (td, <i>J</i> = 8.6, 2.4 Hz, 1H), 4.51 (dd, <i>J</i> = 15.1, 6.3 Hz, 1H), 4.38–4.30 (m, 2H), 3.95 (q, <i>J</i> = 7.1 Hz, 2H), 3.64 (dd, <i>J</i> = 15.2, 6.4 Hz, 1H), 3.18 (dd, <i>J</i> = 12.8, 8.1 Hz, 1H), 2.11–1.93 (m, 1H), 1.92–1.87 (m, 2H), 1.80–1.76 (m, 1H), 1.03 (q, <i>J</i> = 7.0 Hz, 3H). ESI-MS <i>m</i>/<i>z</i>: 473.2 (MH<sup>+</sup>). HRMS calcd C<sub>23</sub>H<sub>23</sub>F<sub>2</sub>N<sub>4</sub>O<sub>5</sub> [MH<sup>+</sup>], 473.1631; found, 473.1618.</div></div><div id="sec4_3_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 4-Amino-<i>N</i>-(2,4-difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide (<b>5v</b>)</h4><div class="NLM_p last">Treatment of <b>10v</b> as described under general procedure B and purification by preparative HPLC (linear gradient of 30% B to 50% B over 30 min; retention time = 19.5 min) provided <b>5v</b> as a white solid in 47% yield. <sup>1</sup>H NMR (400 MHz, DMSO-d<sup>6</sup>) δ 10.59 (t, <i>J</i> = 5.8 Hz, 1H), 8.66 (dd, <i>J</i> = 4.5, 1.4 Hz, 1H), 8.61 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 7.36 (d, <i>J</i> = 6.6 Hz, 1H), 7.30 (dd, <i>J</i> = 8.1, 4.6 Hz, 1H), 7.18 (d, <i>J</i> = 9.2 Hz, 1H), 7.00 (d, <i>J</i> = 2.4 Hz, 1H), 4.46 (d, <i>J</i> = 5.8 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 347.1 (MH<sup>+</sup>). HRMS calcd C<sub>16</sub>H<sub>13</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub> [MH<sup>+</sup>], 347.0950; found, 347.0953.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Integrase Biochemical Assays</h3><div class="NLM_p last">Determination of IN 3′- P and ST inhibitory values using an in vitro assay IN reactions were carried out using [γ-<sup>32</sup>P]-labeled DNA as previously described.<a onclick="showRef(event, 'ref9 ref22'); return false;" href="javascript:void(0);" class="ref ref9 ref22">(9, 22)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Cellular Cytotoxicity Assays</h3><div class="NLM_p last">Cytotoxicity was measured using the human osteosarcoma cell line, HOS (Dr. Richard Schwartz, Michigan State University, East Lansing, MI), by monitoring ATP levels using a luciferase reporter assay as previously reported.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Single-Round HIV-1 Infectivity Assays</h3><div class="NLM_p last">As previously described,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> the human embryonic kidney cell line 293T was transfected with the pNLNgoMIVR<sup>–</sup>ΔLUC vector, which was made from pNLNgoMIVR<sup>–</sup>Δ<i>E</i>nv.HSA by removing the HSA reporter gene and replacing it with a luciferase reporter gene between the NotI and XhoI restriction sites.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> VSV-<i>g</i>-pseudotyped HIV was produced transfecting 293T cells as described previously.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> On the day prior to transfection, 293T cells were plated on 100 mm diameter dishes at a density of 1.5 × 10<sup>6</sup> cells per plate. 293T cells were transfected with 16 μg of pNLNgoMIVR<sup>–</sup>ΔLUC and 4 μg of pHCMV-g (obtained from Dr. Jane Burns, University of California, San Diego) using the calcium phosphate method. At approximately 6 h after the calcium phosphate precipitate was added, the 293T cells were washed twice with phosphate-buffered saline (PBS) and incubated with fresh media (48 h). The virus-containing supernatants were then harvested, clarified by low-speed centrifugation, filtered, and diluted for preparation in infection assays. On the day prior to the screen, HOS cells were seeded in a 96-well luminescence cell culture plate at a density of 4000 cells in 100 μL per well. On the day of the screen, cells were treated with the compounds from a concentration range of 10 μM to 0.0005 μM using 11 serial dilutions and then incubated at 37 °C (3 h). After this incubation, 100 μL of virus stock diluted to achieve a maximum luciferase signal between 0.2 and 1.5 RLUs was added to each well and the plates were incubated at 37 °C (48 h). Infectivity was measured by using the Steady-lite plus luminescence reporter gene assay system (PerkinElmer, Waltham, MA). Luciferase activity was measured by adding 100 μL of Steady-lite plus buffer (PerkinElmer) to the cells, incubating at room temperature (20 min), and measuring luminescence using a microplate reader. Activity was normalized to infectivity in the absence of target compounds. KaleidaGraph (Synergy Software, Reading, PA) was used to perform regression analysis on the data. EC<sub>50</sub> values were determined from the fit model.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Vector Constructs</h3><div class="NLM_p last">pNLNgoMIVR<sup>–</sup>Δ<i>E</i>nv.LUC has been described previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The IN coding region was removed from pNLNgoMIVR<sup>–</sup>Δ<i>E</i>nv.LUC (between <i>Kpn</i>I and <i>Sal</i>I sites) and inserted between the <i>Kpn</i>I and <i>Sal</i>I sites of pBluescript II KS+. Using this construct as the wild-type template, the following IN-resistant mutants were prepared via the QuikChange II XL (Stratagene, La Jolla, CA) site-directed mutagenesis protocol: G118R, Y143R, Q148H, Q148 K, N155H, G140S + Q148H, G140A + Q148 K, and E138 K + Q148 K. The following sense with cognate antisense (not shown) oligonucleotides (Integrated DNA Technologies, Coralville, IA) were used in the mutagenesis: G118R, 5′-GTACATACAGACAATCGCAGCAATTTCACCAGTAC-3′; E138 K, 5′-GGCGGGGATCAAGCAGAAATTTGGCATTCCCTA-3′; G140A, 5′-GGGGATCAAGCAGGAATTTGCCATTCCCTACAATC-3′; G140S, 5′-GGGGATCAAGCAGGAATTTAGCATTCCCTACAATC-3′; Y143R, 5′-GCAGGAATTTGGCATTCCCCGCAATCCCCAAAGTCAAGGA-3′; Q148H, 5′-CATTCCCTACAATCCCCAAAGTCATGGAGTAATAGAATCTA-3′; Q148 K, 5′-CATTCCCTACAATCCCCAAAGTAAAGGAGTAATAGAATCTATGAA-3′; N155H, 5′-CCAAAGTCAAGGAGTAATAGAATCTATGCATAAAGAATTAAAGAAAATTATAGGACA-3′. The double mutation G140S + Q148H was constructed by using the previously generated Q148H mutant and the appropriate oligonucleotide for the second mutation, G140S. The double mutation G140A + Q148 K was made by using the Q148 K mutant and the appropriate oligonucleotide for the second mutation, G140A. The double mutation E138 K + Q148 K was made by using the Q148 K mutant and the appropriate oligonucleotide for the second mutation, E138 K. The DNA sequence of each construct was verified independently by DNA sequence determination. The mutant IN coding sequences from pBluescript II KS+ were then subcloned into pNLNgoMIVR<sup>–</sup>Δ<i>E</i>nv.LUC (between the <i>Kpn</i>I and <i>Sal</i>I sites) to produce the full-length mutant HIV-1 IN constructs. These DNA sequences were checked independently by DNA sequence determination.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Reverse Transcriptase (RT) Assays</h3><div class="NLM_p last">The assay used to determine whether the compounds inhibit the of polymerase activity of RT has been previously described.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Briefly, the −47 sequencing primer (5′-CGCCAGGGTTTTCCCAGTCACGAC-3′; New England Biolabs) was 5′ end-labeled with [γ-<sup>32</sup>P] ATP and T4 polynucleotide kinase. After purification, the labeled primer was annealed to single-stranded M13mp18 DNA (1 μg of DNA for each sample to be assayed) by heating and slow cooling. For each sample, 0.1 μg of wild-type RT (approximately 17 nM final) added to the labeled primer template (approximately 9.0 nM) in 25 mM Tris–HCl (pH 8.0), 75 mM KCl, 10 mM MgCl<sub>2</sub>, 100 μg of BSA per mL, and 10 mM CHAPS. The reaction mixture was supplemented with 0.5 μM (each) of dATP, dCTP, dGTP, and TTP. The compounds were added to give final concentrations of 0, 0.02, 0.1, 0.5, 1, or 10 μM. The reactions were allowed to proceed at 37 °C for 60 min and were stopped by the addition of EDTA. The samples were precipitated by the addition of two volumes of EtOH, fractionated by electrophoresis on a 6.0% polyacrylamide gel, and the gel was autoradiographed. Reactions were carried out in duplicate.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> RNaseH Assays</h3><div class="NLM_p last">This procedure has been previously described.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Briefly, RNA oligonucleotide (5′-GGGGCCACUUUUUAAAAGAAAAGGGGGGACUGGAAGGGCUAAUUCACUCAC-3′) was obtained from Dharmacon Research, Inc. The RNA oligonucleotide was 5′-end labeled and was then annealed to a DNA oligonucleotide (5′-GAGTGAATTAGCCCTTCCAGTCCC-3′) by heating and slow cooling. A 0.2 μM concentration of the RNA/DNA hybrid was suspended in 25 mM Tris (pH 8.0), 50 mM NaCl, 5.0 mM MgCl<sub>2</sub>, 100 μg of bovine serum albumin/mL, 10 mM CHAPS, and 1 U of Superasin (Ambion). The compounds were added to the reactions to give the following final concentrations (0, 0.1, 0.5, 1, and 10 μM). The reaction volume was 12 μL. The reactions were initiated by the addition of 50.0 ng of RT and were incubated at 37 °C. Aliquots were removed at the indicated time points, and the reactions halted by addition of 2× gel loading buffer (Ambion). The reaction products were fractionated on a 15% polyacrylamide sequencing gel. Products were visualized by exposure to X-ray film.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm5001908" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terrence R. Burke</span> - <span class="hlFld-Affiliation affiliation">†Chemical Biology Laboratory,
and ‡HIV Drug Resistance
Program, Center for Cancer
Research, NCI at Frederick, National Institutes
of Health, Building 376,
Boyles Street, P.O. Box B, Frederick, Maryland 21702, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c0a2b5b2aba5b4a580a8a5aca9b8eeaea9a8eea7afb6"><span class="__cf_email__" data-cfemail="197b6c6b727c6d7c59717c75706137777071377e766f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xue Zhi Zhao</span> - <span class="hlFld-Affiliation affiliation">†Chemical Biology Laboratory,
and ‡HIV Drug Resistance
Program, Center for Cancer
Research, NCI at Frederick, National Institutes
of Health, Building 376,
Boyles Street, P.O. Box B, Frederick, Maryland 21702, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven J. Smith</span> - <span class="hlFld-Affiliation affiliation">†Chemical Biology Laboratory,
and ‡HIV Drug Resistance
Program, Center for Cancer
Research, NCI at Frederick, National Institutes
of Health, Building 376,
Boyles Street, P.O. Box B, Frederick, Maryland 21702, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathieu Métifiot</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Marchand</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul L. Boyer</span> - <span class="hlFld-Affiliation affiliation">†Chemical Biology Laboratory,
and ‡HIV Drug Resistance
Program, Center for Cancer
Research, NCI at Frederick, National Institutes
of Health, Building 376,
Boyles Street, P.O. Box B, Frederick, Maryland 21702, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yves Pommier</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen H. Hughes</span> - <span class="hlFld-Affiliation affiliation">†Chemical Biology Laboratory,
and ‡HIV Drug Resistance
Program, Center for Cancer
Research, NCI at Frederick, National Institutes
of Health, Building 376,
Boyles Street, P.O. Box B, Frederick, Maryland 21702, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Pharmacology, Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1633e7061-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported in part by the Intramural Research Program of the NIH, Center for Cancer Research, National Institutes of Health, NCI at Frederick, and the Joint Science and Technology Office of the Department of Defense and funds from the Intramural AIDS Targeted Antiviral Program. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i80" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i80"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> Abbreviations Used</h2><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus type 1</p></td></tr><tr><td class="NLM_term">AIDS</td><td class="NLM_def"><p class="first last">acquired immune deficiency syndrome</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">IN</td><td class="NLM_def"><p class="first last">integrase</p></td></tr><tr><td class="NLM_term">RNase H</td><td class="NLM_def"><p class="first last">ribonuclease H</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">reverse transcriptase</p></td></tr><tr><td class="NLM_term">NNRTI</td><td class="NLM_def"><p class="first last">nonnucleoside reverse transcriptase inhibitor</p></td></tr><tr><td class="NLM_term">NT</td><td class="NLM_def"><p class="first last">nucleotides</p></td></tr><tr><td class="NLM_term">RAL</td><td class="NLM_def"><p class="first last">raltegravir</p></td></tr><tr><td class="NLM_term">EVG</td><td class="NLM_def"><p class="first last">elvitegravir</p></td></tr><tr><td class="NLM_term">DTG</td><td class="NLM_def"><p class="first last">dolutegravir</p></td></tr><tr><td class="NLM_term">3′-P</td><td class="NLM_def"><p class="first last">3′-processing</p></td></tr><tr><td class="NLM_term">ST</td><td class="NLM_def"><p class="first last">strand transfer</p></td></tr><tr><td class="NLM_term">INSTIs</td><td class="NLM_def"><p class="first last">integrase strand transfer inhibitors</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">deoxyribonucleic acid</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximum inhibitory concentration</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal effective concentration</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Cherepanov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maertens, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, S.</span><span> </span><span class="NLM_article-title">Structural insights into the retroviral DNA integration apparatus</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1016%2Fj.sbi.2010.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=21277766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Kis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=249-256&author=P.+Cherepanovauthor=G.+N.+Maertensauthor=S.+Hare&title=Structural+insights+into+the+retroviral+DNA+integration+apparatus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the retroviral DNA integration apparatus</span></div><div class="casAuthors">Cherepanov, Peter; Maertens, Goedele N.; Hare, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-256</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Retroviral replication depends on successful integration of the viral genetic material into a host cell chromosome.  Virally encoded integrase, an enzyme from the DDE(D) nucleotidyltransferase superfamily, is responsible for the key DNA cutting and joining steps assocd. with this process.  Insights into the structural and mechanistic aspects of integration are directly relevant for the development of antiretroviral drugs.  Recent breakthroughs have led to biochem. and structural characterization of the principal integration intermediates revealing the tetramer of integrase that catalyzes insertion of both 3' viral DNA ends into a sharply bent target DNA.  This review discusses the mechanism of retroviral DNA integration and the mode of action of HIV-1 integrase strand transfer inhibitors in light of the recent visualization of the prototype foamy virus intasome, target DNA capture and strand transfer complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzt41KftkBkbVg90H21EOLACvtfcHk0ljMwkbNb8VyIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Kis7c%253D&md5=b60c38e193175b2576a27b8a7a40ad80</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2010.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2010.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DCherepanov%26aufirst%3DP.%26aulast%3DMaertens%26aufirst%3DG.%2BN.%26aulast%3DHare%26aufirst%3DS.%26atitle%3DStructural%2520insights%2520into%2520the%2520retroviral%2520DNA%2520integration%2520apparatus%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D249%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Croxtall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. J.</span><span> </span><span class="NLM_article-title">Raltegravir: in treatment-naive patients with HIV-1 infection</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=631-642&author=J.+D.+Croxtallauthor=L.+J.+Scott&title=Raltegravir%3A+in+treatment-naive+patients+with+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCroxtall%26aufirst%3DJ.%2BD.%26aulast%3DScott%26aufirst%3DL.%2BJ.%26atitle%3DRaltegravir%253A%2520in%2520treatment-naive%2520patients%2520with%2520HIV-1%2520infection%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26spage%3D631%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wills, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, V.</span><span> </span><span class="NLM_article-title">Elvitegravir: a once-daily inhibitor of HIV-1 integrase</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=395-401&author=T.+Willsauthor=V.+Vega&title=Elvitegravir%3A+a+once-daily+inhibitor+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWills%26aufirst%3DT.%26aulast%3DVega%26aufirst%3DV.%26atitle%3DElvitegravir%253A%2520a%2520once-daily%2520inhibitor%2520of%2520HIV-1%2520integrase%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D395%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">HIV-1 IN inhibitors: 2010 update and perspectives</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1016</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.2174%2F156802609789630910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=19747122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1016-1037&author=C.+Marchandauthor=K.+Maddaliauthor=M.+Metifiotauthor=Y.+Pommier&title=HIV-1+IN+inhibitors%3A+2010+update+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 IN inhibitors: 2010 update and perspectives</span></div><div class="casAuthors">Marchand, Christophe; Maddali, Kasthuraiah; Metifiot, Mathieu; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1016-1037</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Integrase (IN) is the newest validated target against AIDS and retroviral infections.  The remarkable activity of raltegravir (Isentress) led to its rapid approval by the FDA in 2007 as the first IN inhibitor.  Several other IN strand transfer inhibitors (STIs) are in development with the primary goal to overcome resistance due to the rapid occurrence of IN mutations in raltegravir-treated patients.  Thus, many scientists and drug companies are actively pursuing clin. useful IN inhibitors.  The objective of this review is to provide an update on the IN inhibitors reported in the last two years, including second generation STI, recently developed hydroxylated aroms., natural products, peptide, antibody and oligonucleotide inhibitors.  Addnl., the targeting of IN cofactors such as LEDGF and Vpr will be discussed as novel strategies for the treatment of AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovpn7mNYPX9bVg90H21EOLACvtfcHk0ljMwkbNb8VyIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbzN&md5=f1820ab6d7faa583030f4fd5c6872acb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F156802609789630910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789630910%26sid%3Dliteratum%253Aachs%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DHIV-1%2520IN%2520inhibitors%253A%25202010%2520update%2520and%2520perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1016%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mesplede, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quashie, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span> </span><span class="NLM_article-title">Resistance to HIV integrase inhibitors</span> <span class="citation_source-journal">Curr. Opin. HIV AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1097%2FCOH.0b013e328356db89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=22789986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2htLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=401-408&author=T.+Mespledeauthor=P.+K.+Quashieauthor=M.+A.+Wainberg&title=Resistance+to+HIV+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to HIV integrase inhibitors</span></div><div class="casAuthors">Mesplede, Thibault; Quashie, Peter K.; Wainberg, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in HIV & AIDS</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">401-408</span>CODEN:
                <span class="NLM_cas:coden">COHABM</span>;
        ISSN:<span class="NLM_cas:issn">1746-630X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: HIV integrase inhibitors are potent antiretroviral drugs that efficiently decrease viral load in patients.  Emergence of resistance mutations against this new class of drugs represents a threat to their long-term efficacy.  The purpose of this review is to provide new information about the most recent mutations identified and other mutations that confer resistance to several integrase inhibitors.  Recent findings: New resistance mutations, such as G118R, R263K and S153Y, have been recently identified through in-vitro selection studies with second-generation integrase strand-transfer inhibitors (INSTIs).  These add to the three main resistance pathways involving mutations at positions Y143, N155 and Q148.  Structural modeling, biochem. analyses and deep sequencing are methods that currently help in the understanding of the mechanisms of resistance conferred by these mutations.  Although these new resistance mutations appear to confer only low levels of cross-resistance to second-generation drugs, the Q148 pathway with numerous secondary mutations has the potential to significantly decrease susceptibility to all drugs of the INSTI family.  Summary: Recent mutations selected in vitro with second-generation INSTIs suggest the existence of low levels of cross-resistance between these drugs and first-generation compds.  In clin. practice, the emergence of mutations at position Q148 should be monitored whenever possible.  More datasets are needed to assess the long-term efficacy of second-generation INSTIs in patients failing older INSTIs such as raltegravir and elvitegravir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsULhoKhjr9bVg90H21EOLACvtfcHk0ljFjLcF38uePA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2htLrO&md5=aea851c3b23668be783f7584cb9e9507</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e328356db89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e328356db89%26sid%3Dliteratum%253Aachs%26aulast%3DMesplede%26aufirst%3DT.%26aulast%3DQuashie%26aufirst%3DP.%2BK.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26atitle%3DResistance%2520to%2520HIV%2520integrase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2012%26volume%3D7%26spage%3D401%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Geretti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armenia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccherini-Silberstein, F.</span><span> </span><span class="NLM_article-title">Emerging patterns and implications of HIV-1 integrase inhibitor resistance</span> <span class="citation_source-journal">Curr. Opin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1097%2FQCO.0b013e32835a1de7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=23086187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1OltbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=677-686&author=A.+M.+Gerettiauthor=D.+Armeniaauthor=F.+Ceccherini-Silberstein&title=Emerging+patterns+and+implications+of+HIV-1+integrase+inhibitor+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging patterns and implications of HIV-1 integrase inhibitor resistance</span></div><div class="casAuthors">Geretti, Anna Maria; Armenia, Daniele; Ceccherini-Silberstein, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Infectious Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">677-686</span>CODEN:
                <span class="NLM_cas:coden">COIDE5</span>;
        ISSN:<span class="NLM_cas:issn">0951-7375</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review highlights recent data on the pathways of resistance that impact the clin. activity of first-generation and second-generation integrase inhibitors.  Recent findings: Raltegravir (RAL) and elvitegravir (EVG) are highly efficacious in first-line antiretroviral therapy, with small nos. of virol. failures obsd. in clin. trials.  Durable activity in treatment-experienced patients requires a fully supportive background regimen.  RAL and EVG show a low-to-moderate genetic barrier to resistance and extensive cross-resistance, which preclude their sequential use.  Resistance to dolutegravir (DTG) is not selected as readily in vitro and has not emerged in studies of treatment-naive patients to date.  Both in vitro and in vivo, DTG retains activity against several RAL and EVG resistant strains, but susceptibility is variably impaired by multiple mutations within the G148 pathway, which are common after RAL or EVG failure.  Cross-resistance can be partially overcome by doubling DTG dosing to twice daily, but durability of responses remains dependent on a supportive background regimen.  There is variability in the integrase gene of circulating HIV strains, which does not appear to reduce drug activity, although it may influence the emergence and evolution of integrase resistance.  Transmission of integrase resistance remains rare but surveillance is required.  Summary: Integrase inhibitors provide a potent option for the treatment of HIV infection.  Drug resistance remains a challenge, which may be partially overcome by the introduction of second-generation compds.  Prompt management of RAL and EVG failure is required to prevent the accumulation of multiple resistance mutations that reduce DTG susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJNLh3j8EBULVg90H21EOLACvtfcHk0ljFjLcF38uePA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1OltbfE&md5=ad104b6dff368c146f9cef84a553506f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2FQCO.0b013e32835a1de7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0b013e32835a1de7%26sid%3Dliteratum%253Aachs%26aulast%3DGeretti%26aufirst%3DA.%2BM.%26aulast%3DArmenia%26aufirst%3DD.%26aulast%3DCeccherini-Silberstein%26aufirst%3DF.%26atitle%3DEmerging%2520patterns%2520and%2520implications%2520of%2520HIV-1%2520integrase%2520inhibitor%2520resistance%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D25%26spage%3D677%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Katlama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R.</span><span> </span><span class="NLM_article-title">Dolutegravir for the treatment of HIV</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=523-530&author=C.+Katlamaauthor=R.+Murphy&title=Dolutegravir+for+the+treatment+of+HIV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatlama%26aufirst%3DC.%26aulast%3DMurphy%26aufirst%3DR.%26atitle%3DDolutegravir%2520for%2520the%2520treatment%2520of%2520HIV%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D523%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ballantyne, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, C. M.</span><span> </span><span class="NLM_article-title">Dolutegravir: first global approval</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=1627-1637&author=A.+D.+Ballantyneauthor=C.+M.+Perry&title=Dolutegravir%3A+first+global+approval"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallantyne%26aufirst%3DA.%2BD.%26aulast%3DPerry%26aufirst%3DC.%2BM.%26atitle%3DDolutegravir%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2013%26volume%3D73%26spage%3D1627%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high antiviral potency against cells harboring raltegravir-resistant integrase mutants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1573</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401902n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1573-1582&author=X.+Z.+Zhaoauthor=S.+J.+Smithauthor=M.+Metifiotauthor=C.+Marchandauthor=Y.+Pommierauthor=S.+H.+Hughesauthor=T.+R.+Burke&title=4-Amino-1-hydroxy-2-oxo-1%2C8-naphthyridine-containing+compounds+having+high+antiviral+potency+against+cells+harboring+raltegravir-resistant+integrase+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm401902n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401902n%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3D4-Amino-1-hydroxy-2-oxo-1%252C8-naphthyridine-containing%2520compounds%2520having%2520high%2520antiviral%2520potency%2520against%2520cells%2520harboring%2520raltegravir-resistant%2520integrase%2520mutants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1573%26epage%3D1582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span> </span><span class="NLM_article-title">HCV NS5b RNA-dependent RNA polymerase inhibitors: From alpha, gamma-diketoacids to 4,5-dihydroxypyrimidine- or 3-methyl-5- hydroxypyrimidinonecarboxylic acids. Design and synthesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5336</span><span class="NLM_x">–</span> <span class="NLM_lpage">5339</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494669" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5336-5339&author=V.+Summaauthor=A.+Petrocchiauthor=V.+G.+Matassaauthor=M.+Talianiauthor=R.+Lauferauthor=R.+De+Francescoauthor=S.+Altamuraauthor=P.+Pace&title=HCV+NS5b+RNA-dependent+RNA+polymerase+inhibitors%3A+From+alpha%2C+gamma-diketoacids+to+4%2C5-dihydroxypyrimidine-+or+3-methyl-5-+hydroxypyrimidinonecarboxylic+acids.+Design+and+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm0494669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494669%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DTaliani%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DPace%26aufirst%3DP.%26atitle%3DHCV%2520NS5b%2520RNA-dependent%2520RNA%2520polymerase%2520inhibitors%253A%2520From%2520alpha%252C%2520gamma-diketoacids%2520to%25204%252C5-dihydroxypyrimidine-%2520or%25203-methyl-5-%2520hydroxypyrimidinonecarboxylic%2520acids.%2520Design%2520and%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5336%26epage%3D5339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paz, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span> </span><span class="NLM_article-title">4,5-Dihydroxypyrimidine carboxamides and <i>N</i>-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic rofiles in preclinical species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6646</span><span class="NLM_x">–</span> <span class="NLM_lpage">6649</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060854f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6646-6649&author=V.+Summaauthor=A.+Petrocchiauthor=V.+G.+Matassaauthor=C.+Gardelliauthor=E.+Muragliaauthor=M.+Rowleyauthor=O.+G.+Pazauthor=R.+Lauferauthor=E.+Monteagudoauthor=P.+Pace&title=4%2C5-Dihydroxypyrimidine+carboxamides+and+N-alkyl-5-hydroxypyrimidinone+carboxamides+are+potent%2C+selective+HIV+integrase+inhibitors+with+good+pharmacokinetic+rofiles+in+preclinical+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm060854f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060854f%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DPaz%26aufirst%3DO.%2BG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26atitle%3D4%252C5-Dihydroxypyrimidine%2520carboxamides%2520and%2520N-alkyl-5-hydroxypyrimidinone%2520carboxamides%2520are%2520potent%252C%2520selective%2520HIV%2520integrase%2520inhibitors%2520with%2520good%2520pharmacokinetic%2520rofiles%2520in%2520preclinical%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6646%26epage%3D6649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Williams, P. D.; Venkatraman, S.; Langford, H. M.; Kim, B.; Booth, T. M.; Grobler, J. A.; Staas, D.; Ruzek, R. D.; Embrey, M. W.; Wiscount, C. M.; Lyle, T. A.</span><span> </span><span class="NLM_article-title">Preparation of 1-hydroxynaphthyridin-2(1<i>H</i>)-one derivatives as anti-HIV agents</span>. (<span class="NLM_publisher-name">Merck & Co., Inc.</span>) WO2008010964A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+D.+Williams&author=S.+Venkatraman&author=H.+M.+Langford&author=B.+Kim&author=T.+M.+Booth&author=J.+A.+Grobler&author=D.+Staas&author=R.+D.+Ruzek&author=M.+W.+Embrey&author=C.+M.+Wiscount&author=T.+A.+Lyle&title=Preparation+of+1-hydroxynaphthyridin-2%281H%29-one+derivatives+as+anti-HIV+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26atitle%3DPreparation%2520of%25201-hydroxynaphthyridin-2%25281H%2529-one%2520derivatives%2520as%2520anti-HIV%2520agents%26pub%3DMerck%2520%2526%2520Co.%252C%2520Inc%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Su, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywickrema, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darke, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span> </span><span class="NLM_article-title">Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">7625</span><span class="NLM_x">–</span> <span class="NLM_lpage">7633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1128%2FJVI.00353-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=20484498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVejt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=7625-7633&author=H.-P.+Suauthor=Y.+Yanauthor=G.+S.+Prasadauthor=R.+F.+Smithauthor=C.+L.+Danielsauthor=P.+D.+Abeywickremaauthor=J.+C.+Reidauthor=H.+M.+Loughranauthor=M.+Kornienkoauthor=S.+Sharmaauthor=J.+A.+Groblerauthor=B.+Xuauthor=V.+Sardanaauthor=T.+J.+Allisonauthor=P.+D.+Williamsauthor=P.+L.+Darkeauthor=D.+J.+Hazudaauthor=S.+Munshi&title=Structural+basis+for+the+inhibition+of+RNase+H+activity+of+HIV-1+reverse+transcriptase+by+RNase+H+active+site-directed+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors</span></div><div class="casAuthors">Su, Hua-Poo; Yan, Youwei; Prasad, G. Sridhar; Smith, Robert F.; Daniels, Christopher L.; Abeywickrema, Pravien D.; Reid, John C.; Loughran, H. Marie; Kornienko, Maria; Sharma, Sujata; Grobler, Jay A.; Xu, Bei; Sardana, Vinod; Allison, Timothy J.; Williams, Peter D.; Darke, Paul L.; Hazuda, Daria J.; Munshi, Sanjeev</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7625-7633</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">HIV/AIDS continues to be a menace to public health.  Several drugs currently on the market have successfully improved the ability to manage the viral burden in infected patients.  However, new drugs are needed to combat the rapid emergence of mutated forms of the virus that are resistant to existing therapies.  Currently, approved drugs target three of the four major enzyme activities encoded by the virus that are crit. to the HIV life cycle.  Although a no. of inhibitors of HIV RNase H activity have been reported, few inhibit by directly engaging the RNase H active site.  Here, we describe structures of naphthyridinone-contg. inhibitors bound to the RNase H active site.  This class of compds. binds to the active site via two metal ions that are coordinated by catalytic site residues, D443, E478, D498, and D549.  The directionality of the naphthyridinone pharmacophore is restricted by the ordering of D549 and H539 in the RNase H domain.  In addn., one of the naphthyridinone-based compds. was found to bind at a second site close to the polymerase active site and non-nucleoside/nucleotide inhibitor sites in a metal-independent manner.  Further characterization, using fluorescence-based thermal denaturation and a crystal structure of the isolated RNase H domain reveals that this compd. can also bind the RNase H site and retains the metal-dependent binding mode of this class of mols.  These structures provide a means for structurally guided design of novel RNase H inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofoAtMsynlGbVg90H21EOLACvtfcHk0limg_2QycXQQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVejt77L&md5=67296baed7573ed339c9fcf985b2ff20</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FJVI.00353-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00353-10%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DH.-P.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DPrasad%26aufirst%3DG.%2BS.%26aulast%3DSmith%26aufirst%3DR.%2BF.%26aulast%3DDaniels%26aufirst%3DC.%2BL.%26aulast%3DAbeywickrema%26aufirst%3DP.%2BD.%26aulast%3DReid%26aufirst%3DJ.%2BC.%26aulast%3DLoughran%26aufirst%3DH.%2BM.%26aulast%3DKornienko%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DAllison%26aufirst%3DT.%2BJ.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMunshi%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520RNase%2520H%2520activity%2520of%2520HIV-1%2520reverse%2520transcriptase%2520by%2520RNase%2520H%2520active%2520site-directed%2520inhibitors%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D7625%26epage%3D7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzek, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feuston, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecto, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, S. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahnck, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmelberger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dornadula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrin, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span> </span><span class="NLM_article-title">Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1<i>H</i>)-one scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6754</span><span class="NLM_x">–</span> <span class="NLM_lpage">6757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6754-6757&author=P.+D.+Williamsauthor=D.+D.+Staasauthor=S.+Venkatramanauthor=H.+M.+Loughranauthor=R.+D.+Ruzekauthor=T.+M.+Boothauthor=T.+A.+Lyleauthor=J.+S.+Waiauthor=J.+P.+Vaccaauthor=B.+P.+Feustonauthor=L.+T.+Ectoauthor=J.+A.+Flynnauthor=S.+D.+J.+Diauthor=D.+J.+Hazudaauthor=C.+M.+Bahnckauthor=A.+L.+Himmelbergerauthor=G.+Dornadulaauthor=R.+C.+Hrinauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=M.+D.+Millerauthor=J.+A.+Grobler&title=Potent+and+selective+HIV-1+ribonuclease+H+inhibitors+based+on+a+1-hydroxy-1%2C8-naphthyridin-2%281H%29-one+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DStaas%26aufirst%3DD.%2BD.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DLoughran%26aufirst%3DH.%2BM.%26aulast%3DRuzek%26aufirst%3DR.%2BD.%26aulast%3DBooth%26aufirst%3DT.%2BM.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DFeuston%26aufirst%3DB.%2BP.%26aulast%3DEcto%26aufirst%3DL.%2BT.%26aulast%3DFlynn%26aufirst%3DJ.%2BA.%26aulast%3DDi%26aufirst%3DS.%2BD.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DBahnck%26aufirst%3DC.%2BM.%26aulast%3DHimmelberger%26aufirst%3DA.%2BL.%26aulast%3DDornadula%26aufirst%3DG.%26aulast%3DHrin%26aufirst%3DR.%2BC.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26atitle%3DPotent%2520and%2520selective%2520HIV-1%2520ribonuclease%2520H%2520inhibitors%2520based%2520on%2520a%25201-hydroxy-1%252C8-naphthyridin-2%25281H%2529-one%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6754%26epage%3D6757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzucoli Crucitti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scipione, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinzula, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tramontano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, R.</span><span> </span><span class="NLM_article-title">6-(1-Benzyl-1<i>H</i>-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8588</span><span class="NLM_x">–</span> <span class="NLM_lpage">8598</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401040b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8588-8598&author=R.+Costiauthor=M.+Metifiotauthor=F.+Espositoauthor=G.+Cuzzucoli+Crucittiauthor=L.+Pescatoriauthor=A.+Messoreauthor=L.+Scipioneauthor=S.+Tortorellaauthor=L.+Zinzulaauthor=C.+Marchandauthor=Y.+Pommierauthor=E.+Tramontanoauthor=R.+Di+Santo&title=6-%281-Benzyl-1H-pyrrol-2-yl%29-2%2C4-dioxo-5-hexenoic+acids+as+dual+inhibitors+of+recombinant+HIV-1+integrase+and+ribonuclease+H%2C+synthesized+by+a+parallel+synthesis+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401040b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401040b%26sid%3Dliteratum%253Aachs%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DEsposito%26aufirst%3DF.%26aulast%3DCuzzucoli%2BCrucitti%26aufirst%3DG.%26aulast%3DPescatori%26aufirst%3DL.%26aulast%3DMessore%26aufirst%3DA.%26aulast%3DScipione%26aufirst%3DL.%26aulast%3DTortorella%26aufirst%3DS.%26aulast%3DZinzula%26aufirst%3DL.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DTramontano%26aufirst%3DE.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3D6-%25281-Benzyl-1H-pyrrol-2-yl%2529-2%252C4-dioxo-5-hexenoic%2520acids%2520as%2520dual%2520inhibitors%2520of%2520recombinant%2520HIV-1%2520integrase%2520and%2520ribonuclease%2520H%252C%2520synthesized%2520by%2520a%2520parallel%2520synthesis%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8588%26epage%3D8598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Esposito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tramontano, E.</span><span> </span><span class="NLM_article-title">Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors</span> <span class="citation_source-journal">Antivir. Chem. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.3851%2FIMP2690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVOis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=129-144&author=F.+Espositoauthor=E.+Tramontano&title=Past+and+future.+Current+drugs+targeting+HIV-1+integrase+and+reverse+transcriptase-associated+ribonuclease+H+activity%3A+single+and+dual+active+site+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitor</span></div><div class="casAuthors">Esposito, Francesca; Tramontano, Enzo</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Chemistry & Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">129-144, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">ACCHEH</span>;
        ISSN:<span class="NLM_cas:issn">0956-3202</span>.
    
            (<span class="NLM_cas:orgname">International Medical Press, Ltd.</span>)
        </div><div class="casAbstract">A review.  Catalytic HIV type-1 (HIV-1) integrase (IN) and RNase H (RNase H) domains belong to the polynucleotidyl transferase superfamily and are characterized by highly conserved motifs that coordinate two divalent Mg2+ cations and are attractive targets for new antiviral agents.  Several structural features of both domains are now available.  Drugs targeting the HIV-1 IN are currently approved for anti-HIV therapy, while no drug targeting the HIV-1 RNase H function is yet available.  This review describes HIV-1 IN and the RNase H function and structures, compds. targeting their active sites and dual inhibition as a new approach for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9vIiN5tSqELVg90H21EOLACvtfcHk0ljrAuvjizWGow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVOis70%253D&md5=a92ea5750f8353d3eb4215eb8e9ab551</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3851%2FIMP2690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3851%252FIMP2690%26sid%3Dliteratum%253Aachs%26aulast%3DEsposito%26aufirst%3DF.%26aulast%3DTramontano%26aufirst%3DE.%26atitle%3DPast%2520and%2520future.%2520Current%2520drugs%2520targeting%2520HIV-1%2520integrase%2520and%2520reverse%2520transcriptase-associated%2520ribonuclease%2520H%2520activity%253A%2520single%2520and%2520dual%2520active%2520site%2520inhibitors%26jtitle%3DAntivir.%2520Chem.%2520Chemother.%26date%3D2013%26volume%3D23%26spage%3D129%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes Stephen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke Terrence, R.,  Jr.</span><span> </span><span class="NLM_article-title">Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1<i>H</i>-isoindol-1-ones and 4,5-dihydroxy-1<i>H</i>-isoindole-1,3(2<i>H</i>)-diones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">–</span> <span class="NLM_lpage">2717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2714-2717&author=X.+Z.+Zhaoauthor=K.+Maddaliauthor=B.+C.+Vuauthor=C.+Marchandauthor=H.+Hughes+Stephenauthor=Y.+Pommierauthor=R.+Burke+Terrence&title=Examination+of+halogen+substituent+effects+on+HIV-1+integrase+inhibitors+derived+from+2%2C3-dihydro-6%2C7-dihydroxy-1H-isoindol-1-ones+and+4%2C5-dihydroxy-1H-isoindole-1%2C3%282H%29-diones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%2BStephen%26aufirst%3DH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%2BTerrence%26aufirst%3DR.%26atitle%3DExamination%2520of%2520halogen%2520substituent%2520effects%2520on%2520HIV-1%2520integrase%2520inhibitors%2520derived%2520from%25202%252C3-dihydro-6%252C7-dihydroxy-1H-isoindol-1-ones%2520and%25204%252C5-dihydroxy-1H-isoindole-1%252C3%25282H%2529-diones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2714%26epage%3D2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8735</span><span class="NLM_x">–</span> <span class="NLM_lpage">8744</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3010459" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8735-8744&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=T.+Taishiauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+1.+Molecular+design+and+establishment+of+an+advanced+two-metal+binding+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm3010459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010459%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25201.%2520Molecular%2520design%2520and%2520establishment%2520of%2520an%2520advanced%2520two-metal%2520binding%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8735%26epage%3D8744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikamiyama-Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301550c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVeltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1124-1135&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=J.+G.+Weatherheadauthor=T.+Akiyamaauthor=T.+Taishiauthor=Y.+Taodaauthor=M.+Mikamiyama-Iwataauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+2.+Bi-+and+tricyclic+derivatives+result+in+superior+antiviral+and+pharmacokinetic+profiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 2. Bi- and Tricyclic Derivatives Result in Superior Antiviral and Pharmacokinetic Profiles</span></div><div class="casAuthors">Kawasuji, Takashi; Johns, Brian A.; Yoshida, Hiroshi; Weatherhead, Jason G.; Akiyama, Toshiyuki; Taishi, Teruhiko; Taoda, Yoshiyuki; Mikamiyama-Iwata, Minako; Murai, Hitoshi; Kiyama, Ryuichi; Fuji, Masahiro; Tanimoto, Norihiko; Yoshinaga, Tomokazu; Seki, Takahiro; Kobayashi, Masanori; Sato, Akihiko; Garvey, Edward P.; Fujiwara, Tamio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1124-1135</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work is a continuation of our initial discovery of a potent monocyclic carbamoyl pyridone human immunodeficiency virus type-1 (HIV-1) integrase inhibitor that displayed favorable antiviral and pharmacokinetic properties.  We report herein a series of bicyclic carbamoylpyridone (I; satd. and unsatd. bridge; R = e.g., alkoxyethyl) analogs to address conformational issues from our initial SAR studies.  This modification of the core unit succeeded to deliver low nanomolar potency in std. antiviral assays.  An addnl. hydroxyl substituent on the bicyclic scaffold provides remarkable improvement of antiviral efficacies against clin. relevant resistant viruses.  These findings led to addnl. cyclic tethering of the naked hydroxyl group resulting in tricyclic carbamoyl pyridone inhibitors (II; Y = O, N; n = 0-2; R' = e.g., alkyl, Ac, methanesulfonyl) to address remaining issues and deliver potential clin. candidates.  The tricyclic carbamoyl pyridone derivs. described herein served as the immediate leads in mols. to the next generation integrase inhibitor dolutegravir which is currently in late stage clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQLpPj5UB1TbVg90H21EOLACvtfcHk0lg-IpAOh2ABrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVeltA%253D%253D&md5=4bfe919f8fdbbc84e346e3f01e084b70</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm301550c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301550c%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMikamiyama-Iwata%26aufirst%3DM.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25202.%2520Bi-%2520and%2520tricyclic%2520derivatives%2520result%2520in%2520superior%2520antiviral%2520and%2520pharmacokinetic%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1124%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temelkoff, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5901</span><span class="NLM_x">–</span> <span class="NLM_lpage">5916</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400645w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5901-5916&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=T.+Taishiauthor=D.+P.+Temelkoffauthor=H.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=J.+Jeffreyauthor=S.+A.+Fosterauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=M.+N.+Johnsonauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors+3.+A+diastereomeric+approach+to+chiral+nonracemic+tricyclic+ring+systems+and+the+discovery+of+dolutegravir+%28S%2FGSK1349572%29+and+%28S%2FGSK1265744%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm400645w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400645w%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BN.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors%25203.%2520A%2520diastereomeric%2520approach%2520to%2520chiral%2520nonracemic%2520tricyclic%2520ring%2520systems%2520and%2520the%2520discovery%2520of%2520dolutegravir%2520%2528S%252FGSK1349572%2529%2520and%2520%2528S%252FGSK1265744%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5901%26epage%3D5916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Pratt, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDaniel, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maring, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kati, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlbrenner, W.</span><span> </span><span class="NLM_article-title">Inhibitors of HCV NS5B polymerase: synthesis and structure–activity relationships of <i>N</i>-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines</span> <span class="citation_source-journal">Bioor. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1577</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1016%2Fj.bmcl.2005.01.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=15745800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvF2ntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1577-1582&author=J.+K.+Prattauthor=P.+Donnerauthor=K.+F.+McDanielauthor=C.+J.+Maringauthor=W.+M.+Katiauthor=H.+Moauthor=T.+Middletonauthor=Y.+Liuauthor=T.+Ngauthor=Q.+Xieauthor=R.+Zhangauthor=D.+Montgomeryauthor=A.+Mollaauthor=D.+J.+Kempfauthor=W.+Kohlbrenner&title=Inhibitors+of+HCV+NS5B+polymerase%3A+synthesis+and+structure%E2%80%93activity+relationships+of+N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines</span></div><div class="casAuthors">Pratt, John K.; Donner, Pamela; McDaniel, Keith F.; Maring, Clarence J.; Kati, Warren M.; Mo, Hongmei; Middleton, Tim; Liu, Yaya; Ng, Teresa; Xie, Qinghua; Zhang, Rong; Montgomery, Debra; Molla, Akhteruzzaman; Kempf, Dale J.; Kohlbrenner, William</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1577-1582</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-1-Alkylamino and N-1-alkyloxy-4-hydroxyquinolon-3-yl benzothiadiazines were synthesized and evaluated as inhibitors of genotype 1 HCV polymerase.  The N-1-alkyloxy derivs. were not potent inhibitors, however N-1-alkylamino derivs. displayed comparable potency to carbon analogs.  Analogs with aliph. substituents were significantly more potent than those with benzylic substituents against genotype 1a polymerase.  The most potent inhibitors contained small alkyl or carbocyclic substituents and exhibited IC50's of 50-100 and 200-400 nM against genotype 1b and 1a HCV polymerase, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSYPV33mk65LVg90H21EOLACvtfcHk0lg-IpAOh2ABrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvF2ntb4%253D&md5=6645dd292495b18bfdddd3093c419e32</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.01.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.01.071%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DDonner%26aufirst%3DP.%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DMaring%26aufirst%3DC.%2BJ.%26aulast%3DKati%26aufirst%3DW.%2BM.%26aulast%3DMo%26aufirst%3DH.%26aulast%3DMiddleton%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNg%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DMontgomery%26aufirst%3DD.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DKohlbrenner%26aufirst%3DW.%26atitle%3DInhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines%26jtitle%3DBioor.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1577%26epage%3D1582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenova, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">2,3-Dihydro-6,7-dihydroxy-1<i>H</i>-isoindol-1-one-based HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070715d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=251-259&author=X.+Z.+Zhaoauthor=E.+A.+Semenovaauthor=B.+C.+Vuauthor=K.+Maddaliauthor=C.+Marchandauthor=S.+H.+Hughesauthor=Y.+Pommierauthor=T.+R.+Burke&title=2%2C3-Dihydro-6%2C7-dihydroxy-1H-isoindol-1-one-based+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm070715d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070715d%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DSemenova%26aufirst%3DE.%2BA.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3D2%252C3-Dihydro-6%252C7-dihydroxy-1H-isoindol-1-one-based%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Malet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delelis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valantin, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchertanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peytavin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouscadet, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katlama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcelin, A.-G.</span><span> </span><span class="NLM_article-title">Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1351-1358&author=I.+Maletauthor=O.+Delelisauthor=M.-A.+Valantinauthor=B.+Montesauthor=C.+Soulieauthor=M.+Wirdenauthor=L.+Tchertanovauthor=G.+Peytavinauthor=J.+Reynesauthor=J.-F.+Mouscadetauthor=C.+Katlamaauthor=V.+Calvezauthor=A.-G.+Marcelin&title=Mutations+associated+with+failure+of+raltegravir+treatment+affect+integrase+sensitivity+to+the+inhibitor+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalet%26aufirst%3DI.%26aulast%3DDelelis%26aufirst%3DO.%26aulast%3DValantin%26aufirst%3DM.-A.%26aulast%3DMontes%26aufirst%3DB.%26aulast%3DSoulie%26aufirst%3DC.%26aulast%3DWirden%26aufirst%3DM.%26aulast%3DTchertanov%26aufirst%3DL.%26aulast%3DPeytavin%26aufirst%3DG.%26aulast%3DReynes%26aufirst%3DJ.%26aulast%3DMouscadet%26aufirst%3DJ.-F.%26aulast%3DKatlama%26aufirst%3DC.%26aulast%3DCalvez%26aufirst%3DV.%26aulast%3DMarcelin%26aufirst%3DA.-G.%26atitle%3DMutations%2520associated%2520with%2520failure%2520of%2520raltegravir%2520treatment%2520affect%2520integrase%2520sensitivity%2520to%2520the%2520inhibitor%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1351%26epage%3D1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Delelis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thierry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alloui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcelin, A.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchertanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouscadet, J.-F.</span><span> </span><span class="NLM_article-title">Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2009&pages=491-501&author=O.+Delelisauthor=S.+Thierryauthor=F.+Subraauthor=F.+Simonauthor=I.+Maletauthor=C.+Allouiauthor=S.+Sayonauthor=V.+Calvezauthor=E.+Deprezauthor=A.-G.+Marcelinauthor=L.+Tchertanovauthor=J.-F.+Mouscadet&title=Impact+of+Y143+HIV-1+integrase+mutations+on+resistance+to+raltegravir+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelelis%26aufirst%3DO.%26aulast%3DThierry%26aufirst%3DS.%26aulast%3DSubra%26aufirst%3DF.%26aulast%3DSimon%26aufirst%3DF.%26aulast%3DMalet%26aufirst%3DI.%26aulast%3DAlloui%26aufirst%3DC.%26aulast%3DSayon%26aufirst%3DS.%26aulast%3DCalvez%26aufirst%3DV.%26aulast%3DDeprez%26aufirst%3DE.%26aulast%3DMarcelin%26aufirst%3DA.-G.%26aulast%3DTchertanov%26aufirst%3DL.%26aulast%3DMouscadet%26aufirst%3DJ.-F.%26atitle%3DImpact%2520of%2520Y143%2520HIV-1%2520integrase%2520mutations%2520on%2520resistance%2520to%2520raltegravir%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D54%26spage%3D491%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naumova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3715</span><span class="NLM_x">–</span> <span class="NLM_lpage">3722</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi100130f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3715-3722&author=M.+Metifiotauthor=K.+Maddaliauthor=A.+Naumovaauthor=X.+Zhangauthor=C.+Marchandauthor=Y.+Pommier&title=Biochemical+and+pharmacological+analyses+of+HIV-1+integrase+flexible+loop+mutants+resistant+to+raltegravir"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi100130f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi100130f%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DNaumova%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DBiochemical%2520and%2520pharmacological%2520analyses%2520of%2520HIV-1%2520integrase%2520flexible%2520loop%2520mutants%2520resistant%2520to%2520raltegravir%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D3715%26epage%3D3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherepanov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Activities, crystal structures and molecular dynamics of dihydro-1<i>H</i>-isoindole derivatives, inhibitors of HIV-1 integrase</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb300471n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=209-217&author=M.+Metifiotauthor=K.+Maddaliauthor=B.+C.+Johnsonauthor=S.+Hareauthor=S.+J.+Smithauthor=X.+Z.+Zhaoauthor=C.+Marchandauthor=T.+R.+Burkeauthor=S.+H.+Hughesauthor=P.+Cherepanovauthor=Y.+Pommier&title=Activities%2C+crystal+structures+and+molecular+dynamics+of+dihydro-1H-isoindole+derivatives%2C+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcb300471n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300471n%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DB.%2BC.%26aulast%3DHare%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DCherepanov%26aufirst%3DP.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DActivities%252C%2520crystal%2520structures%2520and%2520molecular%2520dynamics%2520of%2520dihydro-1H-isoindole%2520derivatives%252C%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Jacobo-Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanni, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantillo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, P.</span><span> </span><span class="NLM_article-title">Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">6320</span><span class="NLM_x">–</span> <span class="NLM_lpage">6324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=6320-6324&author=A.+Jacobo-Molinaauthor=J.+Dingauthor=R.+G.+Nanniauthor=A.+D.+Clarkauthor=X.+Luauthor=C.+Tantilloauthor=R.+L.+Williamsauthor=G.+Kamerauthor=A.+L.+Ferrisauthor=P.+Clark&title=Crystal+structure+of+human+immunodeficiency+virus+type+1+reverse+transcriptase+complexed+with+double-stranded+DNA+at+3.0+A+resolution+shows+bent+DNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobo-Molina%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DNanni%26aufirst%3DR.%2BG.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DTantillo%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DKamer%26aufirst%3DG.%26aulast%3DFerris%26aufirst%3DA.%2BL.%26aulast%3DClark%26aufirst%3DP.%26atitle%3DCrystal%2520structure%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%2520complexed%2520with%2520double-stranded%2520DNA%2520at%25203.0%2520A%2520resolution%2520shows%2520bent%2520DNA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D6320%26epage%3D6324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">Bicyclic hydroxy-1<i>H</i>-pyrrolopyridine-trione containing HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1111%2Fj.1747-0285.2011.01270.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=22107736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=157-165&author=X.+Z.+Zhaoauthor=K.+Maddaliauthor=M.+Metifiotauthor=S.+J.+Smithauthor=B.+C.+Vuauthor=C.+Marchandauthor=S.+H.+Hughesauthor=Y.+Pommierauthor=T.+R.+Burke&title=Bicyclic+hydroxy-1H-pyrrolopyridine-trione+containing+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors</span></div><div class="casAuthors">Zhao, Xue Zhi; Maddali, Kasthuraiah; Metifiot, Mathieu; Smith, Steven J.; Vu, B. Christie; Marchand, Christophe; Hughes, Stephen H.; Pommier, Yves; Burke, Terrence R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-165</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">HIV-1 integrase (IN) is a validated therapeutic target for the treatment of AIDS.  However, the emergence of resistance to raltegravir, the sole marketed FDA-approved IN inhibitor, emphasizes the need to develop second-generation inhibitors that retain efficacy against clin. relevant IN mutants.  We report herein bicyclic hydroxy-1H-pyrrolopyridinetriones as a new family of HIV-1 integrase inhibitors that were efficiently prepd. using a key "Pummerer cyclization deprotonation cycloaddn." cascade of imidosulfoxides.  In in vitro HIV-1 integrase assays, the analogs showed low micromolar inhibitory potencies with selectivity for strand transfer reactions as compared with 3'-processing inhibition.  A representative chlorofluorobenzyl hydroxypyrrolopyridinetrione retained most of its inhibitory potency against the three major raltegravir-resistant IN mutant enzymes, G140S/Q148H, Y143R, and N155H.  In antiviral assays employing viral vectors coding these IN mutants, the chlorofluorobenzyl hydroxypyrrolopyridinetrione was approx. 200- and 20-fold less affected than raltegravir against the G140S/Q148H and Y143R mutations, resp.  The representative chlorofluorobenzyl hydroxypyrrolopyridinetrione was affected approx. 10-fold less by the N155H mutation than raltegravir.  Hydroxypyrrolopyridinetriones are a novel structural class that may be further optimized to obtain HIV-1 integrase inhibitors capable of overcoming raltegravir resistance in HIV-1 strains possessing G140S/Q148H mutations in HIV-1 integrase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_-V1xazfn1LVg90H21EOLACvtfcHk0ljnqtf2HM1zpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWrtLY%253D&md5=467e940ff1b737e55486e8f578db6da0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01270.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01270.x%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DBicyclic%2520hydroxy-1H-pyrrolopyridine-trione%2520containing%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D79%26spage%3D157%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Brachmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldbruegge, M.</span><span> </span><span class="NLM_article-title">A reverse genetic approach for generating gene replacement mutants in <i>Ustilago maydis</i></span> <span class="citation_source-journal">Mol. Genet. Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1007%2Fs00438-004-1067-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=15316769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1eqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2004&pages=216-226&author=A.+Brachmannauthor=J.+Koenigauthor=C.+Juliusauthor=M.+Feldbruegge&title=A+reverse+genetic+approach+for+generating+gene+replacement+mutants+in+Ustilago+maydis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A reverse genetic approach for generating gene replacement mutants in Ustilago maydis</span></div><div class="casAuthors">Brachmann, A.; Koenig, J.; Julius, C.; Feldbruegge, M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Genomics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-226</span>CODEN:
                <span class="NLM_cas:coden">MGGOAA</span>;
        ISSN:<span class="NLM_cas:issn">1617-4615</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">We describe a versatile strategy for generating gene replacement mutants in the phytopathogenic fungus Ustilago maydis.  The system includes the choice of 32 different insertion cassettes for genetic engineering purposes, such as gene disruption and more sophisticated insertions of reporter genes, heterologous promoters or combinations of the two.  PCR-amplified flanking sequences needed for homologous recombination are ligated to the resp. insertion cassettes via Sfi I sites.  As proof of principle we generated two replacement mutants in which the endogenous promoter of the pheromone gene mfa1 drives expression of the Green Fluorescent Protein gene (gfp).  Simultaneously, expression of the mfa1 ORF is controlled either by the carbon source-regulated crg1 promoter or the nitrogen source-regulated nar1 promoter.  In both cases gfp expression was pheromone-inducible and pheromone expression was only detected when the heterologous promoters were active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqckY_KQd6m37Vg90H21EOLACvtfcHk0ljnqtf2HM1zpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1eqsLg%253D&md5=ae76faf1e45e14ef570b2cf60e8d67a3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00438-004-1067-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00438-004-1067-8%26sid%3Dliteratum%253Aachs%26aulast%3DBrachmann%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DJ.%26aulast%3DJulius%26aufirst%3DC.%26aulast%3DFeldbruegge%26aufirst%3DM.%26atitle%3DA%2520reverse%2520genetic%2520approach%2520for%2520generating%2520gene%2520replacement%2520mutants%2520in%2520Ustilago%2520maydis%26jtitle%3DMol.%2520Genet.%2520Genomics%26date%3D2004%26volume%3D272%26spage%3D216%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ivetac, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naughton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span> </span><span class="NLM_article-title">Discovery of novel inhibitors of HIV-1 reverse transcriptase through virtual screening of experimental and theoretical ensembles</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1111%2Fcbdd.12277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=24405985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2014&pages=521-531&author=A.+Ivetacauthor=S.+E.+Swiftauthor=P.+L.+Boyerauthor=A.+Diazauthor=J.+Naughtonauthor=J.+A.+T.+Youngauthor=S.+H.+Hughesauthor=J.+A.+McCammon&title=Discovery+of+novel+inhibitors+of+HIV-1+reverse+transcriptase+through+virtual+screening+of+experimental+and+theoretical+ensembles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Inhibitors of HIV-1 Reverse Transcriptase Through Virtual Screening of Experimental and Theoretical Ensembles</span></div><div class="casAuthors">Ivetac, Anthony; Swift, Sara E.; Boyer, Paul L.; Diaz, Arturo; Naughton, John; Young, John A. T.; Hughes, Stephen H.; McCammon, J. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">521-531</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are potent anti-HIV chemotherapeutics.  Although there are FDA-approved NNRTIs, challenges such as the development of resistance have limited their utility.  Here, the authors describe the identification of novel NNRTIs through a combination of computational and exptl. approaches.  Based on the known plasticity of the NNRTI binding pocket (NNIBP), the authors adopted an ensemble-based virtual screening strategy: coupling receptor conformations from 10 x-ray crystal structures with 120 snapshots from a total of 480 ns of mol. dynamics (MD) trajectories.  A screening library of 2864 National Cancer Institute (NCI) compds. was built and docked against the ensembles in a hierarchical fashion.  Sixteen diverse compds. were tested for their ability to block HIV infection in human tissue cultures using a luciferase-based reporter assay.  Three promising compds. were further characterized, using a HIV-1 RT-based polymerase assay, to det. the specific mechanism of inhibition.  The authors found that 2 of the three compds. inhibited the polymerase activity of RT (with potency similar to the pos. control, the FDA-approved drug nevirapine).  Through a computational approach, the authors were able to discover two compds. which inhibit HIV replication and block the activity of RT, thus offering the potential for optimization into mature inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomuodBYpQtSbVg90H21EOLACvtfcHk0ljnqtf2HM1zpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWmsrw%253D&md5=386dc35f21b1ebe52b51594c66b45f31</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12277%26sid%3Dliteratum%253Aachs%26aulast%3DIvetac%26aufirst%3DA.%26aulast%3DSwift%26aufirst%3DS.%2BE.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DDiaz%26aufirst%3DA.%26aulast%3DNaughton%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DJ.%2BA.%2BT.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520novel%2520inhibitors%2520of%2520HIV-1%2520reverse%2520transcriptase%2520through%2520virtual%2520screening%2520of%2520experimental%2520and%2520theoretical%2520ensembles%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2014%26volume%3D83%26spage%3D521%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Shubhranshu Shekhar Choudhury, Subhrakant Jena, Dipak Kumar Sahoo, Shamasoddin Shekh, Rajiv K. Kar, Ambuj Dhakad, Konkallu Hanumae Gowd, <span class="NLM_string-name hlFld-ContribAuthor">Himansu S. Biswal</span>. </span><span class="cited-content_cbyCitation_article-title">Gram-Scale Synthesis of 1,8-Naphthyridines in Water: The Friedlander Reaction Revisited. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (29)
                                     , 19304-19313. <a href="https://doi.org/10.1021/acsomega.1c02798" title="DOI URL">https://doi.org/10.1021/acsomega.1c02798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c02798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c02798%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DGram-Scale%252BSynthesis%252Bof%252B1%25252C8-Naphthyridines%252Bin%252BWater%25253A%252BThe%252BFriedlander%252BReaction%252BRevisited%26aulast%3DChoudhury%26aufirst%3DShubhranshu%2BShekhar%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D28052021%26date%3D29062021%26date%3D12072021%26volume%3D6%26issue%3D29%26spage%3D19304%26epage%3D19313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Steven J. Smith, Xue Zhi Zhao, Dario Oliveira Passos, Valerie E. Pye, Peter Cherepanov, Dmitry Lyumkis, Terrence R. Burke, Jr., <span class="NLM_string-name hlFld-ContribAuthor">Stephen H. Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (6)
                                     , 1469-1482. <a href="https://doi.org/10.1021/acsinfecdis.0c00819" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00819%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DHIV-1%252BIntegrase%252BInhibitors%252Bwith%252BModifications%252BThat%252BAffect%252BTheir%252BPotencies%252Bagainst%252BDrug%252BResistant%252BIntegrase%252BMutants%26aulast%3DSmith%26aufirst%3DSteven%2BJ.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D23112020%26date%3D09032021%26volume%3D7%26issue%3D6%26spage%3D1469%26epage%3D1482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Maskell</span>, <span class="hlFld-ContribAuthor ">Mathieu  Métifiot</span>, <span class="hlFld-ContribAuthor ">Valerie E.  Pye</span>, <span class="hlFld-ContribAuthor ">Katherine  Fesen</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Peter  Cherepanov</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, and <span class="hlFld-ContribAuthor ">Terrence R.  Burke, Jr.</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7315-7332. <a href="https://doi.org/10.1021/acs.jmedchem.7b00596" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00596%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BOptimization%252Bof%252BHIV%252BIntegrase%252BStrand%252BTransfer%252BInhibitors%26aulast%3DZhao%26aufirst%3DXue%2BZhi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D24042017%26date%3D10082017%26date%3D14092017%26date%3D24072017%26volume%3D60%26issue%3D17%26spage%3D7315%26epage%3D7332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Maskell</span>, <span class="hlFld-ContribAuthor ">Mathieu  Metifiot</span>, <span class="hlFld-ContribAuthor ">Valerie E.  Pye</span>, <span class="hlFld-ContribAuthor ">Katherine  Fesen</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Peter  Cherepanov</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, and <span class="hlFld-ContribAuthor ">Terrence R.  Burke, Jr.</span>  . </span><span class="cited-content_cbyCitation_article-title">HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (4)
                                     , 1074-1081. <a href="https://doi.org/10.1021/acschembio.5b00948" title="DOI URL">https://doi.org/10.1021/acschembio.5b00948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.5b00948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.5b00948%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DHIV-1%252BIntegrase%252BStrand%252BTransfer%252BInhibitors%252Bwith%252BReduced%252BSusceptibility%252Bto%252BDrug%252BResistant%252BMutant%252BIntegrases%26aulast%3DZhao%26aufirst%3DXue%2BZhi%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D17112015%26date%3D25012016%26date%3D05022016%26date%3D15042016%26date%3D25012016%26volume%3D11%26issue%3D4%26spage%3D1074%26epage%3D1081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Endika  Martín-Encinas</span>, <span class="hlFld-ContribAuthor ">Gloria  Rubiales</span>, <span class="hlFld-ContribAuthor ">Birgitta R.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Francisco  Palacios</span>, <span class="hlFld-ContribAuthor ">Concepción  Alonso</span>. </span><span class="cited-content_cbyCitation_article-title">Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>40 </em>, 116177. <a href="https://doi.org/10.1016/j.bmc.2021.116177" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116177%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DFused%252Bchromeno%252Band%252Bquinolino%25255B1%25252C8%25255Dnaphthyridines%25253A%252BSynthesis%252Band%252Bbiological%252Bevaluation%252Bas%252Btopoisomerase%252BI%252Binhibitors%252Band%252Bantiproliferative%252Bagents%26aulast%3DMart%25C3%25ADn-Encinas%26aufirst%3DEndika%26date%3D2021%26volume%3D40%26spage%3D116177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Dario Oliveira  Passos</span>, <span class="hlFld-ContribAuthor ">Dmitry  Lyumkis</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs. </span><span class="cited-content_cbyCitation_journal-name">Viruses</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 205. <a href="https://doi.org/10.3390/v13020205" title="DOI URL">https://doi.org/10.3390/v13020205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/v13020205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fv13020205%26sid%3Dliteratum%253Aachs%26jtitle%3DViruses%26atitle%3DIntegrase%252BStrand%252BTransfer%252BInhibitors%252BAre%252BEffective%252BAnti-HIV%252BDrugs%26aulast%3DSmith%26aufirst%3DSteven%2BJ.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilona K.  Jóźwik</span>, <span class="hlFld-ContribAuthor ">Dario O.  Passos</span>, <span class="hlFld-ContribAuthor ">Dmitry  Lyumkis</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Biology of HIV Integrase Strand Transfer Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2020,</strong> <em>41 </em>
                                    (9)
                                     , 611-626. <a href="https://doi.org/10.1016/j.tips.2020.06.003" title="DOI URL">https://doi.org/10.1016/j.tips.2020.06.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2020.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2020.06.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DStructural%252BBiology%252Bof%252BHIV%252BIntegrase%252BStrand%252BTransfer%252BInhibitors%26aulast%3DJ%25C3%25B3%25C5%25BAwik%26aufirst%3DIlona%2BK.%26date%3D2020%26volume%3D41%26issue%3D9%26spage%3D611%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dario Oliveira  Passos</span>, <span class="hlFld-ContribAuthor ">Min  Li</span>, <span class="hlFld-ContribAuthor ">Ilona K.  Jóźwik</span>, <span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Diogo  Santos-Martins</span>, <span class="hlFld-ContribAuthor ">Renbin  Yang</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Youngmin  Jeon</span>, <span class="hlFld-ContribAuthor ">Stefano  Forli</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Robert  Craigie</span>, <span class="hlFld-ContribAuthor ">Dmitry  Lyumkis</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis for strand-transfer inhibitor binding to HIV intasomes. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2020,</strong> <em>367 </em>
                                    (6479)
                                     , 810-814. <a href="https://doi.org/10.1126/science.aay8015" title="DOI URL">https://doi.org/10.1126/science.aay8015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.aay8015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.aay8015%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DStructural%252Bbasis%252Bfor%252Bstrand-transfer%252Binhibitor%252Bbinding%252Bto%252BHIV%252Bintasomes%26aulast%3DPassos%26aufirst%3DDario%2BOliveira%26date%3D2020%26date%3D2020%26volume%3D367%26issue%3D6479%26spage%3D810%26epage%3D814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sailu  Betala</span>, <span class="hlFld-ContribAuthor ">Hanumandlu  Racha</span>, <span class="hlFld-ContribAuthor ">Chiranjeevi  Abba</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel Triazolothione, Thiadiazole, Triazole and Oxadiazole Functionalized Tri-fluoromethylnaphthyridine Derivatives and their Anticancer Activity & Antimicrobial Activity. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2020,</strong> <em>32 </em>
                                    (8)
                                     , 1931-1940. <a href="https://doi.org/10.14233/ajchem.2020.22688" title="DOI URL">https://doi.org/10.14233/ajchem.2020.22688</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2020.22688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2020.22688%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Bof%252BNovel%252BTriazolothione%25252C%252BThiadiazole%25252C%252BTriazole%252Band%252BOxadiazole%252BFunctionalized%252BTri-fluoromethylnaphthyridine%252BDerivatives%252Band%252Btheir%252BAnticancer%252BActivity%252B%252526%252BAntimicrobial%252BActivity%26aulast%3DBetala%26aufirst%3DSailu%26date%3D2020%26date%3D2020%26volume%3D32%26issue%3D8%26spage%3D1931%26epage%3D1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruo  Wang</span>, <span class="hlFld-ContribAuthor ">Kai  Xu</span>, <span class="hlFld-ContribAuthor ">Weixiong  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Quinolone derivatives: Potential anti‐HIV agent—development and application. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (9)
                                     , 1900045. <a href="https://doi.org/10.1002/ardp.201900045" title="DOI URL">https://doi.org/10.1002/ardp.201900045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900045%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DQuinolone%252Bderivatives%25253A%252BPotential%252Banti%2525E2%252580%252590HIV%252Bagent%2525E2%252580%252594development%252Band%252Bapplication%26aulast%3DWang%26aufirst%3DRuo%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D9%26spage%3D1900045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">RAMALINGAM  KUNDENAPALLY</span>, <span class="hlFld-ContribAuthor ">RAMESH  DOMALA</span>, <span class="hlFld-ContribAuthor ">B.  SREENIVASULU</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Synthesis of Novel [N-(4-Oxo-3-(2-phenyl-1,8-naphthyridin-3-yl)-thiazolidin-2-ylidene)]acetamide/benzamides and their Biological Activity. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Chemistry</span><span> <strong>2019,</strong> <em>31 </em>
                                    (6)
                                     , 1246-1250. <a href="https://doi.org/10.14233/ajchem.2019.21881" title="DOI URL">https://doi.org/10.14233/ajchem.2019.21881</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.14233/ajchem.2019.21881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.14233%2Fajchem.2019.21881%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Chemistry%26atitle%3DRegioselective%252BSynthesis%252Bof%252BNovel%252B%25255BN-%2525284-Oxo-3-%2525282-phenyl-1%25252C8-naphthyridin-3-yl%252529-thiazolidin-2-ylidene%252529%25255Dacetamide%25252Fbenzamides%252Band%252Btheir%252BBiological%252BActivity%26aulast%3DKUNDENAPALLY%26aufirst%3DRAMALINGAM%26date%3D2019%26date%3D2019%26volume%3D31%26issue%3D6%26spage%3D1246%26epage%3D1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farideh Badichi  Akher</span>, <span class="hlFld-ContribAuthor ">Abdolkarim  Farrokhzadeh</span>, <span class="hlFld-ContribAuthor ">Bahareh  Honarparvar</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of substituent and π-stacking interaction on the metal chelation ability of 7-subestituted 2-oxyisoquinoline-1,3(2H,4H)-diones as an HIV integrase inhibitor: A DFT study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1175 </em>, 734-744. <a href="https://doi.org/10.1016/j.molstruc.2018.08.042" title="DOI URL">https://doi.org/10.1016/j.molstruc.2018.08.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2018.08.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2018.08.042%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DEffect%252Bof%252Bsubstituent%252Band%252B%2525CF%252580-stacking%252Binteraction%252Bon%252Bthe%252Bmetal%252Bchelation%252Bability%252Bof%252B7-subestituted%252B2-oxyisoquinoline-1%25252C3%2525282H%25252C4H%252529-diones%252Bas%252Ban%252BHIV%252Bintegrase%252Binhibitor%25253A%252BA%252BDFT%252Bstudy%26aulast%3DAkher%26aufirst%3DFarideh%2BBadichi%26date%3D2019%26volume%3D1175%26spage%3D734%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants. </span><span class="cited-content_cbyCitation_journal-name">Retrovirology</span><span> <strong>2018,</strong> <em>15 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12977-018-0420-7" title="DOI URL">https://doi.org/10.1186/s12977-018-0420-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12977-018-0420-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12977-018-0420-7%26sid%3Dliteratum%253Aachs%26jtitle%3DRetrovirology%26atitle%3DEfficacies%252Bof%252BCabotegravir%252Band%252BBictegravir%252Bagainst%252Bdrug-resistant%252BHIV-1%252Bintegrase%252Bmutants%26aulast%3DSmith%26aufirst%3DSteven%2BJ.%26date%3D2018%26date%3D2018%26volume%3D15%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guiqing  Xu</span>, <span class="hlFld-ContribAuthor ">Yuan  Gao</span>, <span class="hlFld-ContribAuthor ">Bin  Sun</span>, <span class="hlFld-ContribAuthor ">Lizeng  Peng</span>, <span class="hlFld-ContribAuthor ">Longfei  Mao</span>, <span class="hlFld-ContribAuthor ">Yuqin  Jiang</span>, <span class="hlFld-ContribAuthor ">Qingjie  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">A Convenient Synthesis and Biological Research of Novel 5,6,7,8-Tetrahydro-1,6-naphthyridin-2(1
              H
              )-one Derivatives Hydrochloride as Cytotoxic Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2018,</strong> <em>55 </em>
                                    (9)
                                     , 2151-2156. <a href="https://doi.org/10.1002/jhet.3273" title="DOI URL">https://doi.org/10.1002/jhet.3273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3273%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DA%252BConvenient%252BSynthesis%252Band%252BBiological%252BResearch%252Bof%252BNovel%252B5%25252C6%25252C7%25252C8-Tetrahydro-1%25252C6-naphthyridin-2%2525281%252BH%252B%252529-one%252BDerivatives%252BHydrochloride%252Bas%252BCytotoxic%252BAgents%26aulast%3DXu%26aufirst%3DGuiqing%26date%3D2018%26date%3D2018%26volume%3D55%26issue%3D9%26spage%3D2151%26epage%3D2156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul L.  Boyer</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Kalyan  Das</span>, <span class="hlFld-ContribAuthor ">Kevin  Gruber</span>, <span class="hlFld-ContribAuthor ">Eddy  Arnold</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, . </span><span class="cited-content_cbyCitation_article-title">Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2018,</strong> <em>92 </em>
                                    (13)
                                     <a href="https://doi.org/10.1128/JVI.02203-17" title="DOI URL">https://doi.org/10.1128/JVI.02203-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.02203-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.02203-17%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DDeveloping%252Band%252BEvaluating%252BInhibitors%252Bagainst%252Bthe%252BRNase%252BH%252BActive%252BSite%252Bof%252BHIV-1%252BReverse%252BTranscriptase%26aulast%3DBoyer%26aufirst%3DPaul%2BL.%26date%3D2018%26volume%3D92%26issue%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.  Croix</span>, <span class="hlFld-ContribAuthor ">S.  Massip</span>, <span class="hlFld-ContribAuthor ">M.-C.  Viaud-Massuard</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of naphthyridin-2(1
              H
              )-one derivatives
              via
              ring expansion of 3-substituted-1
              H
              -pyrrolo[2,3-
              b
              ]pyridin-2(3
              H
              )-one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (44)
                                     , 5538-5541. <a href="https://doi.org/10.1039/C8CC01518J" title="DOI URL">https://doi.org/10.1039/C8CC01518J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC01518J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC01518J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DSynthesis%252Bof%252Bnaphthyridin-2%2525281%252BH%252B%252529-one%252Bderivatives%252Bvia%252Bring%252Bexpansion%252Bof%252B3-substituted-1%252BH%252B-pyrrolo%25255B2%25252C3-%252Bb%252B%25255Dpyridin-2%2525283%252BH%252B%252529-one%252Bderivatives%26aulast%3DCroix%26aufirst%3DC.%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D44%26spage%3D5538%26epage%3D5541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie B.  Ealy</span>, <span class="hlFld-ContribAuthor ">Noorhaan  Abouomar</span>, <span class="hlFld-ContribAuthor ">Justin  Cogan</span>, <span class="hlFld-ContribAuthor ">Paolo  Flauta</span>, <span class="hlFld-ContribAuthor ">Liliana  Nassar</span>, <span class="hlFld-ContribAuthor ">Matthew  Mekolochik</span>, <span class="hlFld-ContribAuthor ">Sarah  Ramzy</span>, <span class="hlFld-ContribAuthor ">Christopher  Shannon</span>, <span class="hlFld-ContribAuthor ">Habib  Yazgi</span>. </span><span class="cited-content_cbyCitation_article-title">Estimated Binding Energies of Drug-Like and Nondrug-Like Molecules in the Active Site of HIV-1 Integrase, 1BIS.pdb, and Two Mutant Models: Y143R and N155H. </span><span class="cited-content_cbyCitation_journal-name">Advances in Bioscience and Biotechnology</span><span> <strong>2017,</strong> <em>08 </em>
                                    (05)
                                     , 163-183. <a href="https://doi.org/10.4236/abb.2017.85013" title="DOI URL">https://doi.org/10.4236/abb.2017.85013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4236/abb.2017.85013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4236%2Fabb.2017.85013%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvances%2520in%2520Bioscience%2520and%2520Biotechnology%26atitle%3DEstimated%252BBinding%252BEnergies%252Bof%252BDrug-Like%252Band%252BNondrug-Like%252BMolecules%252Bin%252Bthe%252BActive%252BSite%252Bof%252BHIV-1%252BIntegrase%25252C%252B1BIS.pdb%25252C%252Band%252BTwo%252BMutant%252BModels%25253A%252BY143R%252Band%252BN155H%26aulast%3DEaly%26aufirst%3DJulie%2BB.%26date%3D2017%26volume%3D08%26issue%3D05%26spage%3D163%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guan-Nan  Liu</span>, <span class="hlFld-ContribAuthor ">Rong-Hua  Luo</span>, <span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Xing-Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Liu-Meng  Yang</span>, <span class="hlFld-ContribAuthor ">Yong-Tang  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anti-HIV-1 Activity Evaluation for Novel 3a,6a-Dihydro-1H-pyrrolo[3,4-c]pyrazole-4,6-dione Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (9)
                                     , 1198. <a href="https://doi.org/10.3390/molecules21091198" title="DOI URL">https://doi.org/10.3390/molecules21091198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21091198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21091198%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BAnti-HIV-1%252BActivity%252BEvaluation%252Bfor%252BNovel%252B3a%25252C6a-Dihydro-1H-pyrrolo%25255B3%25252C4-c%25255Dpyrazole-4%25252C6-dione%252BDerivatives%26aulast%3DLiu%26aufirst%3DGuan-Nan%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D9%26spage%3D1198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathieu  Métifiot</span>, <span class="hlFld-ContribAuthor ">Barry C.  Johnson</span>, <span class="hlFld-ContribAuthor ">Evgeny  Kiselev</span>, <span class="hlFld-ContribAuthor ">Laura  Marler</span>, <span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Terrence R.  Burke</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>. </span><span class="cited-content_cbyCitation_article-title">Selectivity for strand-transfer over 3′-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme–DNA interactions in the active site. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acids Research</span><span> <strong>2016,</strong> <em>44 </em>
                                    (14)
                                     , 6896-6906. <a href="https://doi.org/10.1093/nar/gkw592" title="DOI URL">https://doi.org/10.1093/nar/gkw592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/nar/gkw592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fnar%2Fgkw592%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acids%2520Research%26atitle%3DSelectivity%252Bfor%252Bstrand-transfer%252Bover%252B3%2525E2%252580%2525B2-processing%252Band%252Bsusceptibility%252Bto%252Bclinical%252Bresistance%252Bof%252BHIV-1%252Bintegrase%252Binhibitors%252Bare%252Bdriven%252Bby%252Bkey%252Benzyme%2525E2%252580%252593DNA%252Binteractions%252Bin%252Bthe%252Bactive%252Bsite%26aulast%3DM%25C3%25A9tifiot%26aufirst%3DMathieu%26date%3D2016%26date%3D2016%26volume%3D44%26issue%3D14%26spage%3D6896%26epage%3D6906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin-Bin  Feng</span>, <span class="hlFld-ContribAuthor ">Lian  Lu</span>, <span class="hlFld-ContribAuthor ">Chao  Li</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine-catalyzed synthesis of dibenzo[b,h][1,6]naphthyridine-11-carboxamides via a domino reaction involving double elimination of hydrogen bromide. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (9)
                                     , 2774-2779. <a href="https://doi.org/10.1039/C5OB02620B" title="DOI URL">https://doi.org/10.1039/C5OB02620B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02620B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02620B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DIodine-catalyzed%252Bsynthesis%252Bof%252Bdibenzo%25255Bb%25252Ch%25255D%25255B1%25252C6%25255Dnaphthyridine-11-carboxamides%252Bvia%252Ba%252Bdomino%252Breaction%252Binvolving%252Bdouble%252Belimination%252Bof%252Bhydrogen%252Bbromide%26aulast%3DFeng%26aufirst%3DBin-Bin%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D9%26spage%3D2774%26epage%3D2779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alka  Madaan</span>, <span class="hlFld-ContribAuthor ">Ritu  Verma</span>, <span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Anu T.  Singh</span>, <span class="hlFld-ContribAuthor ">Swatantra K.  Jain</span>, <span class="hlFld-ContribAuthor ">Manu  Jaggi</span>. </span><span class="cited-content_cbyCitation_article-title">1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2015,</strong> <em>348 </em>
                                    (12)
                                     , 837-860. <a href="https://doi.org/10.1002/ardp.201500237" title="DOI URL">https://doi.org/10.1002/ardp.201500237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201500237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201500237%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3D1%25252C8-Naphthyridine%252BDerivatives%25253A%252BA%252BReview%252Bof%252BMultiple%252BBiological%252BActivities%26aulast%3DMadaan%26aufirst%3DAlka%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D12%26spage%3D837%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001908&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of HIV-1 integrase inhibitors described in the text. Mg<sup>2+</sup>-chelating heteroatoms are shown in red, with the 4-position of the 1-hydroxy-1,8-naphthyridin-2(1<i>H</i>)-one ring being indicated in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001908&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. HIV-1 ribonuclease H (RNase H) inhibitors <b>6</b> and integrase inhibitor <b>5a</b> with the core metal-chelating 1-hydroxy-1,8-naphthyridin-2(1<i>H</i>)-one system shown in red and the key 4-amino group indicated in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001908&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-Amino-<i>N</i>-(2,4-difluorobenzyl)-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamides <b>5a</b>–<b>5v</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001908&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2,4-diFBnNH<sub>2</sub>; (ii) TsCl, TEA, MeCN; (iii) R<sup>1</sup>R<sup>2</sup>NH or R<sup>1</sup>R<sup>2</sup>NH-HCl, DIEA, DMF; (iv) Ac<sub>2</sub>O, TEA, DCM; (v) TFA, DCM; (vi) H<sub>2</sub>, 10% Pd·C, MeOH.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/medium/jm-2014-001908_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Polymerase and RNase H inhibition assays (A): The effects of <b>5p</b>, <b>5q</b>, and <b>5v</b> on the DNA-dependent DNA polymerase activity of RT are shown. Reactions were performed with WT RT in the presence of various concentrations of compounds (0, 0.02, 0.1, 0.5, 1, or 10 μM). Samples were precipitated with EtOH and then fractionated on a 15% polyacrylamide sequencing gel. After electrophoresis, the gel was exposed to X-ray film. RNase H inhibition assay (B,C,D): The effects of <b>5p</b>, <b>5q</b>, and <b>5v</b> on the RNase H activity of RT are shown. The reactions were incubated for the amount of time indicated (1, 5, 10, and 15 min) in the presence of the indicated concentration of the individual compounds (0, 0.1, 0.5, 1, and 10 μM). The size of intact RNA (full length) is 60 NT, as shown in the “No-RT” lane. The RNA fragments derived from the −17 and −8 families of cleavages are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-12/jm5001908/20150605/images/large/jm-2014-001908_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001908&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i82">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Cherepanov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maertens, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, S.</span><span> </span><span class="NLM_article-title">Structural insights into the retroviral DNA integration apparatus</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1016%2Fj.sbi.2010.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=21277766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Kis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=249-256&author=P.+Cherepanovauthor=G.+N.+Maertensauthor=S.+Hare&title=Structural+insights+into+the+retroviral+DNA+integration+apparatus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the retroviral DNA integration apparatus</span></div><div class="casAuthors">Cherepanov, Peter; Maertens, Goedele N.; Hare, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-256</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Retroviral replication depends on successful integration of the viral genetic material into a host cell chromosome.  Virally encoded integrase, an enzyme from the DDE(D) nucleotidyltransferase superfamily, is responsible for the key DNA cutting and joining steps assocd. with this process.  Insights into the structural and mechanistic aspects of integration are directly relevant for the development of antiretroviral drugs.  Recent breakthroughs have led to biochem. and structural characterization of the principal integration intermediates revealing the tetramer of integrase that catalyzes insertion of both 3' viral DNA ends into a sharply bent target DNA.  This review discusses the mechanism of retroviral DNA integration and the mode of action of HIV-1 integrase strand transfer inhibitors in light of the recent visualization of the prototype foamy virus intasome, target DNA capture and strand transfer complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzt41KftkBkbVg90H21EOLACvtfcHk0lh4z29w4qoRqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Kis7c%253D&md5=b60c38e193175b2576a27b8a7a40ad80</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2010.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2010.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DCherepanov%26aufirst%3DP.%26aulast%3DMaertens%26aufirst%3DG.%2BN.%26aulast%3DHare%26aufirst%3DS.%26atitle%3DStructural%2520insights%2520into%2520the%2520retroviral%2520DNA%2520integration%2520apparatus%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D249%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Croxtall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. J.</span><span> </span><span class="NLM_article-title">Raltegravir: in treatment-naive patients with HIV-1 infection</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=631-642&author=J.+D.+Croxtallauthor=L.+J.+Scott&title=Raltegravir%3A+in+treatment-naive+patients+with+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCroxtall%26aufirst%3DJ.%2BD.%26aulast%3DScott%26aufirst%3DL.%2BJ.%26atitle%3DRaltegravir%253A%2520in%2520treatment-naive%2520patients%2520with%2520HIV-1%2520infection%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26spage%3D631%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wills, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, V.</span><span> </span><span class="NLM_article-title">Elvitegravir: a once-daily inhibitor of HIV-1 integrase</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=395-401&author=T.+Willsauthor=V.+Vega&title=Elvitegravir%3A+a+once-daily+inhibitor+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWills%26aufirst%3DT.%26aulast%3DVega%26aufirst%3DV.%26atitle%3DElvitegravir%253A%2520a%2520once-daily%2520inhibitor%2520of%2520HIV-1%2520integrase%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D395%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">HIV-1 IN inhibitors: 2010 update and perspectives</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1016</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.2174%2F156802609789630910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=19747122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1016-1037&author=C.+Marchandauthor=K.+Maddaliauthor=M.+Metifiotauthor=Y.+Pommier&title=HIV-1+IN+inhibitors%3A+2010+update+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 IN inhibitors: 2010 update and perspectives</span></div><div class="casAuthors">Marchand, Christophe; Maddali, Kasthuraiah; Metifiot, Mathieu; Pommier, Yves</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1016-1037</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Integrase (IN) is the newest validated target against AIDS and retroviral infections.  The remarkable activity of raltegravir (Isentress) led to its rapid approval by the FDA in 2007 as the first IN inhibitor.  Several other IN strand transfer inhibitors (STIs) are in development with the primary goal to overcome resistance due to the rapid occurrence of IN mutations in raltegravir-treated patients.  Thus, many scientists and drug companies are actively pursuing clin. useful IN inhibitors.  The objective of this review is to provide an update on the IN inhibitors reported in the last two years, including second generation STI, recently developed hydroxylated aroms., natural products, peptide, antibody and oligonucleotide inhibitors.  Addnl., the targeting of IN cofactors such as LEDGF and Vpr will be discussed as novel strategies for the treatment of AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovpn7mNYPX9bVg90H21EOLACvtfcHk0lj0UyXNQPxtoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWisbzN&md5=f1820ab6d7faa583030f4fd5c6872acb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F156802609789630910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789630910%26sid%3Dliteratum%253Aachs%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DHIV-1%2520IN%2520inhibitors%253A%25202010%2520update%2520and%2520perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1016%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mesplede, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quashie, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wainberg, M. A.</span><span> </span><span class="NLM_article-title">Resistance to HIV integrase inhibitors</span> <span class="citation_source-journal">Curr. Opin. HIV AIDS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1097%2FCOH.0b013e328356db89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=22789986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtF2htLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=401-408&author=T.+Mespledeauthor=P.+K.+Quashieauthor=M.+A.+Wainberg&title=Resistance+to+HIV+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance to HIV integrase inhibitors</span></div><div class="casAuthors">Mesplede, Thibault; Quashie, Peter K.; Wainberg, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in HIV & AIDS</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">401-408</span>CODEN:
                <span class="NLM_cas:coden">COHABM</span>;
        ISSN:<span class="NLM_cas:issn">1746-630X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: HIV integrase inhibitors are potent antiretroviral drugs that efficiently decrease viral load in patients.  Emergence of resistance mutations against this new class of drugs represents a threat to their long-term efficacy.  The purpose of this review is to provide new information about the most recent mutations identified and other mutations that confer resistance to several integrase inhibitors.  Recent findings: New resistance mutations, such as G118R, R263K and S153Y, have been recently identified through in-vitro selection studies with second-generation integrase strand-transfer inhibitors (INSTIs).  These add to the three main resistance pathways involving mutations at positions Y143, N155 and Q148.  Structural modeling, biochem. analyses and deep sequencing are methods that currently help in the understanding of the mechanisms of resistance conferred by these mutations.  Although these new resistance mutations appear to confer only low levels of cross-resistance to second-generation drugs, the Q148 pathway with numerous secondary mutations has the potential to significantly decrease susceptibility to all drugs of the INSTI family.  Summary: Recent mutations selected in vitro with second-generation INSTIs suggest the existence of low levels of cross-resistance between these drugs and first-generation compds.  In clin. practice, the emergence of mutations at position Q148 should be monitored whenever possible.  More datasets are needed to assess the long-term efficacy of second-generation INSTIs in patients failing older INSTIs such as raltegravir and elvitegravir.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsULhoKhjr9bVg90H21EOLACvtfcHk0lgILqr-uAuCvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtF2htLrO&md5=aea851c3b23668be783f7584cb9e9507</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e328356db89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e328356db89%26sid%3Dliteratum%253Aachs%26aulast%3DMesplede%26aufirst%3DT.%26aulast%3DQuashie%26aufirst%3DP.%2BK.%26aulast%3DWainberg%26aufirst%3DM.%2BA.%26atitle%3DResistance%2520to%2520HIV%2520integrase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2012%26volume%3D7%26spage%3D401%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Geretti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armenia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccherini-Silberstein, F.</span><span> </span><span class="NLM_article-title">Emerging patterns and implications of HIV-1 integrase inhibitor resistance</span> <span class="citation_source-journal">Curr. Opin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1097%2FQCO.0b013e32835a1de7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=23086187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1OltbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2012&pages=677-686&author=A.+M.+Gerettiauthor=D.+Armeniaauthor=F.+Ceccherini-Silberstein&title=Emerging+patterns+and+implications+of+HIV-1+integrase+inhibitor+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging patterns and implications of HIV-1 integrase inhibitor resistance</span></div><div class="casAuthors">Geretti, Anna Maria; Armenia, Daniele; Ceccherini-Silberstein, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Infectious Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">677-686</span>CODEN:
                <span class="NLM_cas:coden">COIDE5</span>;
        ISSN:<span class="NLM_cas:issn">0951-7375</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review highlights recent data on the pathways of resistance that impact the clin. activity of first-generation and second-generation integrase inhibitors.  Recent findings: Raltegravir (RAL) and elvitegravir (EVG) are highly efficacious in first-line antiretroviral therapy, with small nos. of virol. failures obsd. in clin. trials.  Durable activity in treatment-experienced patients requires a fully supportive background regimen.  RAL and EVG show a low-to-moderate genetic barrier to resistance and extensive cross-resistance, which preclude their sequential use.  Resistance to dolutegravir (DTG) is not selected as readily in vitro and has not emerged in studies of treatment-naive patients to date.  Both in vitro and in vivo, DTG retains activity against several RAL and EVG resistant strains, but susceptibility is variably impaired by multiple mutations within the G148 pathway, which are common after RAL or EVG failure.  Cross-resistance can be partially overcome by doubling DTG dosing to twice daily, but durability of responses remains dependent on a supportive background regimen.  There is variability in the integrase gene of circulating HIV strains, which does not appear to reduce drug activity, although it may influence the emergence and evolution of integrase resistance.  Transmission of integrase resistance remains rare but surveillance is required.  Summary: Integrase inhibitors provide a potent option for the treatment of HIV infection.  Drug resistance remains a challenge, which may be partially overcome by the introduction of second-generation compds.  Prompt management of RAL and EVG failure is required to prevent the accumulation of multiple resistance mutations that reduce DTG susceptibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJNLh3j8EBULVg90H21EOLACvtfcHk0ljT4Cj9pGnqVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1OltbfE&md5=ad104b6dff368c146f9cef84a553506f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1097%2FQCO.0b013e32835a1de7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQCO.0b013e32835a1de7%26sid%3Dliteratum%253Aachs%26aulast%3DGeretti%26aufirst%3DA.%2BM.%26aulast%3DArmenia%26aufirst%3DD.%26aulast%3DCeccherini-Silberstein%26aufirst%3DF.%26atitle%3DEmerging%2520patterns%2520and%2520implications%2520of%2520HIV-1%2520integrase%2520inhibitor%2520resistance%26jtitle%3DCurr.%2520Opin.%2520Infect.%2520Dis.%26date%3D2012%26volume%3D25%26spage%3D677%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Katlama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R.</span><span> </span><span class="NLM_article-title">Dolutegravir for the treatment of HIV</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=523-530&author=C.+Katlamaauthor=R.+Murphy&title=Dolutegravir+for+the+treatment+of+HIV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatlama%26aufirst%3DC.%26aulast%3DMurphy%26aufirst%3DR.%26atitle%3DDolutegravir%2520for%2520the%2520treatment%2520of%2520HIV%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D523%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ballantyne, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, C. M.</span><span> </span><span class="NLM_article-title">Dolutegravir: first global approval</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1637</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=1627-1637&author=A.+D.+Ballantyneauthor=C.+M.+Perry&title=Dolutegravir%3A+first+global+approval"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallantyne%26aufirst%3DA.%2BD.%26aulast%3DPerry%26aufirst%3DC.%2BM.%26atitle%3DDolutegravir%253A%2520first%2520global%2520approval%26jtitle%3DDrugs%26date%3D2013%26volume%3D73%26spage%3D1627%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high antiviral potency against cells harboring raltegravir-resistant integrase mutants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1573</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401902n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1573-1582&author=X.+Z.+Zhaoauthor=S.+J.+Smithauthor=M.+Metifiotauthor=C.+Marchandauthor=Y.+Pommierauthor=S.+H.+Hughesauthor=T.+R.+Burke&title=4-Amino-1-hydroxy-2-oxo-1%2C8-naphthyridine-containing+compounds+having+high+antiviral+potency+against+cells+harboring+raltegravir-resistant+integrase+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm401902n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401902n%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3D4-Amino-1-hydroxy-2-oxo-1%252C8-naphthyridine-containing%2520compounds%2520having%2520high%2520antiviral%2520potency%2520against%2520cells%2520harboring%2520raltegravir-resistant%2520integrase%2520mutants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1573%26epage%3D1582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span> </span><span class="NLM_article-title">HCV NS5b RNA-dependent RNA polymerase inhibitors: From alpha, gamma-diketoacids to 4,5-dihydroxypyrimidine- or 3-methyl-5- hydroxypyrimidinonecarboxylic acids. Design and synthesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5336</span><span class="NLM_x">–</span> <span class="NLM_lpage">5339</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494669" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5336-5339&author=V.+Summaauthor=A.+Petrocchiauthor=V.+G.+Matassaauthor=M.+Talianiauthor=R.+Lauferauthor=R.+De+Francescoauthor=S.+Altamuraauthor=P.+Pace&title=HCV+NS5b+RNA-dependent+RNA+polymerase+inhibitors%3A+From+alpha%2C+gamma-diketoacids+to+4%2C5-dihydroxypyrimidine-+or+3-methyl-5-+hydroxypyrimidinonecarboxylic+acids.+Design+and+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm0494669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494669%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DTaliani%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DPace%26aufirst%3DP.%26atitle%3DHCV%2520NS5b%2520RNA-dependent%2520RNA%2520polymerase%2520inhibitors%253A%2520From%2520alpha%252C%2520gamma-diketoacids%2520to%25204%252C5-dihydroxypyrimidine-%2520or%25203-methyl-5-%2520hydroxypyrimidinonecarboxylic%2520acids.%2520Design%2520and%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5336%26epage%3D5339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paz, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span> </span><span class="NLM_article-title">4,5-Dihydroxypyrimidine carboxamides and <i>N</i>-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic rofiles in preclinical species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6646</span><span class="NLM_x">–</span> <span class="NLM_lpage">6649</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060854f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6646-6649&author=V.+Summaauthor=A.+Petrocchiauthor=V.+G.+Matassaauthor=C.+Gardelliauthor=E.+Muragliaauthor=M.+Rowleyauthor=O.+G.+Pazauthor=R.+Lauferauthor=E.+Monteagudoauthor=P.+Pace&title=4%2C5-Dihydroxypyrimidine+carboxamides+and+N-alkyl-5-hydroxypyrimidinone+carboxamides+are+potent%2C+selective+HIV+integrase+inhibitors+with+good+pharmacokinetic+rofiles+in+preclinical+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm060854f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060854f%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DPaz%26aufirst%3DO.%2BG.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26atitle%3D4%252C5-Dihydroxypyrimidine%2520carboxamides%2520and%2520N-alkyl-5-hydroxypyrimidinone%2520carboxamides%2520are%2520potent%252C%2520selective%2520HIV%2520integrase%2520inhibitors%2520with%2520good%2520pharmacokinetic%2520rofiles%2520in%2520preclinical%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6646%26epage%3D6649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Williams, P. D.; Venkatraman, S.; Langford, H. M.; Kim, B.; Booth, T. M.; Grobler, J. A.; Staas, D.; Ruzek, R. D.; Embrey, M. W.; Wiscount, C. M.; Lyle, T. A.</span><span> </span><span class="NLM_article-title">Preparation of 1-hydroxynaphthyridin-2(1<i>H</i>)-one derivatives as anti-HIV agents</span>. (<span class="NLM_publisher-name">Merck & Co., Inc.</span>) WO2008010964A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+D.+Williams&author=S.+Venkatraman&author=H.+M.+Langford&author=B.+Kim&author=T.+M.+Booth&author=J.+A.+Grobler&author=D.+Staas&author=R.+D.+Ruzek&author=M.+W.+Embrey&author=C.+M.+Wiscount&author=T.+A.+Lyle&title=Preparation+of+1-hydroxynaphthyridin-2%281H%29-one+derivatives+as+anti-HIV+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26atitle%3DPreparation%2520of%25201-hydroxynaphthyridin-2%25281H%2529-one%2520derivatives%2520as%2520anti-HIV%2520agents%26pub%3DMerck%2520%2526%2520Co.%252C%2520Inc%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Su, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeywickrema, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darke, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span> </span><span class="NLM_article-title">Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">7625</span><span class="NLM_x">–</span> <span class="NLM_lpage">7633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1128%2FJVI.00353-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=20484498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVejt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=7625-7633&author=H.-P.+Suauthor=Y.+Yanauthor=G.+S.+Prasadauthor=R.+F.+Smithauthor=C.+L.+Danielsauthor=P.+D.+Abeywickremaauthor=J.+C.+Reidauthor=H.+M.+Loughranauthor=M.+Kornienkoauthor=S.+Sharmaauthor=J.+A.+Groblerauthor=B.+Xuauthor=V.+Sardanaauthor=T.+J.+Allisonauthor=P.+D.+Williamsauthor=P.+L.+Darkeauthor=D.+J.+Hazudaauthor=S.+Munshi&title=Structural+basis+for+the+inhibition+of+RNase+H+activity+of+HIV-1+reverse+transcriptase+by+RNase+H+active+site-directed+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitors</span></div><div class="casAuthors">Su, Hua-Poo; Yan, Youwei; Prasad, G. Sridhar; Smith, Robert F.; Daniels, Christopher L.; Abeywickrema, Pravien D.; Reid, John C.; Loughran, H. Marie; Kornienko, Maria; Sharma, Sujata; Grobler, Jay A.; Xu, Bei; Sardana, Vinod; Allison, Timothy J.; Williams, Peter D.; Darke, Paul L.; Hazuda, Daria J.; Munshi, Sanjeev</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7625-7633</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">HIV/AIDS continues to be a menace to public health.  Several drugs currently on the market have successfully improved the ability to manage the viral burden in infected patients.  However, new drugs are needed to combat the rapid emergence of mutated forms of the virus that are resistant to existing therapies.  Currently, approved drugs target three of the four major enzyme activities encoded by the virus that are crit. to the HIV life cycle.  Although a no. of inhibitors of HIV RNase H activity have been reported, few inhibit by directly engaging the RNase H active site.  Here, we describe structures of naphthyridinone-contg. inhibitors bound to the RNase H active site.  This class of compds. binds to the active site via two metal ions that are coordinated by catalytic site residues, D443, E478, D498, and D549.  The directionality of the naphthyridinone pharmacophore is restricted by the ordering of D549 and H539 in the RNase H domain.  In addn., one of the naphthyridinone-based compds. was found to bind at a second site close to the polymerase active site and non-nucleoside/nucleotide inhibitor sites in a metal-independent manner.  Further characterization, using fluorescence-based thermal denaturation and a crystal structure of the isolated RNase H domain reveals that this compd. can also bind the RNase H site and retains the metal-dependent binding mode of this class of mols.  These structures provide a means for structurally guided design of novel RNase H inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofoAtMsynlGbVg90H21EOLACvtfcHk0ljn5jOiE2FOfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVejt77L&md5=67296baed7573ed339c9fcf985b2ff20</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1128%2FJVI.00353-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00353-10%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DH.-P.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DPrasad%26aufirst%3DG.%2BS.%26aulast%3DSmith%26aufirst%3DR.%2BF.%26aulast%3DDaniels%26aufirst%3DC.%2BL.%26aulast%3DAbeywickrema%26aufirst%3DP.%2BD.%26aulast%3DReid%26aufirst%3DJ.%2BC.%26aulast%3DLoughran%26aufirst%3DH.%2BM.%26aulast%3DKornienko%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DAllison%26aufirst%3DT.%2BJ.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DDarke%26aufirst%3DP.%2BL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DMunshi%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520RNase%2520H%2520activity%2520of%2520HIV-1%2520reverse%2520transcriptase%2520by%2520RNase%2520H%2520active%2520site-directed%2520inhibitors%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D7625%26epage%3D7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughran, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzek, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wai, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feuston, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecto, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, S. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahnck, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmelberger, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dornadula, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrin, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span> </span><span class="NLM_article-title">Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1<i>H</i>)-one scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6754</span><span class="NLM_x">–</span> <span class="NLM_lpage">6757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6754-6757&author=P.+D.+Williamsauthor=D.+D.+Staasauthor=S.+Venkatramanauthor=H.+M.+Loughranauthor=R.+D.+Ruzekauthor=T.+M.+Boothauthor=T.+A.+Lyleauthor=J.+S.+Waiauthor=J.+P.+Vaccaauthor=B.+P.+Feustonauthor=L.+T.+Ectoauthor=J.+A.+Flynnauthor=S.+D.+J.+Diauthor=D.+J.+Hazudaauthor=C.+M.+Bahnckauthor=A.+L.+Himmelbergerauthor=G.+Dornadulaauthor=R.+C.+Hrinauthor=K.+A.+Stillmockauthor=M.+V.+Witmerauthor=M.+D.+Millerauthor=J.+A.+Grobler&title=Potent+and+selective+HIV-1+ribonuclease+H+inhibitors+based+on+a+1-hydroxy-1%2C8-naphthyridin-2%281H%29-one+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DStaas%26aufirst%3DD.%2BD.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DLoughran%26aufirst%3DH.%2BM.%26aulast%3DRuzek%26aufirst%3DR.%2BD.%26aulast%3DBooth%26aufirst%3DT.%2BM.%26aulast%3DLyle%26aufirst%3DT.%2BA.%26aulast%3DWai%26aufirst%3DJ.%2BS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DFeuston%26aufirst%3DB.%2BP.%26aulast%3DEcto%26aufirst%3DL.%2BT.%26aulast%3DFlynn%26aufirst%3DJ.%2BA.%26aulast%3DDi%26aufirst%3DS.%2BD.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DBahnck%26aufirst%3DC.%2BM.%26aulast%3DHimmelberger%26aufirst%3DA.%2BL.%26aulast%3DDornadula%26aufirst%3DG.%26aulast%3DHrin%26aufirst%3DR.%2BC.%26aulast%3DStillmock%26aufirst%3DK.%2BA.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26atitle%3DPotent%2520and%2520selective%2520HIV-1%2520ribonuclease%2520H%2520inhibitors%2520based%2520on%2520a%25201-hydroxy-1%252C8-naphthyridin-2%25281H%2529-one%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6754%26epage%3D6757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Costi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzucoli Crucitti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scipione, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinzula, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tramontano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, R.</span><span> </span><span class="NLM_article-title">6-(1-Benzyl-1<i>H</i>-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8588</span><span class="NLM_x">–</span> <span class="NLM_lpage">8598</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401040b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8588-8598&author=R.+Costiauthor=M.+Metifiotauthor=F.+Espositoauthor=G.+Cuzzucoli+Crucittiauthor=L.+Pescatoriauthor=A.+Messoreauthor=L.+Scipioneauthor=S.+Tortorellaauthor=L.+Zinzulaauthor=C.+Marchandauthor=Y.+Pommierauthor=E.+Tramontanoauthor=R.+Di+Santo&title=6-%281-Benzyl-1H-pyrrol-2-yl%29-2%2C4-dioxo-5-hexenoic+acids+as+dual+inhibitors+of+recombinant+HIV-1+integrase+and+ribonuclease+H%2C+synthesized+by+a+parallel+synthesis+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401040b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401040b%26sid%3Dliteratum%253Aachs%26aulast%3DCosti%26aufirst%3DR.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DEsposito%26aufirst%3DF.%26aulast%3DCuzzucoli%2BCrucitti%26aufirst%3DG.%26aulast%3DPescatori%26aufirst%3DL.%26aulast%3DMessore%26aufirst%3DA.%26aulast%3DScipione%26aufirst%3DL.%26aulast%3DTortorella%26aufirst%3DS.%26aulast%3DZinzula%26aufirst%3DL.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DTramontano%26aufirst%3DE.%26aulast%3DDi%2BSanto%26aufirst%3DR.%26atitle%3D6-%25281-Benzyl-1H-pyrrol-2-yl%2529-2%252C4-dioxo-5-hexenoic%2520acids%2520as%2520dual%2520inhibitors%2520of%2520recombinant%2520HIV-1%2520integrase%2520and%2520ribonuclease%2520H%252C%2520synthesized%2520by%2520a%2520parallel%2520synthesis%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8588%26epage%3D8598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Esposito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tramontano, E.</span><span> </span><span class="NLM_article-title">Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors</span> <span class="citation_source-journal">Antivir. Chem. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.3851%2FIMP2690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVOis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=129-144&author=F.+Espositoauthor=E.+Tramontano&title=Past+and+future.+Current+drugs+targeting+HIV-1+integrase+and+reverse+transcriptase-associated+ribonuclease+H+activity%3A+single+and+dual+active+site+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitor</span></div><div class="casAuthors">Esposito, Francesca; Tramontano, Enzo</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Chemistry & Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">129-144, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">ACCHEH</span>;
        ISSN:<span class="NLM_cas:issn">0956-3202</span>.
    
            (<span class="NLM_cas:orgname">International Medical Press, Ltd.</span>)
        </div><div class="casAbstract">A review.  Catalytic HIV type-1 (HIV-1) integrase (IN) and RNase H (RNase H) domains belong to the polynucleotidyl transferase superfamily and are characterized by highly conserved motifs that coordinate two divalent Mg2+ cations and are attractive targets for new antiviral agents.  Several structural features of both domains are now available.  Drugs targeting the HIV-1 IN are currently approved for anti-HIV therapy, while no drug targeting the HIV-1 RNase H function is yet available.  This review describes HIV-1 IN and the RNase H function and structures, compds. targeting their active sites and dual inhibition as a new approach for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9vIiN5tSqELVg90H21EOLACvtfcHk0lhNYdob0ac0fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVOis70%253D&md5=a92ea5750f8353d3eb4215eb8e9ab551</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3851%2FIMP2690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3851%252FIMP2690%26sid%3Dliteratum%253Aachs%26aulast%3DEsposito%26aufirst%3DF.%26aulast%3DTramontano%26aufirst%3DE.%26atitle%3DPast%2520and%2520future.%2520Current%2520drugs%2520targeting%2520HIV-1%2520integrase%2520and%2520reverse%2520transcriptase-associated%2520ribonuclease%2520H%2520activity%253A%2520single%2520and%2520dual%2520active%2520site%2520inhibitors%26jtitle%3DAntivir.%2520Chem.%2520Chemother.%26date%3D2013%26volume%3D23%26spage%3D129%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes Stephen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke Terrence, R.,  Jr.</span><span> </span><span class="NLM_article-title">Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1<i>H</i>-isoindol-1-ones and 4,5-dihydroxy-1<i>H</i>-isoindole-1,3(2<i>H</i>)-diones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">–</span> <span class="NLM_lpage">2717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2714-2717&author=X.+Z.+Zhaoauthor=K.+Maddaliauthor=B.+C.+Vuauthor=C.+Marchandauthor=H.+Hughes+Stephenauthor=Y.+Pommierauthor=R.+Burke+Terrence&title=Examination+of+halogen+substituent+effects+on+HIV-1+integrase+inhibitors+derived+from+2%2C3-dihydro-6%2C7-dihydroxy-1H-isoindol-1-ones+and+4%2C5-dihydroxy-1H-isoindole-1%2C3%282H%29-diones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%2BStephen%26aufirst%3DH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%2BTerrence%26aufirst%3DR.%26atitle%3DExamination%2520of%2520halogen%2520substituent%2520effects%2520on%2520HIV-1%2520integrase%2520inhibitors%2520derived%2520from%25202%252C3-dihydro-6%252C7-dihydroxy-1H-isoindol-1-ones%2520and%25204%252C5-dihydroxy-1H-isoindole-1%252C3%25282H%2529-diones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2714%26epage%3D2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8735</span><span class="NLM_x">–</span> <span class="NLM_lpage">8744</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3010459" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8735-8744&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=T.+Taishiauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+1.+Molecular+design+and+establishment+of+an+advanced+two-metal+binding+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm3010459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010459%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25201.%2520Molecular%2520design%2520and%2520establishment%2520of%2520an%2520advanced%2520two-metal%2520binding%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8735%26epage%3D8744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikamiyama-Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1135</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301550c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVeltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1124-1135&author=T.+Kawasujiauthor=B.+A.+Johnsauthor=H.+Yoshidaauthor=J.+G.+Weatherheadauthor=T.+Akiyamaauthor=T.+Taishiauthor=Y.+Taodaauthor=M.+Mikamiyama-Iwataauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors.+2.+Bi-+and+tricyclic+derivatives+result+in+superior+antiviral+and+pharmacokinetic+profiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoyl Pyridone HIV-1 Integrase Inhibitors. 2. Bi- and Tricyclic Derivatives Result in Superior Antiviral and Pharmacokinetic Profiles</span></div><div class="casAuthors">Kawasuji, Takashi; Johns, Brian A.; Yoshida, Hiroshi; Weatherhead, Jason G.; Akiyama, Toshiyuki; Taishi, Teruhiko; Taoda, Yoshiyuki; Mikamiyama-Iwata, Minako; Murai, Hitoshi; Kiyama, Ryuichi; Fuji, Masahiro; Tanimoto, Norihiko; Yoshinaga, Tomokazu; Seki, Takahiro; Kobayashi, Masanori; Sato, Akihiko; Garvey, Edward P.; Fujiwara, Tamio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1124-1135</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work is a continuation of our initial discovery of a potent monocyclic carbamoyl pyridone human immunodeficiency virus type-1 (HIV-1) integrase inhibitor that displayed favorable antiviral and pharmacokinetic properties.  We report herein a series of bicyclic carbamoylpyridone (I; satd. and unsatd. bridge; R = e.g., alkoxyethyl) analogs to address conformational issues from our initial SAR studies.  This modification of the core unit succeeded to deliver low nanomolar potency in std. antiviral assays.  An addnl. hydroxyl substituent on the bicyclic scaffold provides remarkable improvement of antiviral efficacies against clin. relevant resistant viruses.  These findings led to addnl. cyclic tethering of the naked hydroxyl group resulting in tricyclic carbamoyl pyridone inhibitors (II; Y = O, N; n = 0-2; R' = e.g., alkyl, Ac, methanesulfonyl) to address remaining issues and deliver potential clin. candidates.  The tricyclic carbamoyl pyridone derivs. described herein served as the immediate leads in mols. to the next generation integrase inhibitor dolutegravir which is currently in late stage clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQLpPj5UB1TbVg90H21EOLACvtfcHk0lhNYdob0ac0fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVeltA%253D%253D&md5=4bfe919f8fdbbc84e346e3f01e084b70</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm301550c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301550c%26sid%3Dliteratum%253Aachs%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMikamiyama-Iwata%26aufirst%3DM.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors.%25202.%2520Bi-%2520and%2520tricyclic%2520derivatives%2520result%2520in%2520superior%2520antiviral%2520and%2520pharmacokinetic%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1124%26epage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Johns, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasuji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weatherhead, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temelkoff, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshinaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span> </span><span class="NLM_article-title">Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5901</span><span class="NLM_x">–</span> <span class="NLM_lpage">5916</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400645w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5901-5916&author=B.+A.+Johnsauthor=T.+Kawasujiauthor=J.+G.+Weatherheadauthor=T.+Taishiauthor=D.+P.+Temelkoffauthor=H.+Yoshidaauthor=T.+Akiyamaauthor=Y.+Taodaauthor=H.+Muraiauthor=R.+Kiyamaauthor=M.+Fujiauthor=N.+Tanimotoauthor=J.+Jeffreyauthor=S.+A.+Fosterauthor=T.+Yoshinagaauthor=T.+Sekiauthor=M.+Kobayashiauthor=A.+Satoauthor=M.+N.+Johnsonauthor=E.+P.+Garveyauthor=T.+Fujiwara&title=Carbamoyl+pyridone+HIV-1+integrase+inhibitors+3.+A+diastereomeric+approach+to+chiral+nonracemic+tricyclic+ring+systems+and+the+discovery+of+dolutegravir+%28S%2FGSK1349572%29+and+%28S%2FGSK1265744%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm400645w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400645w%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%2BA.%26aulast%3DKawasuji%26aufirst%3DT.%26aulast%3DWeatherhead%26aufirst%3DJ.%2BG.%26aulast%3DTaishi%26aufirst%3DT.%26aulast%3DTemelkoff%26aufirst%3DD.%2BP.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DTaoda%26aufirst%3DY.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DKiyama%26aufirst%3DR.%26aulast%3DFuji%26aufirst%3DM.%26aulast%3DTanimoto%26aufirst%3DN.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DS.%2BA.%26aulast%3DYoshinaga%26aufirst%3DT.%26aulast%3DSeki%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BN.%26aulast%3DGarvey%26aufirst%3DE.%2BP.%26aulast%3DFujiwara%26aufirst%3DT.%26atitle%3DCarbamoyl%2520pyridone%2520HIV-1%2520integrase%2520inhibitors%25203.%2520A%2520diastereomeric%2520approach%2520to%2520chiral%2520nonracemic%2520tricyclic%2520ring%2520systems%2520and%2520the%2520discovery%2520of%2520dolutegravir%2520%2528S%252FGSK1349572%2529%2520and%2520%2528S%252FGSK1265744%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5901%26epage%3D5916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Pratt, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDaniel, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maring, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kati, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlbrenner, W.</span><span> </span><span class="NLM_article-title">Inhibitors of HCV NS5B polymerase: synthesis and structure–activity relationships of <i>N</i>-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines</span> <span class="citation_source-journal">Bioor. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1577</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1016%2Fj.bmcl.2005.01.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=15745800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvF2ntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1577-1582&author=J.+K.+Prattauthor=P.+Donnerauthor=K.+F.+McDanielauthor=C.+J.+Maringauthor=W.+M.+Katiauthor=H.+Moauthor=T.+Middletonauthor=Y.+Liuauthor=T.+Ngauthor=Q.+Xieauthor=R.+Zhangauthor=D.+Montgomeryauthor=A.+Mollaauthor=D.+J.+Kempfauthor=W.+Kohlbrenner&title=Inhibitors+of+HCV+NS5B+polymerase%3A+synthesis+and+structure%E2%80%93activity+relationships+of+N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines</span></div><div class="casAuthors">Pratt, John K.; Donner, Pamela; McDaniel, Keith F.; Maring, Clarence J.; Kati, Warren M.; Mo, Hongmei; Middleton, Tim; Liu, Yaya; Ng, Teresa; Xie, Qinghua; Zhang, Rong; Montgomery, Debra; Molla, Akhteruzzaman; Kempf, Dale J.; Kohlbrenner, William</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1577-1582</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-1-Alkylamino and N-1-alkyloxy-4-hydroxyquinolon-3-yl benzothiadiazines were synthesized and evaluated as inhibitors of genotype 1 HCV polymerase.  The N-1-alkyloxy derivs. were not potent inhibitors, however N-1-alkylamino derivs. displayed comparable potency to carbon analogs.  Analogs with aliph. substituents were significantly more potent than those with benzylic substituents against genotype 1a polymerase.  The most potent inhibitors contained small alkyl or carbocyclic substituents and exhibited IC50's of 50-100 and 200-400 nM against genotype 1b and 1a HCV polymerase, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSYPV33mk65LVg90H21EOLACvtfcHk0lhbssNEkD6mAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvF2ntb4%253D&md5=6645dd292495b18bfdddd3093c419e32</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.01.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.01.071%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DDonner%26aufirst%3DP.%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DMaring%26aufirst%3DC.%2BJ.%26aulast%3DKati%26aufirst%3DW.%2BM.%26aulast%3DMo%26aufirst%3DH.%26aulast%3DMiddleton%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DNg%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DMontgomery%26aufirst%3DD.%26aulast%3DMolla%26aufirst%3DA.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DKohlbrenner%26aufirst%3DW.%26atitle%3DInhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines%26jtitle%3DBioor.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1577%26epage%3D1582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenova, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">2,3-Dihydro-6,7-dihydroxy-1<i>H</i>-isoindol-1-one-based HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070715d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=251-259&author=X.+Z.+Zhaoauthor=E.+A.+Semenovaauthor=B.+C.+Vuauthor=K.+Maddaliauthor=C.+Marchandauthor=S.+H.+Hughesauthor=Y.+Pommierauthor=T.+R.+Burke&title=2%2C3-Dihydro-6%2C7-dihydroxy-1H-isoindol-1-one-based+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm070715d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070715d%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DSemenova%26aufirst%3DE.%2BA.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3D2%252C3-Dihydro-6%252C7-dihydroxy-1H-isoindol-1-one-based%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D251%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Malet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delelis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valantin, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchertanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peytavin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouscadet, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katlama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcelin, A.-G.</span><span> </span><span class="NLM_article-title">Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1351</span><span class="NLM_x">–</span> <span class="NLM_lpage">1358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1351-1358&author=I.+Maletauthor=O.+Delelisauthor=M.-A.+Valantinauthor=B.+Montesauthor=C.+Soulieauthor=M.+Wirdenauthor=L.+Tchertanovauthor=G.+Peytavinauthor=J.+Reynesauthor=J.-F.+Mouscadetauthor=C.+Katlamaauthor=V.+Calvezauthor=A.-G.+Marcelin&title=Mutations+associated+with+failure+of+raltegravir+treatment+affect+integrase+sensitivity+to+the+inhibitor+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalet%26aufirst%3DI.%26aulast%3DDelelis%26aufirst%3DO.%26aulast%3DValantin%26aufirst%3DM.-A.%26aulast%3DMontes%26aufirst%3DB.%26aulast%3DSoulie%26aufirst%3DC.%26aulast%3DWirden%26aufirst%3DM.%26aulast%3DTchertanov%26aufirst%3DL.%26aulast%3DPeytavin%26aufirst%3DG.%26aulast%3DReynes%26aufirst%3DJ.%26aulast%3DMouscadet%26aufirst%3DJ.-F.%26aulast%3DKatlama%26aufirst%3DC.%26aulast%3DCalvez%26aufirst%3DV.%26aulast%3DMarcelin%26aufirst%3DA.-G.%26atitle%3DMutations%2520associated%2520with%2520failure%2520of%2520raltegravir%2520treatment%2520affect%2520integrase%2520sensitivity%2520to%2520the%2520inhibitor%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1351%26epage%3D1358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Delelis, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thierry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malet, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alloui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcelin, A.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchertanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouscadet, J.-F.</span><span> </span><span class="NLM_article-title">Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2009&pages=491-501&author=O.+Delelisauthor=S.+Thierryauthor=F.+Subraauthor=F.+Simonauthor=I.+Maletauthor=C.+Allouiauthor=S.+Sayonauthor=V.+Calvezauthor=E.+Deprezauthor=A.-G.+Marcelinauthor=L.+Tchertanovauthor=J.-F.+Mouscadet&title=Impact+of+Y143+HIV-1+integrase+mutations+on+resistance+to+raltegravir+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelelis%26aufirst%3DO.%26aulast%3DThierry%26aufirst%3DS.%26aulast%3DSubra%26aufirst%3DF.%26aulast%3DSimon%26aufirst%3DF.%26aulast%3DMalet%26aufirst%3DI.%26aulast%3DAlloui%26aufirst%3DC.%26aulast%3DSayon%26aufirst%3DS.%26aulast%3DCalvez%26aufirst%3DV.%26aulast%3DDeprez%26aufirst%3DE.%26aulast%3DMarcelin%26aufirst%3DA.-G.%26aulast%3DTchertanov%26aufirst%3DL.%26aulast%3DMouscadet%26aufirst%3DJ.-F.%26atitle%3DImpact%2520of%2520Y143%2520HIV-1%2520integrase%2520mutations%2520on%2520resistance%2520to%2520raltegravir%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D54%26spage%3D491%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naumova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3715</span><span class="NLM_x">–</span> <span class="NLM_lpage">3722</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi100130f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3715-3722&author=M.+Metifiotauthor=K.+Maddaliauthor=A.+Naumovaauthor=X.+Zhangauthor=C.+Marchandauthor=Y.+Pommier&title=Biochemical+and+pharmacological+analyses+of+HIV-1+integrase+flexible+loop+mutants+resistant+to+raltegravir"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi100130f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi100130f%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DNaumova%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DBiochemical%2520and%2520pharmacological%2520analyses%2520of%2520HIV-1%2520integrase%2520flexible%2520loop%2520mutants%2520resistant%2520to%2520raltegravir%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D3715%26epage%3D3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherepanov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Activities, crystal structures and molecular dynamics of dihydro-1<i>H</i>-isoindole derivatives, inhibitors of HIV-1 integrase</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb300471n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=209-217&author=M.+Metifiotauthor=K.+Maddaliauthor=B.+C.+Johnsonauthor=S.+Hareauthor=S.+J.+Smithauthor=X.+Z.+Zhaoauthor=C.+Marchandauthor=T.+R.+Burkeauthor=S.+H.+Hughesauthor=P.+Cherepanovauthor=Y.+Pommier&title=Activities%2C+crystal+structures+and+molecular+dynamics+of+dihydro-1H-isoindole+derivatives%2C+inhibitors+of+HIV-1+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fcb300471n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300471n%26sid%3Dliteratum%253Aachs%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DB.%2BC.%26aulast%3DHare%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DCherepanov%26aufirst%3DP.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DActivities%252C%2520crystal%2520structures%2520and%2520molecular%2520dynamics%2520of%2520dihydro-1H-isoindole%2520derivatives%252C%2520inhibitors%2520of%2520HIV-1%2520integrase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Jacobo-Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanni, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantillo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, P.</span><span> </span><span class="NLM_article-title">Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">6320</span><span class="NLM_x">–</span> <span class="NLM_lpage">6324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=6320-6324&author=A.+Jacobo-Molinaauthor=J.+Dingauthor=R.+G.+Nanniauthor=A.+D.+Clarkauthor=X.+Luauthor=C.+Tantilloauthor=R.+L.+Williamsauthor=G.+Kamerauthor=A.+L.+Ferrisauthor=P.+Clark&title=Crystal+structure+of+human+immunodeficiency+virus+type+1+reverse+transcriptase+complexed+with+double-stranded+DNA+at+3.0+A+resolution+shows+bent+DNA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobo-Molina%26aufirst%3DA.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DNanni%26aufirst%3DR.%2BG.%26aulast%3DClark%26aufirst%3DA.%2BD.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DTantillo%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DKamer%26aufirst%3DG.%26aulast%3DFerris%26aufirst%3DA.%2BL.%26aulast%3DClark%26aufirst%3DP.%26atitle%3DCrystal%2520structure%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520reverse%2520transcriptase%2520complexed%2520with%2520double-stranded%2520DNA%2520at%25203.0%2520A%2520resolution%2520shows%2520bent%2520DNA%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D6320%26epage%3D6324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Zhao, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metifiot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. R.,  Jr.</span><span> </span><span class="NLM_article-title">Bicyclic hydroxy-1<i>H</i>-pyrrolopyridine-trione containing HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1111%2Fj.1747-0285.2011.01270.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=22107736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlWrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=157-165&author=X.+Z.+Zhaoauthor=K.+Maddaliauthor=M.+Metifiotauthor=S.+J.+Smithauthor=B.+C.+Vuauthor=C.+Marchandauthor=S.+H.+Hughesauthor=Y.+Pommierauthor=T.+R.+Burke&title=Bicyclic+hydroxy-1H-pyrrolopyridine-trione+containing+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors</span></div><div class="casAuthors">Zhao, Xue Zhi; Maddali, Kasthuraiah; Metifiot, Mathieu; Smith, Steven J.; Vu, B. Christie; Marchand, Christophe; Hughes, Stephen H.; Pommier, Yves; Burke, Terrence R., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-165</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">HIV-1 integrase (IN) is a validated therapeutic target for the treatment of AIDS.  However, the emergence of resistance to raltegravir, the sole marketed FDA-approved IN inhibitor, emphasizes the need to develop second-generation inhibitors that retain efficacy against clin. relevant IN mutants.  We report herein bicyclic hydroxy-1H-pyrrolopyridinetriones as a new family of HIV-1 integrase inhibitors that were efficiently prepd. using a key "Pummerer cyclization deprotonation cycloaddn." cascade of imidosulfoxides.  In in vitro HIV-1 integrase assays, the analogs showed low micromolar inhibitory potencies with selectivity for strand transfer reactions as compared with 3'-processing inhibition.  A representative chlorofluorobenzyl hydroxypyrrolopyridinetrione retained most of its inhibitory potency against the three major raltegravir-resistant IN mutant enzymes, G140S/Q148H, Y143R, and N155H.  In antiviral assays employing viral vectors coding these IN mutants, the chlorofluorobenzyl hydroxypyrrolopyridinetrione was approx. 200- and 20-fold less affected than raltegravir against the G140S/Q148H and Y143R mutations, resp.  The representative chlorofluorobenzyl hydroxypyrrolopyridinetrione was affected approx. 10-fold less by the N155H mutation than raltegravir.  Hydroxypyrrolopyridinetriones are a novel structural class that may be further optimized to obtain HIV-1 integrase inhibitors capable of overcoming raltegravir resistance in HIV-1 strains possessing G140S/Q148H mutations in HIV-1 integrase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_-V1xazfn1LVg90H21EOLACvtfcHk0lhHEAkUolh-vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlWrtLY%253D&md5=467e940ff1b737e55486e8f578db6da0</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01270.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01270.x%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DX.%2BZ.%26aulast%3DMaddali%26aufirst%3DK.%26aulast%3DMetifiot%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DVu%26aufirst%3DB.%2BC.%26aulast%3DMarchand%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26atitle%3DBicyclic%2520hydroxy-1H-pyrrolopyridine-trione%2520containing%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D79%26spage%3D157%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Brachmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldbruegge, M.</span><span> </span><span class="NLM_article-title">A reverse genetic approach for generating gene replacement mutants in <i>Ustilago maydis</i></span> <span class="citation_source-journal">Mol. Genet. Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1007%2Fs00438-004-1067-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=15316769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BD2cXns1eqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2004&pages=216-226&author=A.+Brachmannauthor=J.+Koenigauthor=C.+Juliusauthor=M.+Feldbruegge&title=A+reverse+genetic+approach+for+generating+gene+replacement+mutants+in+Ustilago+maydis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A reverse genetic approach for generating gene replacement mutants in Ustilago maydis</span></div><div class="casAuthors">Brachmann, A.; Koenig, J.; Julius, C.; Feldbruegge, M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Genomics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-226</span>CODEN:
                <span class="NLM_cas:coden">MGGOAA</span>;
        ISSN:<span class="NLM_cas:issn">1617-4615</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">We describe a versatile strategy for generating gene replacement mutants in the phytopathogenic fungus Ustilago maydis.  The system includes the choice of 32 different insertion cassettes for genetic engineering purposes, such as gene disruption and more sophisticated insertions of reporter genes, heterologous promoters or combinations of the two.  PCR-amplified flanking sequences needed for homologous recombination are ligated to the resp. insertion cassettes via Sfi I sites.  As proof of principle we generated two replacement mutants in which the endogenous promoter of the pheromone gene mfa1 drives expression of the Green Fluorescent Protein gene (gfp).  Simultaneously, expression of the mfa1 ORF is controlled either by the carbon source-regulated crg1 promoter or the nitrogen source-regulated nar1 promoter.  In both cases gfp expression was pheromone-inducible and pheromone expression was only detected when the heterologous promoters were active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqckY_KQd6m37Vg90H21EOLACvtfcHk0lgl3Eu1mMQn_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXns1eqsLg%253D&md5=ae76faf1e45e14ef570b2cf60e8d67a3</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00438-004-1067-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00438-004-1067-8%26sid%3Dliteratum%253Aachs%26aulast%3DBrachmann%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DJ.%26aulast%3DJulius%26aufirst%3DC.%26aulast%3DFeldbruegge%26aufirst%3DM.%26atitle%3DA%2520reverse%2520genetic%2520approach%2520for%2520generating%2520gene%2520replacement%2520mutants%2520in%2520Ustilago%2520maydis%26jtitle%3DMol.%2520Genet.%2520Genomics%26date%3D2004%26volume%3D272%26spage%3D216%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ivetac, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swift, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naughton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span> </span><span class="NLM_article-title">Discovery of novel inhibitors of HIV-1 reverse transcriptase through virtual screening of experimental and theoretical ensembles</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5001908&amp;key=10.1111%2Fcbdd.12277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5001908&amp;key=24405985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5001908&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2014&pages=521-531&author=A.+Ivetacauthor=S.+E.+Swiftauthor=P.+L.+Boyerauthor=A.+Diazauthor=J.+Naughtonauthor=J.+A.+T.+Youngauthor=S.+H.+Hughesauthor=J.+A.+McCammon&title=Discovery+of+novel+inhibitors+of+HIV-1+reverse+transcriptase+through+virtual+screening+of+experimental+and+theoretical+ensembles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Inhibitors of HIV-1 Reverse Transcriptase Through Virtual Screening of Experimental and Theoretical Ensembles</span></div><div class="casAuthors">Ivetac, Anthony; Swift, Sara E.; Boyer, Paul L.; Diaz, Arturo; Naughton, John; Young, John A. T.; Hughes, Stephen H.; McCammon, J. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">521-531</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are potent anti-HIV chemotherapeutics.  Although there are FDA-approved NNRTIs, challenges such as the development of resistance have limited their utility.  Here, the authors describe the identification of novel NNRTIs through a combination of computational and exptl. approaches.  Based on the known plasticity of the NNRTI binding pocket (NNIBP), the authors adopted an ensemble-based virtual screening strategy: coupling receptor conformations from 10 x-ray crystal structures with 120 snapshots from a total of 480 ns of mol. dynamics (MD) trajectories.  A screening library of 2864 National Cancer Institute (NCI) compds. was built and docked against the ensembles in a hierarchical fashion.  Sixteen diverse compds. were tested for their ability to block HIV infection in human tissue cultures using a luciferase-based reporter assay.  Three promising compds. were further characterized, using a HIV-1 RT-based polymerase assay, to det. the specific mechanism of inhibition.  The authors found that 2 of the three compds. inhibited the polymerase activity of RT (with potency similar to the pos. control, the FDA-approved drug nevirapine).  Through a computational approach, the authors were able to discover two compds. which inhibit HIV replication and block the activity of RT, thus offering the potential for optimization into mature inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomuodBYpQtSbVg90H21EOLACvtfcHk0lgl3Eu1mMQn_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWmsrw%253D&md5=386dc35f21b1ebe52b51594c66b45f31</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12277%26sid%3Dliteratum%253Aachs%26aulast%3DIvetac%26aufirst%3DA.%26aulast%3DSwift%26aufirst%3DS.%2BE.%26aulast%3DBoyer%26aufirst%3DP.%2BL.%26aulast%3DDiaz%26aufirst%3DA.%26aulast%3DNaughton%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DJ.%2BA.%2BT.%26aulast%3DHughes%26aufirst%3DS.%2BH.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520novel%2520inhibitors%2520of%2520HIV-1%2520reverse%2520transcriptase%2520through%2520virtual%2520screening%2520of%2520experimental%2520and%2520theoretical%2520ensembles%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2014%26volume%3D83%26spage%3D521%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5001908&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-12%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm5001908%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5001908" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a9e19ba6d18b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
